<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="EN" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Chem Inf Model</journal-id><journal-id journal-id-type="iso-abbrev">J Chem Inf Model</journal-id><journal-id journal-id-type="pmc-domain-id">822</journal-id><journal-id journal-id-type="pmc-domain">acssd</journal-id><journal-id journal-id-type="publisher-id">ci</journal-id><journal-title-group><journal-title>Journal of Chemical Information and Modeling</journal-title></journal-title-group><issn pub-type="ppub">1549-9596</issn><issn pub-type="epub">1549-960X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>ACS AuthorChoice</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11815851</article-id><article-id pub-id-type="pmcid-ver">PMC11815851.1</article-id><article-id pub-id-type="pmcaid">11815851</article-id><article-id pub-id-type="pmcaiid">11815851</article-id><article-id pub-id-type="pmid">39823383</article-id><article-id pub-id-type="doi">10.1021/acs.jcim.4c01815</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Permeability Benchmarking:
Guidelines for Comparing <italic toggle="yes">in Silico</italic>, <italic toggle="yes">in Vitro</italic>, and <italic toggle="yes">in Vivo</italic> Measurements</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="ath1"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1894-7158</contrib-id><name name-style="western"><surname>Jorgensen</surname><given-names initials="C">Christian</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#8224;</xref><xref rid="aff2" ref-type="aff">&#8225;</xref><xref rid="notes1" ref-type="notes">&#182;</xref></contrib><contrib contrib-type="author" id="ath2"><name name-style="western"><surname>Linville</surname><given-names initials="RM">Raleigh M.</given-names></name><xref rid="aff3" ref-type="aff">&#167;</xref><xref rid="notes1" ref-type="notes">&#182;</xref></contrib><contrib contrib-type="author" id="ath3"><name name-style="western"><surname>Galea</surname><given-names initials="I">Ian</given-names></name><xref rid="aff4" ref-type="aff">&#8741;</xref></contrib><contrib contrib-type="author" id="ath4"><name name-style="western"><surname>Lambden</surname><given-names initials="E">Edward</given-names></name><xref rid="aff5" ref-type="aff">&#8869;</xref></contrib><contrib contrib-type="author" id="ath5"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1712-358X</contrib-id><name name-style="western"><surname>V&#246;gele</surname><given-names initials="M">Martin</given-names></name><xref rid="aff6" ref-type="aff">#</xref><xref rid="aff7" ref-type="aff">7</xref><xref rid="aff8" ref-type="aff">8</xref></contrib><contrib contrib-type="author" id="ath6"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7695-5215</contrib-id><name name-style="western"><surname>Chen</surname><given-names initials="C">Charles</given-names></name><xref rid="aff9" ref-type="aff">9</xref></contrib><contrib contrib-type="author" id="ath7"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4825-4088</contrib-id><name name-style="western"><surname>Troendle</surname><given-names initials="EP">Evan P.</given-names></name><xref rid="aff10" ref-type="aff">10</xref></contrib><contrib contrib-type="author" id="ath8"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7260-3255</contrib-id><name name-style="western"><surname>Ruggiu</surname><given-names initials="F">Fiorella</given-names></name><xref rid="aff11" ref-type="aff">11</xref></contrib><contrib contrib-type="author" id="ath9"><name name-style="western"><surname>Ulmschneider</surname><given-names initials="MB">Martin B.</given-names></name><xref rid="aff5" ref-type="aff">&#8869;</xref></contrib><contrib contrib-type="author" id="ath10"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9937-1562</contrib-id><name name-style="western"><surname>Schi&#248;tt</surname><given-names initials="B">Birgit</given-names></name><xref rid="aff2" ref-type="aff">&#8225;</xref></contrib><contrib contrib-type="author" id="ath11"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1028-4804</contrib-id><name name-style="western"><surname>Lorenz</surname><given-names initials="CD">Christian D.</given-names></name><xref rid="aff12" ref-type="aff">12</xref></contrib><aff id="aff1"><label>&#8224;</label>School
of Medicine, Pharmacy and Biomedical Sciences, Faculty of Science
&amp; Health, <institution>University of Portsmouth</institution>, Portsmouth PO1 2DT, Hampshire, <country>U.K.</country></aff><aff id="aff2"><label>&#8225;</label>Dept.
of Chemistry, <institution>Aarhus University</institution>, Langelandsgade, 140 8000 Aarhus C, <country>Denmark</country></aff><aff id="aff3"><label>&#167;</label>The
Picower Institute for Learning and Memory, <institution>Massachusetts Institute of Technology</institution>, 43 Vassar Street, Cambridge, Massachusetts 02139, <country>United States</country></aff><aff id="aff4"><label>&#8741;</label>Clinical
Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, <institution>University of Southampton</institution>, Southampton SO16 6YD, <country>U.K.</country></aff><aff id="aff5"><label>&#8869;</label>Dept.
of Chemistry, <institution>King&#8217;s College London</institution>, London WC2R 2LS, <country>U.K.</country></aff><aff id="aff6"><label>#</label>Department
of Computer Science, <institution>Stanford University</institution>, Stanford, California 94305, <country>United States</country></aff><aff id="aff7"><label>7</label>Department
of Molecular and Cellular Physiology, <institution>Stanford
University</institution>, Stanford, California 94305, <country>United States</country></aff><aff id="aff8"><label>8</label>Institute
for Computational and Mathematical Engineering, <institution>Stanford University</institution>, Stanford, California 94305, <country>United States</country></aff><aff id="aff9"><label>9</label>Synthetic
Biology Group, Research Laboratory of Electronics, <institution>Massachusetts Institute of Technology</institution>, Cambridge, Massachusetts 02139, <country>United States</country></aff><aff id="aff10"><label>10</label>Wellcome&#8722;Wolfson
Institute for Experimental Medicine, School of Medicine, Dentistry
and Biomedical Sciences, <institution>Queen&#8217;s
University Belfast</institution>, Belfast, County
Antrim, BT9 7BL, <country>Northern Ireland, U.K.</country></aff><aff id="aff11"><label>11</label><institution>Kimia
Therapeutics</institution>, 740 Heinz
Avenue, Berkeley, California 94710, <country>United States</country></aff><aff id="aff12"><label>12</label>Dept. of
Engineering, <institution>King&#8217;s College London</institution>, London WC2R 2LS, <country>U.K.</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email: <email>Christian.Jorgensen@port.ac.uk</email>.</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>01</month><year>2025</year></pub-date><pub-date pub-type="collection"><day>10</day><month>02</month><year>2025</year></pub-date><volume>65</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">481967</issue-id><fpage>1067</fpage><lpage>1084</lpage><history><date date-type="received"><day>12</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>06</day><month>01</month><year>2025</year></date><date date-type="rev-recd"><day>04</day><month>01</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>02</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-15 02:25:46.167"><day>15</day><month>02</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ci4c01815.pdf"/><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="ab-tgr1" position="float" orientation="portrait" xlink:href="ci4c01815_0004.jpg"/></p><p>Permeability is a
measure of the degree to which cells
can transport
molecules across biological barriers. Units of permeability are distance
per unit time (typically cm/s), where accurate measurements are needed
to define drug delivery in homeostasis and to model dysfunction occurring
during disease. This perspective offers a set of community-led guidelines
to benchmark permeability data across multidisciplinary approaches
and different biological contexts. First, we lay out the analytical
framework for three methodologies to calculate permeability: <italic toggle="yes">in silico</italic> assays using either transition-based counting
or the inhomogeneous-solubility diffusion approaches, <italic toggle="yes">in vitro</italic> permeability assays using cells cultured in 2D or 3D geometries,
and <italic toggle="yes">in vivo</italic> assays utilizing <italic toggle="yes">in situ</italic> brain perfusion or multiple time-point regression analysis. Then,
we demonstrate a systematic benchmarking of <italic toggle="yes">in silico</italic> to both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>,
depicting the ways in which each benchmarking is sensitive to the
choices of assay design. Finally, we outline seven recommendations
for best practices in permeability benchmarking and underscore the
significance of tailored permeability assays in driving advancements
in drug delivery research and development. Our exploration encompasses
a discussion of &#8220;generic&#8221; and tissue-specific biological
barriers, including the blood&#8211;brain barrier (BBB), which is
a major hurdle for the delivery of therapeutic agents into the brain.
By addressing challenges in reconciling simulated data with experimental
assays, we aim to provide insights essential for optimizing accuracy
and reliability in permeability modeling.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>National Institute of Neurological Disorders and Stroke</institution><institution-id institution-id-type="doi">10.13039/100000065</institution-id></institution-wrap></funding-source><award-id>F32NS128067</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>HORIZON EUROPE Marie Sklodowska-Curie Actions</institution><institution-id institution-id-type="doi">10.13039/100018694</institution-id></institution-wrap></funding-source><award-id>101023783</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ci4c01815</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ci4c01815</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Drug
delivery research is a multidisciplinary
field aimed at improving
the effectiveness and safety of therapeutic interventions. The challenges
to get a drug on the market are many and well evidenced elsewhere.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> One such challenge is to ensure the safe delivery
of the chemical agents to the site of action in the body. As pointed
out elsewhere,<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> between 2000 and 2015,
less than 14% of drugs at stage 1 clinical trial went on to receive
Food and Drug Administration (FDA) approval,<sup><xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref></sup> highlighting
the scale of the difficulties faced. Consequently, a myriad of precision
medicine <italic toggle="yes">in vitro</italic> or <italic toggle="yes">in vivo</italic> approaches
have been devised to predict drug delivery. However, routine permeability
estimations of therapeutic passage across key biological barriers
remain a formidable challenge.<sup><xref ref-type="bibr" rid="ref3">3</xref></sup></p><p><italic toggle="yes">In silico</italic> computational screening approaches have
been developed to overcome such challenges. For central nervous system
(CNS) delivery, early stage screening models including Lipinski&#8217;s
rule of five,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> as well the pharmacokinetic
predictor <italic toggle="yes">QikProp</italic> program of Schr&#246;dinger,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> enable the prediction on the probability of a
drug crossing membranes based on the chemical properties of a drug.
Additionally, emerging artificial intelligence (AI)-based cheminformatic
models are working to enhance the predictive capabilities by integrating
more complex patterns and interactions.<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> However, these predictive models are limited in providing detailed
insights into the physical process of solutes crossing biological
barriers.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup></p><p>To address the challenge of assessing
barrier penetration beyond
scaffold optimization, additional techniques are required. For transport
across other membranes, such as in kidney disease therapeutics, physiologically
based pharmacokinetic (PBPK) models have proven popular.<sup><xref ref-type="bibr" rid="ref9">9</xref>&#8722;<xref ref-type="bibr" rid="ref13">13</xref></sup> Similarly, a recent systems biology simulation approach integrates
pharmacokinetic models with molecular mechanics techniques to directly
incorporate tissue-specific vascular architectures as model inputs.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup></p><p>The use of tissue-specific permeability
(<italic toggle="yes">P</italic>) as
a precise measure of barrier penetration<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> has proven to be useful in the later stages of drug development.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref17">17</xref>&#8722;<xref ref-type="bibr" rid="ref20">20</xref></sup> It should be noted that permeability can be measured with <italic toggle="yes">in vitro</italic>, <italic toggle="yes">in vivo</italic>, or <italic toggle="yes">in silico</italic> methodologies, each with their own advantages, challenges and limitations.
In recent years, a focus on benchmarking simulated permeability values
to experimental permeabilities has been carried out extensively,<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref20">20</xref>&#8722;<xref ref-type="bibr" rid="ref26">26</xref></sup> with a particular focus on ensuring reproducible values. Despite
all this work, a systematic comparison of permeabilities still comes
with many caveats and is not a routine procedure. Thus, the purpose
of this review article is 2-fold: (1) to provide the theoretical underpinnings
of <italic toggle="yes">in silico</italic> permeability and how to benchmark to
these findings to <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> reference data, and (2) to raise understanding on the inherent challenges
in utilizing experimental data <italic toggle="yes">as is</italic>, including the
inherent statistical variance among different experimental benchmark
data sets. The reader is strongly encouraged to use this work as a
steppingstone to further examine nuances and underlying assumptions
in permeability calculations, beyond the blind use of these data sets.</p><sec id="sec1.1"><title>Complex
Membranes</title><p>Cell membranes contain a large variety
of lipid types and are crowded with embedded proteins. Their inherent
plasticity makes them essential for cell functioning. Complex cellular
membranes are characterized by a heterogeneous lateral organization
that is poorly understood. When molecules are simulated across complex
membranes, the time scales to accurately sample such processes tend
to be longer and computationally more demanding.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></p><p>A prime example of a complex membrane is the plasma
cell membrane, which separates the interior of the cell from the outside
environment and directly regulates the transport of materials.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> The plasma membrane contains hundreds of different
types of lipids,<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> which are organized
in a highly heterogeneous fashion. As such, the plasma membrane is
implicated in all aspects of endogenous drug delivery. Because a plasma
membrane is present across all cells, selective drug delivery has
sought to target more specialized membrane barriers, including the
blood&#8211;brain barrier endothelial membrane<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> for CNS drug delivery,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> and
the human <italic toggle="yes">Stratum Corneum</italic> portion of the outer skin
for transdermal drug delivery.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> These
plasma membranes display highly heterogeneous protein machinery across
cell types, apical versus basolateral surfaces, and disease states,
adding additional complexity for modeling.</p><p>The BBB represents
a critical interface between the bloodstream
and the CNS, regulating the transport of molecules and safeguarding
the brain from potentially harmful substances.<sup><xref ref-type="bibr" rid="ref32">32</xref>,<xref ref-type="bibr" rid="ref33">33</xref></sup> Dysfunction of the BBB is implicated in the pathogenesis of various
neurodegenerative and psychiatric disorders, including Alzheimer&#8217;s
disease, Parkinson&#8217;s disease, and depression.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> Thus, understanding the mechanisms underlying molecular
transport across the BBB is essential for developing effective treatments
for these and other debilitating conditions. While there are approximately
1700 FDA-approved drugs, the brain exposure is only known for around
200 of these compounds.<sup><xref ref-type="bibr" rid="ref35">35</xref>,<xref ref-type="bibr" rid="ref36">36</xref></sup> This knowledge gap
poses a significant barrier to repurposing existing drugs for CNS
disorders, highlighting the critical need for innovative technologies
capable of early identification of therapeutics with the potential
to penetrate the blood&#8211;brain barrier (BBB).<sup><xref ref-type="bibr" rid="ref37">37</xref></sup></p><p>Several experimental techniques were developed to
study complex
heterogeneous membranes such as the BBB, focusing on the lateral organization
of lipids, such as Time-of-Flight Secondary Ion Mass Spectrometry
(ToF-SIMS) imaging,<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> as well as the permeability
of solute through membranes, such as transwell assays.</p><p><italic toggle="yes">In silico</italic> methods to investigate membrane properties
have advanced rapidly in the past decade. Tools such as FATSLiM,<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> LiPyphilic,<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> PyLipID,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> MDTraj<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> and MDAnalysis<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> enable the examination of membrane properties
with atomistic granularity. The lipid diffusion constant and mean-square
displacement (MSD),<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> the membrane curvature
and the applied stress,<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> as well as their
dependence on lipid composition, the angular dynamics of embedded
membrane proteins,<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> the area per lipid
and bilayer thickness,<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> are all commonly
explored parameters. It is furthermore known that membrane composition
affects the permeabilization of biological materials.<sup><xref ref-type="bibr" rid="ref48">48</xref></sup> For this reason, moving away from model membranes to high-resolution
complex membrane compositions is important to get as close to the
experimental conditions.</p></sec><sec id="sec1.2"><title>Experimental Approaches to Vascular Permeability
and ADME</title><p>The ADME principle, denoting <italic toggle="yes">absorption,
distribution,
metabolism, and excretion</italic>, summarizes the internal processes
that describe how a drug moves throughout and is processed by the
body.<sup><xref ref-type="bibr" rid="ref49">49</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> Distribution describes how a drug moves
throughout the body, which is strongly dependent on blood flow, binding
to plasma proteins, and the permeability of capillaries. For example,
drugs that strongly bind to plasma proteins and/or display low permeability
across the BBB will be unable to exert effects within the CNS. A similar
concept, bioavailability, denotes the fraction of the originally administered
drug that arrives in systemic circulation and depends on the properties
of the substance and the mode of administration.<sup><xref ref-type="bibr" rid="ref49">49</xref>,<xref ref-type="bibr" rid="ref50">50</xref></sup> Bioavailability plays a crucial role in the functioning of drugs
regulated by key tissue barriers, be it intestinal, epithelial, or
endothelial, and so forth. Vascular permeability is key to where a
drug goes, and thus, what effect a drug has.</p><p>Numerous experiments
have been conducted to investigate membrane permeability across various
drug types. However, these approaches have inherent limitations and
are applicable only under specific conditions and for certain drug
types, including small molecules, peptides, recombinant proteins,
antibodies, and nanoparticles. Several critical parameters have been
identified, such as molecular volume, rotatable bonds, polar surface
area, and charged groups.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> Generally,
small, lipid soluble, and noncharged compounds exhibit better permeability
to cross cell membranes through passive transport, while charged small
molecules can permeate the membranes via active transport. Further
simplified <italic toggle="yes">in vitro</italic> systems can mimic the lipid bilayer
itself without use of cell culture, including lipid vesicles, supported
lipid bilayers, and droplet interface bilayers. These approaches have
rapidly advanced and have the advantage of being more directly comparable
to <italic toggle="yes">in silico</italic> measurements.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Peptides are sized between small molecules and proteins, and they
can traverse cell membranes either via suitable hydrophobicity and
a neutral charge or through receptor-mediated transcytosis. Peptide
permeation has been studied using both experimental and computational
methods,<sup><xref ref-type="bibr" rid="ref53">53</xref>,<xref ref-type="bibr" rid="ref54">54</xref></sup> and multiple experimental methods have been
widely used in peptide permeation studies, e.g., transwell assay,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> liposome permeation assay,<sup><xref ref-type="bibr" rid="ref56">56</xref>,<xref ref-type="bibr" rid="ref57">57</xref></sup> electrical conductivity<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref58">58</xref></sup> and microfluidic permeation
assay.<sup><xref ref-type="bibr" rid="ref52">52</xref>,<xref ref-type="bibr" rid="ref59">59</xref>&#8722;<xref ref-type="bibr" rid="ref61">61</xref></sup></p><p>In <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> we illustrate
a range of compound permeabilities for the case of establishing tissue-specific
permeability assay, where values are selected from assays that can
serve as a proxy or a model for CNS transport. This table showcases
the challenging and diverse set of assay types used to estimate these.
These challenges will be described in full detail in the section on <italic toggle="yes">Benchmark Challenges</italic>.</p><table-wrap id="tbl1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Dataset of Blood-Brain
Barrier Active
Compounds Ranked by <italic toggle="yes">Decreasing</italic> Permeability Value<xref rid="tbl1-fn1" ref-type="table-fn">a</xref></title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Molecule</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">MW (g&#160;mol<sup>&#8211;1</sup>)</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Log <italic toggle="yes">K</italic><sub>ow</sub></th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">P</italic><sub>app</sub> (cm&#160;s<sup>&#8211;1</sup>)</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">P</italic><sub>app</sub> Reference</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">In vitro</italic> model or <italic toggle="yes">in
vivo</italic> method</th></tr></thead><tbody><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Propanol</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">60.1</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">0.05</td><td style="border:none;" align="left" colspan="1" rowspan="1">3.30&#160;&#215;&#160;10<sup>&#8211;3</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Brahm 1983]<sup><xref ref-type="bibr" rid="ref62">62</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">RBC</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Ethanol</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">46.1</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">&#8211;0.31</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.10&#160;&#215;&#160;10<sup>&#8211;3</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Brahm 1983]<sup><xref ref-type="bibr" rid="ref62">62</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">RBC</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Nicotine</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">162.2</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.17</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.78&#160;&#215;&#160;10<sup>&#8211;4</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Garberg 2005]<sup><xref ref-type="bibr" rid="ref63">63</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2/MDCK</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Ketoprofen</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">254.3</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.12</td><td style="border:none;" align="left" colspan="1" rowspan="1">8.00&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Sun 2002]<sup><xref ref-type="bibr" rid="ref64">64</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Effexor</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">277.0</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.2</td><td style="border:none;" align="left" colspan="1" rowspan="1">6.00&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Hellinger 2012]<sup><xref ref-type="bibr" rid="ref65">65</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2/MDCK</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Bupropion</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">239.7</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.60</td><td style="border:none;" align="left" colspan="1" rowspan="1">4.75&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield 2007]<sup><xref ref-type="bibr" rid="ref66">66</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK-MDR1</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Diazepam</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">284.7</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.82</td><td style="border:none;" align="left" colspan="1" rowspan="1">4.60&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield
2007]<sup><xref ref-type="bibr" rid="ref66">66</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK-MDR1</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Naproxen</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">230.3</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.18</td><td style="border:none;" align="left" colspan="1" rowspan="1">3.90&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Pade 1998]<sup><xref ref-type="bibr" rid="ref67">67</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Clozapine</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">326.8</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.23</td><td style="border:none;" align="left" colspan="1" rowspan="1">3.90&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Yang 2024]<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">hCMECD/D3</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Risperdal</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">410.4</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.49</td><td style="border:none;" align="left" colspan="1" rowspan="1">3.00&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield 2007]<sup><xref ref-type="bibr" rid="ref66">66</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK-MDR1</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Dilantin</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">252.3</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.47</td><td style="border:none;" align="left" colspan="1" rowspan="1">2.70&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield 2007]<sup><xref ref-type="bibr" rid="ref66">66</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK-MDR1</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Ibuprofen</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">206.3</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">3.97</td><td style="border:none;" align="left" colspan="1" rowspan="1">2.70&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Wang
2019]<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Buspirone</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">422.0</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.95</td><td style="border:none;" align="left" colspan="1" rowspan="1">2.50&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Boateng 2023]<sup><xref ref-type="bibr" rid="ref69">69</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Ritalin</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">233.1</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">2.25</td><td style="border:none;" align="left" colspan="1" rowspan="1">2.47&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Yang
2016]<sup><xref ref-type="bibr" rid="ref70">70</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Caffeine</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">194.2</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">&#8211;0.07</td><td style="border:none;" align="left" colspan="1" rowspan="1">2.10&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Wang 2019]<sup><xref ref-type="bibr" rid="ref7">7</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Duloxetine</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">297.4</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">4.00</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.66&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Hellinger 2012]<sup><xref ref-type="bibr" rid="ref65">65</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2/MDCK</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Lacosamide</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">250.3</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">0.73</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.60&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Zhang 2013]<sup><xref ref-type="bibr" rid="ref71">71</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Glycerol</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">92.09</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">&#8211;1.8</td><td style="border:none;" align="left" colspan="1" rowspan="1">9.50&#160;&#215;&#160;10<sup>&#8211;6</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Shah
1989]<sup><xref ref-type="bibr" rid="ref72">72</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">BMEC</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Ethosuximide</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">141.2</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">0.38</td><td style="border:none;" align="left" colspan="1" rowspan="1">9.00&#160;&#215;&#160;10<sup>&#8211;6</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield 2007]<sup><xref ref-type="bibr" rid="ref66">66</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK-MDR1</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Sertraline</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">306.2</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">5.10</td><td style="border:none;" align="left" colspan="1" rowspan="1">2.10&#160;&#215;&#160;10<sup>&#8211;6</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield 2007]<sup><xref ref-type="bibr" rid="ref66">66</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK-MDR1</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Temozolomide</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">194.1</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">0.4</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.86&#160;&#215;&#160;10<sup>&#8211;6</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Avdeef 2012]<sup><xref ref-type="bibr" rid="ref73">73</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Brain perf
(3D)</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Atenolol</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">266.3</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">0.16</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.30&#160;&#215;&#160;10<sup>&#8211;6</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Adson 1995]<sup><xref ref-type="bibr" rid="ref74">74</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Sucrose</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">342.3</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">&#8211;3.7</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.00&#160;&#215;&#160;10<sup>&#8211;6</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Franke 1999]<sup><xref ref-type="bibr" rid="ref75">75</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Nadolol</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">309.4</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">0.81</td><td style="border:none;" align="left" colspan="1" rowspan="1">3.30&#160;&#215;&#160;10<sup>&#8211;7</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Yamashita
2000]<sup><xref ref-type="bibr" rid="ref76">76</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Doxorubicin</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">543.5</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.27</td><td style="border:none;" align="left" colspan="1" rowspan="1">1.00&#160;&#215;&#160;10<sup>&#8211;7</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Hellinger 2012]<sup><xref ref-type="bibr" rid="ref65">65</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Caco-2/MDCK</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1"><bold>Rhodamine 123</bold></td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">380.8</td><td style="border:none;" align="char" char="." colspan="1" rowspan="1">1.06</td><td style="border:none;" align="left" colspan="1" rowspan="1">0.80&#160;&#215;&#160;10<sup>&#8211;7</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Katt 2019]<sup><xref ref-type="bibr" rid="ref77">77</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">iPSC</td></tr></tbody></table><table-wrap-foot><fn id="tbl1-fn1"><label>a</label><p>The following
parameters are
supplied: (A) molecular weight (MW; g/mol), (B) octanol&#8211;water
partition coefficient (Log <italic toggle="yes">K</italic><sub>ow</sub>), (C) experimental
permeability <italic toggle="yes">P</italic><sub>app</sub> (cm s<sup>&#8211;1</sup>), (D) literature reference, (E) The models or methodologies employed
to measure the permeability are red blood cell (RBC), immortalized
cell line of human colorectal adenocarcinoma cells (Caco-2), Madin-Darby
canine kidney (MDCK), Madin-Darby canine kidney with Multidrug Resistance
Protein 1 expressed (MDCK-MDR1), rat brain perfusion (3D), Human Induced
pluripotent stem cells (iPSC)-derived cells, and Human Cerebral Microvascular
Endothelial Cell Line (hCMEC/D3) mono-culture cells.</p></fn></table-wrap-foot></table-wrap><sec id="sec1.2.1"><title>Permeability Estimations</title><sec id="sec1.2.1.1"><title>Diffusion
versus Solvent Drag Components to Flux of Solutes</title><p>Before
outlining the theoretical expressions for permeability <italic toggle="yes">in
silico</italic>, <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo,</italic> we note that the molecular flux used to describe permeability in <italic toggle="yes">in vitro</italic> experiments has both a diffusive component and
a solvent drag component (convective flow), both of which are important.
Dynamics in molecular dynamics simulations are typically diffusive,
and do not include convective flow in the setup, due to the system
size being smaller than those in the experiments. Solvent drag from
convective flow in experiments can be a major component to the permeability,
and is highly dependent on assay parameters like pressure gradients.<sup><xref ref-type="bibr" rid="ref78">78</xref>&#8722;<xref ref-type="bibr" rid="ref81">81</xref></sup> This difference in the theoretical formulation of permeability could
be one reason for the order of magnitude discrepancy between computational
and experimental permeabilities.</p></sec></sec></sec><sec id="sec1.3"><title>Paracellular and Transcellular
Permeability</title><p>While most
bilayer simulations or model setups <italic toggle="yes">in silico</italic> target
solely the transcellular (through-cell) pathway, with associated terminology <italic toggle="yes">P</italic><sub>transcellular</sub>, the paracellular permeability,
with associated terminology <italic toggle="yes">P</italic><sub>paracellular</sub> is another major component of <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> permeability taken by drugs through the extracellular
spaces between adjacent cells (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). In the context of vascular biology, distribution
of drugs can be strongly determined by the paracellular pathway. For
example, certain types of endothelial cells are fenestrated (kidneys,
intestines, endocrine glands) or discontinuous (liver, spleen, bone
marrow) which allows the free passage of large molecules, and serves
the function of facilitating drug filtration and absorption. Most
other organs contain continuous endothelial cells which express junctional
proteins that regulate permeability between them. The BBB has the
highest expression of these proteins, including tight junction protein
claudin-5, which is necessary to provide size-selective control over
paracellular permeability.<sup><xref ref-type="bibr" rid="ref82">82</xref></sup> Only very
small, nonpolar molecules like oxygen, carbon dioxide, and certain
lipid-soluble substances can cross the BBB paracellularly. Larger
molecules must use specific transporter systems, like glucose transporter-1
for glucose. Similarly, <italic toggle="yes">in vitro</italic> assays will be strongly
dependent on paracellular permeability including gaps in monolayers
of cells or differences in tight junction protein expression.<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref84">84</xref></sup> Indeed, tight junction protein expression dramatically alters <italic toggle="yes">in vitro</italic> measurements.<sup><xref ref-type="bibr" rid="ref83">83</xref>,<xref ref-type="bibr" rid="ref85">85</xref>,<xref ref-type="bibr" rid="ref86">86</xref></sup><italic toggle="yes">In vivo</italic> and <italic toggle="yes">in vitro</italic> systems measuring permeability that is dominated by paracellular
transport will be inherently inaccurate relative to <italic toggle="yes">in silico</italic> approaches, which rely on membrane diffusion. In <xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref> we depict the transcellular
pathway compared to the paracellular pathway.</p><fig id="fig1" position="float" orientation="portrait"><label>Figure 1</label><caption><p><bold>Transcellular and
paracellular pathways across cellular barriers.</bold> Schematic of
the apical endothelial cell membrane with embedded
glycoproteins (syndecans, CD44, P-gp). The glycocalyx extends beyond
the endothelial cell membrane and is made up of the chains of glycoproteins
radiating outward, which preorganize the transport of small-molecules
across the endothelial cell membrane.<sup><xref ref-type="bibr" rid="ref96">96</xref>&#8722;<xref ref-type="bibr" rid="ref98">98</xref></sup> Sulfates denoted by
&#11040;, and hyaluronic acid denotes by &#9734;. A transcellular
permeation event with permeability <italic toggle="yes">P</italic><sub>transcellular</sub> for a small molecule is depicted, as well as the substrate recognition
for solutes that are P-gp substrates, and their subsequent efflux.
The cell&#8211;cell tight junction is illustrated, which acts to
restrict the paracellular pathway. Note that on the basolateral surface
of the endothelial cells there is a specialized protein network termed
the basement membrane, which also can be a barrier to permeability.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr1" position="float" orientation="portrait" xlink:href="ci4c01815_0001.jpg"/></fig><p>In addition to discriminating between the transcellular
and paracellular
pathway, complex plasma membranes contain a variety of efflux pumps
and transporters among an array of embedded membrane proteins. The
endothelial membrane expresses P-glycoprotein (P-gp) efflux pumps
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>), a notable
example of ABC transporter, which are implicated in the multidrug
resistance to chemotherapeutics. This pump has received notable interest
since the 1980s,<sup><xref ref-type="bibr" rid="ref87">87</xref>&#8722;<xref ref-type="bibr" rid="ref92">92</xref></sup> but the problem of multidrug resistance of chemotherapeutics persists.<sup><xref ref-type="bibr" rid="ref93">93</xref>&#8722;<xref ref-type="bibr" rid="ref95">95</xref></sup> In the context of permeability, the P-gp pump lowers the effective
drug concentration inside the cell by efflux of the drug out of the
cell.</p><p>In the following sections, we lay out the theoretical
frameworks
for <italic toggle="yes">in silico</italic>, <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> permeability, specifically (A) transition-based
flux counting, (B) inhomogeneous-solubility diffusion framework, (C)
two-dimensional transwell assay, (D) three-dimensional microvessel
assay, (E) <italic toggle="yes">in situ</italic> brain perfusion, and (F) multiple
time-point regression analysis for clinical imaging. For <italic toggle="yes">in
silico</italic> approaches we refer to permeability as &#8220;simulated&#8221;
(<italic toggle="yes">P</italic><sub>sim</sub>), while for <italic toggle="yes">in vivo</italic>/<italic toggle="yes">vitro</italic> approaches we refer to permeability as apparent
(<italic toggle="yes">P</italic><sub>app</sub>).</p><sec id="sec1.3.1"><title>In Silico</title><p>Molecular
Dynamics (MD) simulations utilize
the numerical integration of Newton&#8217;s second law to forward-propagate
the positions and velocities of atoms of an atomic representation
of an assembly of atoms, thereby generating a trajectory of positions
of the atoms of the system.<sup><xref ref-type="bibr" rid="ref99">99</xref>&#8722;<xref ref-type="bibr" rid="ref102">102</xref></sup> The term &#8220;system&#8221; or &#8220;simulation
box&#8221; here can denote any biological assembly, e.g. a cell-mimetic
assembly, consisting of a model membrane, the relevant transmembrane
proteins, solvent and background salt concentration. The use of MD
simulations with a force field (FF) description of the solvated membrane
has proven to be a popular system representation for calculating <italic toggle="yes">in silico</italic> permeability (<italic toggle="yes">P</italic>) values,<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref103">103</xref></sup> and can be used to investigate the free energy of drug permeation
across the transcellular pathway. MD simulations have been used to
study a wide range of membrane types,<sup><xref ref-type="bibr" rid="ref104">104</xref>&#8722;<xref ref-type="bibr" rid="ref108">108</xref></sup> including plasma and mammalian membrane
models. One of the main bottlenecks in using <italic toggle="yes">in silico</italic> techniques lie in the shift between the available computational
sampling (ns to &#956;s) and the inherent biological time scales
for small-molecule permeation (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Most of the top-selling FDA approved drugs<sup><xref ref-type="bibr" rid="ref109">109</xref></sup> have CNS permeabilities of &#8764;10<sup>&#8211;6</sup> cm s<sup>&#8211;1</sup> and below. This renders the real-time simulation
time (<italic toggle="yes">t</italic><sub>computing</sub>; months) of a single
GPU computationally intractable, as it corresponds to <italic toggle="yes">t</italic><sub>computing</sub> values on the order of &#8764;10 to 100 months
for a successful calculation. To overcome this issue, the development
of enhanced sampling techniques such as umbrella sampling,<sup><xref ref-type="bibr" rid="ref110">110</xref></sup> metadynamics,<sup><xref ref-type="bibr" rid="ref111">111</xref></sup> adaptive biasing force (ABF)<sup><xref ref-type="bibr" rid="ref112">112</xref></sup> and steered
MD,<sup><xref ref-type="bibr" rid="ref113">113</xref></sup> have proven instrumental.<sup><xref ref-type="bibr" rid="ref114">114</xref>,<xref ref-type="bibr" rid="ref115">115</xref></sup></p><fig id="fig2" position="float" orientation="portrait"><label>Figure 2</label><caption><p><bold>Basics of transition-based counting approaches for permeability.</bold> (A) Real computational time in calendar months as a function of
the experimental drug permeability (<italic toggle="yes">P</italic><sub>app</sub>) for the example of BBB permeation. This is obtained as a back-calculation<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> in which the experimental permeability is input
into <xref rid="eq6" ref-type="disp-formula">eq <xref rid="eq6" ref-type="disp-formula">6</xref></xref> to calculate
the expected simulation rate constant <italic toggle="yes">k</italic>, and consequently,
the time <italic toggle="yes">t</italic> (<italic toggle="yes">t</italic> = <italic toggle="yes">N</italic><sub>event</sub>/<italic toggle="yes">k</italic>). The time <italic toggle="yes">t</italic> refers to the time (months) to simulate solute transport at 37 &#176;C
using a modern GPU. The system setup for such a benchmark calculation
is a solution volume of &#8764;100 nm<sup>3</sup> and with a bilayer
area of &#8764;25 nm<sup>2</sup>. For purposes of benchmarking, we
assume that a minimum of 100 translocation events are required to
achieve steady-state permeability. This is an estimate we found to
provide plateau values of <italic toggle="yes">k</italic> for our compound set.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup> A benchmark of &#8764;100 ns
per day is assumed. The experimental values used to back-calculate
to the real computational time are (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>) span a range from &#8764;10<sup>&#8211;7</sup> cm s<sup>&#8211;1</sup> (slowest) to &#8764;10<sup>&#8211;3</sup> cm s<sup>&#8211;1</sup> (fastest). (B) Transitions illustrated
for the case of ethanol permeating across a complex membrane in an
unbiased MD simulation, and for which we assume that passive diffusion
to be the primary mechanism of transport. (C) Molar rate constant
for ethanol throughout the MD simulation, revealing the time needed
to converge rate estimates as an input to the permeability calculation.
Adapted from ref (<xref ref-type="bibr" rid="ref8">8</xref>). Copyright 2021 ACS.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr2" position="float" orientation="portrait" xlink:href="ci4c01815_0002.jpg"/></fig><p>When applying MD simulations
specifically to the
problem of calculating
permeabilities, several procedures have been developed for use with
metadynamics<sup><xref ref-type="bibr" rid="ref116">116</xref>,<xref ref-type="bibr" rid="ref117">117</xref></sup> and ABF,<sup><xref ref-type="bibr" rid="ref20">20</xref>,<xref ref-type="bibr" rid="ref106">106</xref></sup> among others. These methods do not directly provide transport rates
without a reweighting of the resulting ensemble or inferences through
an inhomogeneous-solubility diffusion (ISD) framework.<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> Unbiased all-atom MD simulations provide detailed
insights into the molecular mechanisms of transport across the BBB
without the need for <italic toggle="yes">a priori</italic> knowledge of the permeation
pathway or constrained coordinate systems. Kinetics can be calculated
from the transition-based counting (TBC) approach, but this still
requires simulation times in the tens to hundreds of microseconds
per drug partition to achieve converged estimates at 37 &#176;C. This
is currently beyond the limit of realistic sampling for routine MD
simulations. Other methodologies for permeability have only been parametrized
for the fast regime (permeability, <italic toggle="yes">P</italic> &gt; 10<sup>&#8211;5</sup> cm s<sup>&#8211;1</sup>).<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> The recent
development of specialized supercomputing machines such as Anton,
Anton2 and Anton3 systems has made unbiased MD simulations at the
millisecond time scales routinely possible,<sup><xref ref-type="bibr" rid="ref118">118</xref>&#8722;<xref ref-type="bibr" rid="ref120">120</xref></sup> but the democratized access to such machines is still not routine,
and as such, enhanced sampling techniques are still required for users
with access to small numbers of GPUs.</p><p>We describe two approaches
to incorporate enhanced-sampling simulations,
first the TBC framework, and second, the ISD framework, for transcellular
permeability.</p><sec id="sec1.3.1.1"><title>Transition-Based Counting (TBC)</title><p>With this methodology,
the small-molecule permeability is modeled by counting the number
of transport events through planes perpendicular to the bilayer located
at either interface. In practice we define inward-cell and outward-cell
transport planes, with the number of transport events (<italic toggle="yes">N</italic><sub>event</sub>) given by the sum of the inward (<italic toggle="yes">N</italic><sub>i</sub>) and outward (<italic toggle="yes">N</italic><sub>0</sub>) transfers:<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m001.jpg"/><label>1</label></disp-formula></p><p>The rate constant, <italic toggle="yes">k</italic>, for translocation across
the bilayer is calculated from
unbiased MD simulations of spontaneous trans-bilayer solute crossing
as the ratio of the total number of transport events observed during
a simulation by the simulation time:<disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m002.jpg"/><label>2</label></disp-formula></p><p>It is common to use
a molar rate constant (<italic toggle="yes">r = k</italic>/<italic toggle="yes">N</italic><sub><italic toggle="yes">A</italic></sub>) in calculations.</p><p>We proceed to outline
the derivation for the expression of <italic toggle="yes">P</italic><sub>sim</sub>. In the diffusive regime of Fick&#8217;s
law, the solute flux <italic toggle="yes">J</italic> (mol cm<sup>&#8211;2</sup> s<sup>&#8211;1</sup>) for transition events per an area patch in
unit time can be expressed in terms of the simulated permeability <italic toggle="yes">P</italic><sub>sim</sub> (cm s<sup>&#8211;1</sup>) and the concentration
difference between the two sides of the membrane:<disp-formula id="eq3"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m003.jpg"/><label>3</label></disp-formula>where &#916;<italic toggle="yes">C</italic> = <italic toggle="yes">C</italic><sub>0</sub> &#8211; <italic toggle="yes">C</italic><sub>i</sub>, and <italic toggle="yes">C</italic><sub>i</sub> (mol cm<sup>&#8211;3</sup>), <italic toggle="yes">C</italic><sub>0</sub> are the concentrations on either
side of the membrane. Due to the semi-isotropic pressure coupling
imposed by the simulation engine with e.g. the Parrinello&#8211;Rahman
barostat,<sup><xref ref-type="bibr" rid="ref121">121</xref></sup> in which the (XY)-plane of
the box is allowed to relax independently of the (Z)-plane, the box
volume, <italic toggle="yes">V</italic>, and area of the bilayer patch, <italic toggle="yes">A</italic>, will vary during the simulation and need to be averaged. <italic toggle="yes">P</italic><sub>sim</sub> is then obtained from <xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref>, by estimation of the flux <italic toggle="yes">J</italic>, which itself can be obtained as the ratio of the rate <italic toggle="yes">k</italic> (s<sup>&#8211;1</sup>) per unit molar area (<italic toggle="yes">N</italic><sub><italic toggle="yes">A</italic></sub><italic toggle="yes">A</italic>; mol<sup>&#8211;1</sup> cm<sup>2</sup>):<disp-formula id="eq4"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m004.jpg"/><label>4</label></disp-formula>where <italic toggle="yes">N</italic><sub><italic toggle="yes">A</italic></sub> is Avogadro&#8217;s constant. This leads
to a permeability expression of<disp-formula id="eq5"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m005.jpg"/><label>5</label></disp-formula>Here <italic toggle="yes">C</italic> is
the equilibrium concentration of solute in the solvent, which applies
to converged simulations. Because the <italic toggle="yes">in silico</italic> permeability
is calculated for a single apical membrane crossing, the factor of
2 arises to account for the both the forward and backward direction
of these crossing events between the two compartments of the simulation
and prevents overcounting, something which is not occurring for the
supported lipid bilayers in the <italic toggle="yes">in vitro</italic> transwell
assay. For this derivation, the transport across the cytosol is assumed
to be much faster (<italic toggle="yes">k</italic><sub>cytosol</sub> &#8811; <italic toggle="yes">k</italic>).<disp-formula id="eq6"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m006.jpg"/><label>6</label></disp-formula></p><p>MD simulations allow
access to transport properties as a function
of the temperature of the system, such as the diffusion constant for
a small-molecule. Calculation of such properties is nontrivial and
is associated with a number of pitfalls explained elsewhere.<sup><xref ref-type="bibr" rid="ref122">122</xref>,<xref ref-type="bibr" rid="ref123">123</xref></sup> In <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> we provide
an example of the workflow and time constraints for MD simulations
used for permeability estimation.</p><p>Similarly, the use of temperature-enhanced
MD for estimating transport
properties such as the permeability<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> is
not a routine procedure and requires careful reweighting of the transport
model to recover kinetics at 37 &#176;C. Other approaches such as
ABF or Umbrella Sampling require a Bayesian <italic toggle="yes">posthoc</italic> correction.<sup><xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref125">125</xref>,<xref ref-type="bibr" rid="ref126">126</xref></sup></p></sec><sec id="sec1.3.1.2"><title>Inhomogeneous Solubility Diffusion (ISD) Framework and Diffusion
Estimation</title><p>The ISD framework (<xref rid="eq7" ref-type="disp-formula">eq <xref rid="eq7" ref-type="disp-formula">7</xref></xref>) is a popular methodology to calculate <italic toggle="yes">P</italic><sub>sim</sub> (cm s<sup>&#8211;1</sup>) from biased simulations,
as demonstrated by Marrink et al. for water permeation.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref127">127</xref></sup> Uses have been shown with ABF,<sup><xref ref-type="bibr" rid="ref106">106</xref>,<xref ref-type="bibr" rid="ref125">125</xref></sup> metadynamics<sup><xref ref-type="bibr" rid="ref117">117</xref></sup> and umbrella sampling,<sup><xref ref-type="bibr" rid="ref128">128</xref></sup> in which the permeability is calculated from the position-dependent
diffusion <italic toggle="yes">D</italic>(<italic toggle="yes">z</italic>) and the free energy
&#916;<italic toggle="yes">G</italic>(<italic toggle="yes">z</italic>) along the transition
coordinate <italic toggle="yes">z</italic>, and the permeability directly follows
from solving the Smoluchowski equation under stationary conditions:<disp-formula id="eq7"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m007.jpg"/><label>7</label></disp-formula></p><p>This
approach has been
widely covered elsewhere.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref125">125</xref>,<xref ref-type="bibr" rid="ref126">126</xref></sup> One of the key challenges of
these methods is the recognized difficulty to converge such calculations
for heterogeneous membranes. Recently, statistical mechanical frameworks
based on the Green&#8211;Kubo linear response theory have been applied
to calculate <italic toggle="yes">P</italic><sub>sim</sub>.<sup><xref ref-type="bibr" rid="ref129">129</xref></sup></p><p>One of the main requirements for using the ISD framework
is a viable
method to obtain the diffusion coefficients. One such approach employs
Bayesian inference to obtain a consistent joint solution of <italic toggle="yes">D</italic>(<italic toggle="yes">z</italic>) and &#916;<italic toggle="yes">G</italic>(<italic toggle="yes">z</italic>).<sup><xref ref-type="bibr" rid="ref122">122</xref>,<xref ref-type="bibr" rid="ref130">130</xref></sup> This class of methods is compatible
with any kind of bias potential, including time-dependent approaches
like metadynamics<sup><xref ref-type="bibr" rid="ref111">111</xref>,<xref ref-type="bibr" rid="ref131">131</xref>,<xref ref-type="bibr" rid="ref132">132</xref></sup> or ABF.<sup><xref ref-type="bibr" rid="ref126">126</xref></sup> The challenge of this approach
is its assumption of overdamped Brownian motion, which is not always
valid, and its dependence on a time step parameter that is difficult
to determine.<sup><xref ref-type="bibr" rid="ref106">106</xref></sup> While enhanced sampling
techniques remain highly useful and extremely popular, they still
require correction procedures to obtain the unbiased kinetics. The
position-dependent diffusion coefficient <italic toggle="yes">D</italic>(<italic toggle="yes">z</italic>)&#8212;though less dominant in <xref rid="eq7" ref-type="disp-formula">eq <xref rid="eq7" ref-type="disp-formula">7</xref></xref>&#8212;can substantially influence the results
due to the challenges in reliably estimating it.<sup><xref ref-type="bibr" rid="ref106">106</xref></sup></p><p>In neat solvents, diffusion coefficients can be calculated
from
the mean squared displacement (via the Einstein&#8211;Smoluchowski
equation) or from velocity autocorrelation functions (via Green&#8211;Kubo
relations). Within a lipid membrane, however, the asymmetries and
large free-energy barriers preclude the approximation of the solute&#8217;s
motion as a random walk, making these methods difficult to apply.<sup><xref ref-type="bibr" rid="ref133">133</xref></sup> Using a force autocorrelation method<sup><xref ref-type="bibr" rid="ref134">134</xref></sup> avoids this problem but requires constraining
the solute&#8217;s position along <italic toggle="yes">z</italic>, which usually
necessitates additional simulations. Since all these methods have
their own advantages and disadvantages, choosing the right one usually
depends on the free-energy algorithm and should be guided by optimizing
the synergies between them to minimize the overall simulation effort.</p></sec></sec><sec id="sec1.3.2"><title>In Vitro</title><p>Experimentally, the customary method for measuring
the transcellular permeability coefficient is the <italic toggle="yes">in vitro</italic> transwell assay,<sup><xref ref-type="bibr" rid="ref135">135</xref></sup> which uses a cell
support system in which endothelial cells are cultured to form a confluent
monolayer.<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref136">136</xref>&#8722;<xref ref-type="bibr" rid="ref138">138</xref></sup> The role of the membrane is to support the cell layer mechanically,
without acting as a significant diffusion barrier. To meet these requirements,
these membranes have pores that are large enough to not restrict transport
but small enough to enable cells to form monolayers (0.4 &#956;m
pores are very common). The membrane is then placed between two fluid
compartments so that any flux of solutes from one compartment to the
other must pass through the cell layer.</p><p>The apparent permeability
(<italic toggle="yes">P</italic><sub>app</sub>) of the drug is determined by measuring
the amount of the molecule that crosses the monolayer.<sup><xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref></sup> The molecular transport is calculated using a tracer flux assay,
in which the molecular movement is tracked, which is usually done
in the absence of hydrostatic or osmotic pressure gradients by having
the same buffer composition and fluid height between the two chambers;
thus, diffusive mechanisms will dominate and convective flux is minimal.
Fluorescent compounds are commonly used for these assays as their
concentration can be measured using microscopy or a plate reader,
but liquid chromatography-tandem mass spectrometry can be used for
nonfluorescent compounds. Many different cells are used for this assay.
Many cell sources are used to model BBB permeability including Madin&#8211;Darby
Canine Kidney (MDCK) or Caco-2 cells,<sup><xref ref-type="bibr" rid="ref139">139</xref>,<xref ref-type="bibr" rid="ref140">140</xref></sup> primary human
brain microvascular endothelial cell (BMECs),<sup><xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref124">124</xref></sup> and BMEC-like cells derived from induced pluripotent stem cells.<sup><xref ref-type="bibr" rid="ref141">141</xref></sup> Dramatic permeability differences are observed
across these cellular models, due to differences in tight junction
protein expression,<sup><xref ref-type="bibr" rid="ref144">144</xref></sup> differences in epithelial
versus endothelial nature of the cells, and differences in efflux
pump expression.<sup><xref ref-type="bibr" rid="ref142">142</xref></sup></p><p>The data obtained
from these experiments may then be compared to <italic toggle="yes">in silico</italic> simulations of transcellular transport to gain
insights into the mechanisms of BBB permeability.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref20">20</xref>&#8722;<xref ref-type="bibr" rid="ref26">26</xref></sup> However, the choice of cell types and experimental conditions can
significantly influence assay outcomes, underscoring the need for
standardized methodologies and quality control measures. The work
of Wong et al.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> succinctly summarizes
the experimental procedure. We start the derivation from Fick&#8217;s
law of diffusion (<xref rid="eq8" ref-type="disp-formula">eq <xref rid="eq8" ref-type="disp-formula">8</xref></xref>), which governs the solute flux. Let <italic toggle="yes">J</italic> denote the
solute flux, expressed in units of mol m<sup>&#8211;2</sup> s<sup>&#8211;1</sup>, <italic toggle="yes">D</italic> denotes the diffusion constant
of the solute, which is dependent on intrinsic (i.e., size of solute)
and extrinsic (i.e., temperature) parameters, and is expressed in
units of m<sup>2</sup> s<sup>&#8211;1</sup>. Let d<italic toggle="yes">C</italic>/d<italic toggle="yes">x</italic> denote the concentration gradient in ((mol m<sup>&#8211;3</sup>)/m). In Fick&#8217;s Law, the minus sign indicates
that solute is transported in the direction of decreasing concentration:<disp-formula id="eq8"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m008.jpg"/><label>8</label></disp-formula></p><p>This calculation can
be simplified to define the flux (<italic toggle="yes">J</italic>) in units mol
cm<sup>&#8211;2</sup> s<sup>&#8211;1</sup> across a permeable membrane
by assuming steady-state diffusion (constant
concentration gradient) and that the membrane is thin (no complex
gradient). <italic toggle="yes">P</italic> is the permeability coefficient (cm
s<sup>&#8211;1</sup>), and &#916;<italic toggle="yes">C</italic> is the concentration
gradient (mol cm<sup>&#8211;3</sup>).<disp-formula id="eq9"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m009.jpg"/><label>9</label></disp-formula></p><sec id="sec1.3.2.1"><title>Two-Dimensional Transwell Assay</title><p>A Transwell forms a
permeable membrane containing a cell monolayer with area <italic toggle="yes">A</italic> that is separated by an apical and basolateral chamber with volumes
of <italic toggle="yes">V</italic><sub>apical</sub> and <italic toggle="yes">V</italic><sub>basolateral</sub>, respectively, as depicted in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A. To measure permeability,
a compound of known concentration (<italic toggle="yes">C</italic>) is placed in
a chamber to establish a concentration gradient. Typically, this is
done by replacing media from the apical chamber. After media is replaced,
solute will transport into the basolateral chamber eventually reaching
a plateau based on the differences in volume between the chambers
(it will plateau at 50% of initial concentration if the reservoirs
are the same volume). In practice, this means that measurements should
be collected in the linear regime of transport to satisfy steady-state
assumptions. To identify the linear regime, time course studies are
usually conducted to identify when flux starts to plateau (this occurs
much more rapidly for high permeability solutes). Over time, fluids
in the basolateral chamber are collected and replaced with fresh buffer
to re-establish a concentration gradient and to measure the concentration
over time.</p><fig id="fig3" position="float" orientation="portrait"><label>Figure 3</label><caption><p><italic toggle="yes">In vitro</italic><bold>measurements of permeability.</bold> (A) Schematic of 2D Transwell assay for measuring permeability of
cell monolayers. Cells are grown on a porous membrane; if a monolayer
does not form then transport between cells (paracellular) will dominate,
which may not reflect the physiological barrier properties. Solute
or fluorophore is added to one chamber and the concentration over
time is measured in the opposing chamber. Measurements will only be
accurate in the linear regime of d<italic toggle="yes">C</italic>/d<italic toggle="yes">t</italic>. Typically, a standard curve is used to calculate the concentration
of a fluorophore and its change over time in the basolateral chamber
using a plate reader. From this curve, permeability is calculated
by <xref rid="eq13" ref-type="disp-formula">eq <xref rid="eq13" ref-type="disp-formula">13</xref></xref>, which also
is dependent on the geometry of the Transwell membrane (typically
circular). (B) Schematic of a 3D microvessel assay for measuring permeability
of cells patterned into a tube. Tissue-engineering approaches are
used to form a confluent tube of cells (typically endothelial cells)
that resembles a <italic toggle="yes">in vivo</italic> blood vessel. Fluorophore
is perfused through the microvessel and real-time fluorescence microscopy
is conducted to capture filling of the lumen (&#916;<italic toggle="yes">I</italic>) and the rate of fluorophore accumulation into the ECM (d<italic toggle="yes">I</italic>/d<italic toggle="yes">t</italic>), together with geometric properties
of the microvessel enabling permeability calculation (<xref rid="eq17" ref-type="disp-formula">eq <xref rid="eq17" ref-type="disp-formula">17</xref></xref>). In the example plot of fluorescence
intensity, the jump in fluorescence corresponds with perfusion of
dye into the microvessel at time = 5 min. This calculation does not
depend on measuring the concentration of the fluorophore, however,
a range of concentrations should be piloted to confirm linearity with
fluorescence and robustness of measurements. Polydimethylsiloxane
(PDMS); extracellular matrix (ECM).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="gr3" position="float" orientation="portrait" xlink:href="ci4c01815_0003.jpg"/></fig><p>The flux for the transwell assay is defined as
the rate of molecules
crossing the membrane (d<italic toggle="yes">N</italic>/d<italic toggle="yes">t</italic>) divided
by the surface area:<disp-formula id="eq10"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m010.jpg"/><label>10</label></disp-formula>which is the form of <xref rid="eq4" ref-type="disp-formula">eq <xref rid="eq4" ref-type="disp-formula">4</xref></xref> for a circular area. Assuming
that the solute is only present in the apical reservoir, the concentration
gradient d<italic toggle="yes">C</italic> for the transwell assay is defined as<disp-formula id="eq11"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m011.jpg"/><label>11</label></disp-formula></p><p>Thus, apparent permeability
is defined from <xref rid="eq9" ref-type="disp-formula">eq <xref rid="eq9" ref-type="disp-formula">9</xref></xref> as<disp-formula id="eq12"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m012.jpg"/><label>12</label></disp-formula></p><p>By redefining the
permeability in terms of the solute concentration,
we get:<disp-formula id="eq13"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m013.jpg"/><label>13</label></disp-formula></p><p>The first
term can
be calculated as the slope of concentration
across at least two time points of sampling the basolateral compartment.</p></sec><sec id="sec1.3.2.2"><title>Three-Dimensional Microvessel Assay</title><p>A three-dimensional
microvessel is fabricated using cell and tissue engineering techniques,
summarized previously.<sup><xref ref-type="bibr" rid="ref143">143</xref></sup> The microvessel
of length <italic toggle="yes">L</italic> and radius <italic toggle="yes">R</italic> is filled
with solute of amount <italic toggle="yes">N</italic><sub>vessel</sub>, and over
time outside of the blood vessel this solute accumulates at rate d<italic toggle="yes">N</italic>/d<italic toggle="yes">t</italic>. The calculations of permeability
are similar to those in 2D, and the final experimental setup is depicted
in <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B. First,
the molecular flux is similar to the 2D expressions (<xref rid="eq9" ref-type="disp-formula">eqs <xref rid="eq9" ref-type="disp-formula">9</xref></xref>&#8211;<xref rid="eq11" ref-type="disp-formula">11</xref>):<disp-formula id="eq14"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m014.jpg"/><label>14</label></disp-formula><disp-formula id="eq15"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m015.jpg"/><label>15</label></disp-formula></p><p>Solving for permeability,
the expression then becomes<disp-formula id="eq16"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m016.jpg"/><label>16</label></disp-formula></p><p>Typically in these
models, permeability of fluorophores are measured.
Unlike in transwells, where the basolateral chamber is accessible
for fluid collection, in microvessels there is not a tractable way
to sample the interstitial space. Thus, time-lapse fluorescence microscopy
is typically conducted to measure the concentration gradient when
the microvessel lumen fills with fluorophore (&#916;<italic toggle="yes">I</italic>) and how fluorescence intensity changes over time outside the microvessel
(d<italic toggle="yes">I</italic>/d<italic toggle="yes">t</italic>). These equations were applied
in early studies to measure the permeability of single perfused capillaries
of frog mesentery,<sup><xref ref-type="bibr" rid="ref144">144</xref></sup> but have been widely
adopted within the <italic toggle="yes">in vitro</italic> microvessel field.<sup><xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref145">145</xref>,<xref ref-type="bibr" rid="ref146">146</xref></sup><disp-formula id="eq17"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m017.jpg"/><label>17</label></disp-formula></p><p>These calculations
make several assumptions: (1) fluorescence intensity
is linear with concentration, which should be empirically confirmed,
(2) microvessels instantaneously fill with fluorophore (immediate
formation of a concentration gradient); if this is not satisfied then
transport will occur before the final concentration gradient is formed;
using a perfusion system that has a long physical distance from the
site of adding fluorescent dyes to the microvessel can introduce this
challenge, which will particularly effect high permeability measurements,
(3) the concentration gradient is steady-state, (4) that all transport
occurs within the ROI, meaning that the ROI should be chosen to reflect
transport from the singular microvessel, and (5) that diffusion dominates,
while contributions of convective flux (solvent drag) are minimal.
Convective flux is described by the Sterling equation and includes
both hydrostatic and oncotic pressures. Hydrostatic contributions
can be minimized by perfusing microvessels under low pressure, while
oncotic effects can be minimized by ensuring that the interstitial
fluid surrounding microvessels has a similar protein concentration
as the microvessel perfusate. For example, perfusion of high concentration
fluorescently labeled albumin will introduce oncotic effects that
will draw water into the microvessel and alter permeability beyond
diffusive mechanisms.</p></sec></sec><sec id="sec1.3.3"><title>In Vivo</title><p>Historic
studies by Ehrlich and Goldmann found
that dyes injected into the bloodstream did not stain the brain,<sup><xref ref-type="bibr" rid="ref147">147</xref></sup> providing early quantitative evidence of uniquely
low permeability of the BBB. Quantitative and semiqualitative methods
continue to be used to this day using dyes like Evans Blue or biotin
to observe how barrier properties change over development and disease.
Regardless, there remains a need for accurate quantitative measurements
and multiple techniques have been developed to measure permeability
in living animals or humans (<italic toggle="yes">in vivo</italic>).<sup><xref ref-type="bibr" rid="ref148">148</xref>&#8722;<xref ref-type="bibr" rid="ref150">150</xref></sup> These approaches are applied across broad orders of magnitude of
size, from the collection of entire organs to measure drug concentration
to the real-time imaging of a single blood vessel perfused with solute
directly upstream. Calculations across these scales differ widely
and rely on unique sets of assumptions that can bias measurements.
Some early approaches perfused solutes through animal microvessels
and utilized calculations outlined above (<xref rid="eq17" ref-type="disp-formula">eq <xref rid="eq17" ref-type="disp-formula">17</xref></xref>);<sup><xref ref-type="bibr" rid="ref143">143</xref>,<xref ref-type="bibr" rid="ref145">145</xref></sup> these approaches have
also been applied with more advanced imaging modalities and noninvasive
techniques to measure BBB permeability.<sup><xref ref-type="bibr" rid="ref151">151</xref></sup> However, there remains a need for measuring permeability that does
not rely on the direct fluorescent imaging of a vascular bed. We will
describe two such approaches: (1) <italic toggle="yes">in situ</italic> brain perfusion
which is a &#8220;gold standard&#8221; approach to measure permeability
of any drug in laboratory animals, and (2) multiple time-point regression
analysis, including the two-comportment Patlak model, which is widely
used for clinical imaging in humans.</p><sec id="sec1.3.3.1"><title><italic toggle="yes">In Situ</italic> Brain Perfusion</title><p>In this method
the operator takes full control of the cerebral circulation by isolating
and cannulating the internal carotid artery in a freshly euthanized
animal and perfusing with a solution of tracer of known concentration
(<italic toggle="yes">C</italic><sub><italic toggle="yes">p</italic></sub>). The concentration
of tracer in the brain (<italic toggle="yes">C</italic><sub><italic toggle="yes">b</italic></sub>) is quantified, either at a single time point or at multiple time
points. For multiple time points, the initial linear part of the data
is then fitted to this relationship:<disp-formula id="eq18"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m018.jpg"/><label>18</label></disp-formula>where <italic toggle="yes">C</italic><sub><italic toggle="yes">b</italic></sub>/<italic toggle="yes">C</italic><sub><italic toggle="yes">p</italic></sub> is
the apparent volume of distribution, the slope <italic toggle="yes">K</italic><sub>in</sub> is the transfer coefficient (expressed in
mL/min/gram of brain tissue) and the intercept <italic toggle="yes">V</italic><sub>i</sub> (at <italic toggle="yes">t</italic> = 0) reflects the intravascular volume.
For single point assays, <italic toggle="yes">V</italic><sub>i</sub> needs to be
determined empirically and this is done by including in the perfusate
an intravascular space marker which has zero BBB permeability. Multiple
time points are superior to single time point assays since it allows
for inspection of the relationship in <xref rid="eq18" ref-type="disp-formula">eq <xref rid="eq18" ref-type="disp-formula">18</xref></xref>, to ensure the calculation is performed
on the linear portion.</p><p>The determinants of <italic toggle="yes">K</italic><sub>in</sub> are the permeability (<italic toggle="yes">P</italic><sub><italic toggle="yes">,</italic></sub> an intrinsic property of the BBB; when measured
referred to as <italic toggle="yes">P</italic><sub>app</sub> versus <italic toggle="yes">P</italic><sub>sim</sub>), the surface area available for transfer (<italic toggle="yes">S</italic>), and luminal flow (<italic toggle="yes">F</italic>). <italic toggle="yes">P</italic> and <italic toggle="yes">S</italic> are convenient to consider together as a
product (so-called &#8220;PS product&#8221;, or <italic toggle="yes">PS</italic>), since it is frequently difficult to disentangle these two parameters:<disp-formula id="eq19"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m019.jpg"/><label>19</label></disp-formula></p><p><italic toggle="yes">PS</italic> was related to <italic toggle="yes">K</italic><sub><italic toggle="yes">in</italic></sub> and <italic toggle="yes">F</italic> by Renkin<sup><xref ref-type="bibr" rid="ref152">152</xref></sup> and Crone,<sup><xref ref-type="bibr" rid="ref153">153</xref></sup> so <italic toggle="yes">K</italic><sub>in</sub> can be derived
since the flow is controlled by the
experimenter, and is known or can be derived:<disp-formula id="eq20"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m020.jpg"/><label>20</label></disp-formula>rearranged to<disp-formula id="eq21"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m021.jpg"/><label>21</label></disp-formula>but in practice some investigators
assume that <italic toggle="yes">K</italic><sub>in</sub> is numerically equal to <italic toggle="yes">PS</italic> when flow is much larger than the <italic toggle="yes">PS</italic> product (simulations show that when <italic toggle="yes">PS/F</italic> is less
than 0.2, <italic toggle="yes">K</italic><sub>in</sub> approximates to <italic toggle="yes">PS</italic> with error &#8804;10%<sup><xref ref-type="bibr" rid="ref154">154</xref></sup>).</p><p>Finally, <italic toggle="yes">P</italic> (in cm/min) is derived from <italic toggle="yes">PS</italic> by dividing with estimates of vascular surface area (<italic toggle="yes">SA</italic>, in cm<sup>2</sup>/g) from the literature,<sup><xref ref-type="bibr" rid="ref155">155</xref></sup> since from <xref rid="eq19" ref-type="disp-formula">eq <xref rid="eq19" ref-type="disp-formula">19</xref></xref>:<disp-formula id="eq22"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m022.jpg"/><label>22</label></disp-formula></p><p>These experiments
are essentially performed post-mortem and the
brain is deprived of its normal blood supply. While animals are perfused
with a highly oxygenated and warmed solution (sometimes including
washed erythrocytes), it is possible that BBB permeability changes
occur during the course of the experiment as the neurovascular unit
is deprived of its natural environment.</p></sec><sec id="sec1.3.3.2"><title>Multiple Time-Point Regression
Analysis</title><p>A more physiological
extension developed by Patlak and colleagues allows for permeability
estimation after administration of tracer. For CNS permeability, the
procedure involves obtaining concentrations measured in tissue (<italic toggle="yes">C</italic><sub>b</sub>) and blood (usually arterial, so <italic toggle="yes">C</italic><sub>a</sub>) at multiple time points.<sup><xref ref-type="bibr" rid="ref155">155</xref></sup> The Patlak model is used in laboratory studies and clinical imaging
techniques like PET (Positron Emission Tomography) and dynamic contrast-enhanced
magnetic resonance imaging (DCE-MRI);<sup><xref ref-type="bibr" rid="ref156">156</xref>&#8722;<xref ref-type="bibr" rid="ref158">158</xref></sup> it measures the rate
at which an agent (dependent on the imaging modality) moves from the
blood plasma (compartment one) into the tissue (compartment two).
Crucially, this is a two-compartment model which assumes that tracer
is irreversibly transferred from blood to tissue (i.e., no back flow).<disp-formula id="eq23"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m023.jpg"/><label>23</label></disp-formula>since at early time-points,
the influence of <italic toggle="yes">K</italic><sub>out</sub> &#183; <italic toggle="yes">C</italic><sub>a</sub> is very small, as there is very little tracer in the
tissue compared to blood.</p><p>Integration of <xref rid="eq23" ref-type="disp-formula">eq <xref rid="eq23" ref-type="disp-formula">23</xref></xref> leads to<disp-formula id="eq24"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m024.jpg"/><label>24</label></disp-formula></p><p>To the right-hand
side of <xref rid="eq24" ref-type="disp-formula">eq <xref rid="eq24" ref-type="disp-formula">24</xref></xref>, one needs
to add the contribution of intravascular
tracer to <italic toggle="yes">C</italic><sub>b</sub> i.e. <italic toggle="yes">V</italic><sub>b</sub>. <italic toggle="yes">C</italic><sub>a</sub>(<italic toggle="yes">t</italic>) where <italic toggle="yes">V</italic><sub>b</sub> is the cerebral blood volume. This is the
Patlak equation:<disp-formula id="eq25"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m025.jpg"/><label>25</label></disp-formula></p><p>Dividing by <italic toggle="yes">C</italic><sub>a</sub>(<italic toggle="yes">t</italic>)
purely to rearrange into a linear form:<disp-formula id="eq26"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m026.jpg"/><label>26</label></disp-formula>allows the data to be plotted
to derive <italic toggle="yes">K</italic><sub>in</sub> and <italic toggle="yes">V</italic><sub>b</sub> by fitting. The advantage of this method is that tissue concentrations
can be measured <italic toggle="yes">in vivo</italic> using imaging techniques,
and application to humans becomes possible.<sup><xref ref-type="bibr" rid="ref159">159</xref></sup> Further improvements have been made using bidirectional models,<sup><xref ref-type="bibr" rid="ref160">160</xref>,<xref ref-type="bibr" rid="ref161">161</xref></sup> adjustments for noninstantaneous luminal filling,<sup><xref ref-type="bibr" rid="ref162">162</xref></sup> and &#8220;blind&#8221; deconvolution of solute imaging
data.<sup><xref ref-type="bibr" rid="ref157">157</xref>,<xref ref-type="bibr" rid="ref163">163</xref>&#8722;<xref ref-type="bibr" rid="ref165">165</xref></sup> Depending on the context,
different adaptations of the Patlak model can be more or less accurate.
For example, bidirectional models are more accurate when vascular
permeability and vascular volume are high.<sup><xref ref-type="bibr" rid="ref157">157</xref></sup> As with other approaches, this model assumes that the signal is
proportional to concentration, and is popular with a variety of clinical
imaging modalities;<sup><xref ref-type="bibr" rid="ref155">155</xref>,<xref ref-type="bibr" rid="ref166">166</xref>,<xref ref-type="bibr" rid="ref167">167</xref></sup> depending on the imaging sequence, tissue characteristics, and contrast
agent and its concentration, a linear relationship can be approximated. <italic toggle="yes">K</italic><sub>in</sub> is commonly also referred to as <italic toggle="yes">K</italic><sub>i</sub> (or <italic toggle="yes">K</italic><sub>trans</sub>, if <italic toggle="yes">K</italic><sub>i</sub> is corrected for the hematocrit) in MR perfusion studies,
such that<disp-formula id="eq27"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m027.jpg"/><label>27</label></disp-formula></p><p>By constraining <xref rid="eq20" ref-type="disp-formula">eq <xref rid="eq20" ref-type="disp-formula">20</xref></xref> within the physiological
ranges of <italic toggle="yes">F</italic> and <italic toggle="yes">PS</italic> across various
tissues, it is apparent that <italic toggle="yes">K</italic><sub>in</sub> is mostly
influenced by <italic toggle="yes">PS</italic> (luminal
flow (<italic toggle="yes">F</italic>) has little effect), especially when the <italic toggle="yes">PS</italic> is very low. Indeed, in the low permeability context, <italic toggle="yes">K</italic><sub>in</sub> is nearly directly proportional to <italic toggle="yes">PS</italic>.</p></sec></sec></sec><sec id="sec1.4"><title>Challenges in Benchmarking Permeability Measurements</title><sec id="sec1.4.1"><title>Quantifying
the Order of Magnitude Difference between Simulation
and Experiments</title><p>Directly comparing simulated and experimental
permeabilities involves inherent risks. Simulated permeabilities for
the CNS have been found to generally be faster than experimental permeabilities
even after correction procedures. This has been found for simulated
permeabilities obtained with transition-based counting assays<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup> that are then benchmarked to Caco-2, MDCK or rat brain perfusion.
Similarly, for simulated permeability values obtained from the ISD
relationship, benchmarking to <italic toggle="yes">in vivo</italic> intestinal
perfusion assays revealed a disparity of 3&#8211;4 orders of magnitude,<sup><xref ref-type="bibr" rid="ref168">168</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup> with the simulated values being significantly faster. The reason
for this has been extensively explored,<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref124">124</xref>,<xref ref-type="bibr" rid="ref169">169</xref></sup> and appears to be a combination of force field effects,
the uniqueness of each permeating solute in relation to a single assay
that may not respond to all solutes in the same way, as well as the
choice of <italic toggle="yes">in vitro</italic> cell line benchmark or <italic toggle="yes">in vivo</italic> methodology with their inherent limitations. We
will delve more deeply into these issues in the following subsections.</p></sec><sec id="sec1.4.2"><title>Building Atomic-Detail Accurate Models</title><p>One key reason
for the order-of-magnitude disparity between simulations and experiments
is that small-molecule tissue permeability through a cell membrane
is affected by a multitude of biological factors within <italic toggle="yes">in
vivo</italic> and <italic toggle="yes">in vitro</italic> models (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). These factors are only captured
by the simulation model if the corresponding features are explicitly
included. First, brain microvascular endothelial cells (BMECs) are
interconnected by tight junction proteins that form a paracellular
barrier to the transport of large molecules. By electron microscopy
these proteins appear as &#8220;zippers&#8221;.<sup><xref ref-type="bibr" rid="ref170">170</xref>&#8722;<xref ref-type="bibr" rid="ref172">172</xref></sup> Thus, experimental and computational approaches would be expected
to converge for blood&#8211;brain barrier permeability measurements
when paracellular permeability goes to zero. Second, the endothelial
cell membrane is coated in a layer of glycan molecules termed the
glycocalyx, which helps preorganize the transport for small molecules
and blocks the permeation of larger molecules.<sup><xref ref-type="bibr" rid="ref96">96</xref>,<xref ref-type="bibr" rid="ref98">98</xref>,<xref ref-type="bibr" rid="ref173">173</xref></sup> Since simulation models do not routinely
include the glycan layer in their modeling, this is a major system
difference. The permeability for large molecules when benchmarked
to <italic toggle="yes">in silico</italic> permeabilities therefore needs to be
scrutinized extra carefully, and this discrepancy could be mitigated
by stripping the glycocalyx from the cell surface prior to permeability
measurements using compounds like heparinase.</p><p>Third, simulation
models do not routinely incorporate P-glycoprotein efflux, which can
lead to order-of-magnitude differences in <italic toggle="yes">in vitro</italic> permeability.<sup><xref ref-type="bibr" rid="ref174">174</xref>&#8722;<xref ref-type="bibr" rid="ref176">176</xref></sup> To quantify the effect of efflux on the
permeability, we quote the concept of &#8220;efflux ratio&#8221;
(<xref rid="eq28" ref-type="disp-formula">eq <xref rid="eq28" ref-type="disp-formula">28</xref></xref>) to denote the
ratio of the basolateral-to-apical (brain to circulatory direction)
to the apical-to-basolateral (circulatory to brain) directions:<disp-formula id="eq28"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m028.jpg"/><label>28</label></disp-formula></p><p>By rewriting the total
system flux <italic toggle="yes">J</italic> from <xref rid="eq3" ref-type="disp-formula">eq <xref rid="eq3" ref-type="disp-formula">3</xref></xref> in terms of passive and
active transport components, we obtain expressions for both components
to be<disp-formula id="eq29"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="ci4c01815_m029.jpg"/><label>29</label></disp-formula>where <italic toggle="yes">r</italic> is
the transporter turnover rate and <italic toggle="yes">N</italic> is the number
of transporters. The consequence of active transport is that the total
flux may no longer be linearly dependent on the concentration difference,
depending on the rate of active transport. Furthermore, when evaluating <xref rid="eq29" ref-type="disp-formula">eq <xref rid="eq29" ref-type="disp-formula">29</xref></xref>, it may help to point
out that <italic toggle="yes">N</italic> is typically found as the number of transporters
per micron squared.<sup><xref ref-type="bibr" rid="ref29">29</xref>,<xref ref-type="bibr" rid="ref177">177</xref>,<xref ref-type="bibr" rid="ref178">178</xref></sup> In the case of the P-glycoprotein transporter, a value of 100 P-gp
&#956;m<sup>&#8211;2</sup> has been used previously.</p><p>Fourth,
the cell membrane composition <italic toggle="yes">in vivo</italic> is
dynamic and regulates other mechanisms of transcellular permeability
like transcytosis. Relative to other vascular beds, the BBB is enriched
for the transporter protein Mfsd2a<sup><xref ref-type="bibr" rid="ref179">179</xref></sup> which
regulates the lipid composition of the cell membrane to suppress caveolae-mediated
transcytosis.<sup><xref ref-type="bibr" rid="ref180">180</xref></sup> Fifth, many compounds
use specialized transporter systems to cross the BBB, which dramatically
increase permeability of the transcellular pathway; this includes
expression of glucose transpoter-1 by the BBB to shuttle glucose into
the brain. To capture such effects <italic toggle="yes">in silico</italic>, we
are thus advocating for users to move on from model membranes to complex
simulation setups, such as those mimicking the full cell,<sup><xref ref-type="bibr" rid="ref181">181</xref></sup> but this comes at a considerable computational
cost and is not routine.</p></sec><sec id="sec1.4.3"><title>Assumptions of in Vivo Permeability Estimation</title><p>Having
gone over differences between the simulations and the reality of the
cell <italic toggle="yes">in vivo,</italic> we proceed to examine the assumptions
made for <italic toggle="yes">in vivo</italic> permeability estimation of <italic toggle="yes">P</italic>, the gold standard in CNS permeability estimation. For
CNS permeability estimation, one assumes that minimum binding occurs
on the luminal surface of the vasculature, as well as that there is
no additional barriers in the perivascular space; although the permeability
in relation to the cerebrovascular endothelium would be mathematically
correct, it would not be accurate for a systems biological application,
since most therapeutics and biological substances need access to the
brain parenchyma to exert their action. Transfer kinetics are assumed
to follow a one-compartment unidirectional model; multicompartmental
models of increasing complexity<sup><xref ref-type="bibr" rid="ref182">182</xref>,<xref ref-type="bibr" rid="ref183">183</xref></sup> including
those utilizing measurements from extracellular space and cerebrospinal
fluid compartments attempt to deal with this issue,<sup><xref ref-type="bibr" rid="ref184">184</xref>,<xref ref-type="bibr" rid="ref185">185</xref></sup> for which there is a risk of overfitting with large number of parameters.
Absolute quantification of <italic toggle="yes">P</italic> is hampered by the fact
that the surface available for transfer, denoted <italic toggle="yes">S</italic>, is derived from the literature, rather than being experimentally
determined within the same experiment. However, since <italic toggle="yes">S</italic> is essentially a scaling variable, it is acceptable to compare permeabilities
between substances (e.g., <italic toggle="yes">P</italic><sub>app,&#160;substance&#160;1</sub> and <italic toggle="yes">P</italic><sub>app,&#160;substance&#160;2</sub>), or
to compare <italic toggle="yes">P</italic><sub>app</sub> and <italic toggle="yes">P</italic><sub>sim</sub> if a reference substance is used (e.g., comparing <italic toggle="yes">P</italic><sub>app,&#160;substance&#160;1</sub>/<italic toggle="yes">P</italic><sub>app,&#160;ref</sub> and <italic toggle="yes">P</italic><sub>sim,&#160;substance&#160;1</sub>/<italic toggle="yes">P</italic><sub>sim,&#160;reference&#160;substance</sub>).</p></sec><sec id="sec1.4.4"><title>Diversity of Solute Permeability Behavior</title><p>In addition
to these systemic differences between simulations and experiments,
there is a diversity in the behavior and nature of the small molecules
studied, which need to be accounted for in benchmarks and models.
We illustrate this issue for three classes of molecules crossing the
BBB. The first type of compound is one with moderate to high permeability
across lipid membranes. Both caffeine (2 &#215; 10<sup>&#8211;5</sup> cm s<sup>&#8211;1</sup>)<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and ethanol
(1.1 &#215; 10<sup>&#8211;3</sup> cm s<sup>&#8211;1</sup>) serve
as examples for such behavior (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>), and both immediately exert noticeable physiological
effects on the CNS after their respective consumption. A second class
of molecules with moderate to low permeabilities are the opioids,
that have highly opioid-drug specific entry into the brain. Some opioids
are strongly recognized by P-glycoprotein, such as loperamide<sup><xref ref-type="bibr" rid="ref186">186</xref>,<xref ref-type="bibr" rid="ref187">187</xref></sup> (which exerts no CNS actions), while others such as heroin or morphine
are effluxed to a lesser extent.<sup><xref ref-type="bibr" rid="ref188">188</xref>,<xref ref-type="bibr" rid="ref189">189</xref></sup> A third class
of molecules are the very large drugs such as antibodies. Antibodies
display remarkably low permeability unless they are engineered to
hijack receptors expressed by the brain endothelium, including transferrin
receptor.<sup><xref ref-type="bibr" rid="ref190">190</xref></sup> To study the permeability
of large molecules, novel delivery platforms such as the transcytosis-enabling
modules (TEMs)<sup><xref ref-type="bibr" rid="ref191">191</xref>,<xref ref-type="bibr" rid="ref192">192</xref></sup> are needed. In <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref> we illustrate a range of compound
permeabilities for the blood&#8211;brain barrier, showcasing the
diverse set of assay types used to estimate these. Future benchmarks
need to be aware of this diversity and the challenges it poses to
accurate assessment.</p></sec><sec id="sec1.4.5"><title>In Vitro Models Have Inherent Advantages
and Limitations</title><p><italic toggle="yes">In vitro</italic> permeability assays
have a set of common
pitfalls, recently described elsewhere.<sup><xref ref-type="bibr" rid="ref193">193</xref></sup> To summarize, first, only a short-range of <italic toggle="yes">P</italic><sub>app</sub> values allow for the extraction of intrinsic membrane permeability,
as most of the published values are dominated by the diffusion component,
which itself is due to unstirred water layers.<sup><xref ref-type="bibr" rid="ref169">169</xref></sup> Second, it was found that many of the non-CNS <italic toggle="yes">P</italic><sub>app</sub> values are affected by paracellular transport when
using epithelial or intestinal permeability assays. This is not an
issue in CNS permeability, due to the presence of tight junctions
that block paracellular transport. Third, there are recovery issues
in the <italic toggle="yes">in vitro</italic> assays, which are not present in
the simulations, as compounds are lost due to adhesion to membranes
or plastics.</p></sec><sec id="sec1.4.6"><title>Benchmarking Disparities between in Vitro
and in Vivo</title><p><italic toggle="yes">In vitro</italic> systems do not fully
recapitulate the complex
nature of drug delivery <italic toggle="yes">in vivo</italic>, e.g. in humans.
This includes differences in protein/gene expression of endothelial
cells, microenvironmental differences, and incomplete capture of ADME
principles <italic toggle="yes">in vitro</italic>. As a first example, let us consider
the permeability of clozapine, an antipsychotic drug. In <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> we compare the measured
permeability for the antipsychotic clozapine from three sources. While
the experimental sources differ in their assumptions, the fastest
permeability reading was 6.4 times greater than the slowest reading. <italic toggle="yes">In vivo</italic> methods measure molecules crossing the membrane
by all mechanisms. The permeability is therefore not driven by passive
diffusion or unequal concentrations alone. If the delivery depends
on an active transport system, the kinetics will look different than
transport that is just following a gradient, particularly if the concentrations
are very high.</p><table-wrap id="tbl2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Experimental Benchmarks for the Apparent
Permeability of the Antipsychotic Clozapine from the Following Models
or Methods: (A) 2D <italic toggle="yes">in Vitro</italic> Permeability from Human
Cerebral Microvascular Endothelial Cell Line (hCMEC/D3) Monoculture
Cells, (B) 2D <italic toggle="yes">in Vitro</italic> Permeability from Madin-Darby
Canine Kidney Cells with Multidrug Resistance Protein 1 Expressed
(MDCK-MDR1), and (C) 3D <italic toggle="yes">in Vivo</italic> Permeability from
Rat Brain Perfusion</title></caption><table frame="hsides" rules="groups" border="0"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th style="border:none;" align="center" colspan="1" rowspan="1">Molecule</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">MW(g&#160;mol<sup>&#8211;1</sup>)</th><th style="border:none;" align="center" char="." colspan="1" rowspan="1">Log <italic toggle="yes">K</italic><sub>ow</sub></th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">P</italic><sub>app</sub> (cm&#160;s<sup>&#8211;1</sup>)</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">P</italic><sub>app</sub> Reference</th><th style="border:none;" align="center" colspan="1" rowspan="1"><italic toggle="yes">In vitro</italic> model or <italic toggle="yes">in
vivo</italic> method</th></tr></thead><tbody><tr><td rowspan="3" style="border:none;" align="left" colspan="1"><bold>Clozapine</bold></td><td rowspan="3" style="border:none;" align="char" char="." colspan="1">326.8</td><td rowspan="3" style="border:none;" align="char" char="." colspan="1">3.23</td><td style="border:none;" align="left" colspan="1" rowspan="1">3.90&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Yang 2024]<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">hCMECD/D3</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">2.80&#160;&#215;&#160;10<sup>&#8211;5</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield 2007]<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">MDCK-MDR1</td></tr><tr><td style="border:none;" align="left" colspan="1" rowspan="1">2.50&#160;&#215;&#160;10<sup>&#8211;4</sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">[Summerfield
2007]<sup><xref ref-type="bibr" rid="ref68">68</xref></sup></td><td style="border:none;" align="left" colspan="1" rowspan="1">Brain perf (3D)</td></tr></tbody></table></table-wrap><p>Second, a recent study<sup><xref ref-type="bibr" rid="ref194">194</xref></sup> collected
222 <italic toggle="yes">P</italic><sub>app</sub> values from MDCK cell lines,
and 143 <italic toggle="yes">P</italic><sub>app</sub> values from Caco-2 cell lines.
When analyzing the <italic toggle="yes">P</italic><sub>app</sub> values for the
same chemical, it was found the <italic toggle="yes">P</italic><sub>app</sub> to
differ by up to &#8764;1.83 log units with a median of 0.57 when
collected from different sources. When analyzing <italic toggle="yes">P</italic><sub>app</sub> values of the same chemical from the same source where
only the choice of cell line was different, the values differed by
up to &#8764;1.31 log units with a median value of 0.31. This highlights
the choice of the cell line as having an impact on benchmarking. The
observed differences in permeability between Caco-2 and MDCK cells
are primarily attributed to variations in lipid and protein composition,
as well as cellular morphology, with Caco-2 cells more closely mimicking
the human intestinal barrier while MDCK cells resemble renal epithelium;
these distinctions underscore the importance of cell line selection
in accurately modeling permeability.<sup><xref ref-type="bibr" rid="ref195">195</xref></sup></p><p>Third, <italic toggle="yes">in vitro</italic> studies commonly cite <italic toggle="yes">in vivo</italic> measurements as a reference point for permeability
values. This is typically used as evidence for an <italic toggle="yes">in vitro</italic> model displaying &#8220;physiological&#8221; barrier properties.
Unfortunately, this practice has large potential for error as there
is not an accepted <italic toggle="yes">in vivo</italic> value for many compounds
as they are highly dependent on the approach used. Pairs of <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> studies identify similar
permeability values, but values are still highly variable across approaches;
examples of congruent permeability findings for two compounds include
for lucifer yellow<sup><xref ref-type="bibr" rid="ref137">137</xref>,<xref ref-type="bibr" rid="ref196">196</xref></sup> and 10 kDa dextran.<sup><xref ref-type="bibr" rid="ref197">197</xref>,<xref ref-type="bibr" rid="ref198">198</xref></sup></p><p>Fourth, <italic toggle="yes">in vitro</italic> methods rely on spectroscopy
to detect fluorescence intensity. Some limitations that may compromise
accurate measurements include nonspecific binding of fluorophores
to Transwells, photobleaching of the fluorophore, interference or
autofluorescence of cell culture media (thus why transport buffers
are usually used during the assay), and instrument sensitivity.</p></sec><sec id="sec1.4.7"><title>Measuring Modulation in Permeability</title><p>Vascular permeability
is highly dynamic in homeostasis and disease. Additionally, many approaches
seek to actively increase permeability to delivery therapeutic agents
into the brain. There is a large range of approaches utilized including
inhibition of efflux pumps, transient disruption of tight junctions
(by hyperosmotic/chemical agents, focused ultrasound), hijacking of
receptor-mediated transcytosis, and use of viral vectors, nanoparticles,
or exosomes.<sup><xref ref-type="bibr" rid="ref199">199</xref>,<xref ref-type="bibr" rid="ref200">200</xref></sup><italic toggle="yes">In silico, in vitro</italic>, and <italic toggle="yes">in vivo</italic> approaches have all been applied toward
developing approaches to modulate drug permeability. However, some
benchmarking challenges persist. For example, due to species differences
it is possible that permeability measurements may be distinct between <italic toggle="yes">in vivo</italic> studies in rodents versus studies using human cells <italic toggle="yes">in vitro</italic>; the relative contribution of species differences
versus technical artifacts is not known but could at least partially
be determined by conducting gene and protein expression analysis across
these assays. Crucially, while assumptions may be satisfied in one
context, once permeability is modulated they may no longer be valid.
For example, many chemicals can induce &#8220;focal leaks&#8221;
within 3D <italic toggle="yes">in vitro</italic> models where plums of fluorophore
are observed to transiently exit between adjacent endothelial cells.<sup><xref ref-type="bibr" rid="ref145">145</xref>,<xref ref-type="bibr" rid="ref201">201</xref></sup> These transient effects are local sites of extremely high paracellular
permeability and suggest that the ratio of transcellular:paracellular
permeability is not constant in time or space. Permeability may be
underestimated in the presence of focal leaks as the concentration
gradient is poorly maintained. Despite these challenges, this highlights
a major advantage of 3D models: the direct imaging of fluorophore
dynamics, which is not visible in 2D models where fluid is passively
collected from reservoirs.</p></sec></sec><sec id="sec1.5"><title>Guideline Recommendations
for Improving Permeability Assay Design</title><p>The previous section
discussed the challenges on benchmarking,
with the ultimate goal to improving agreement between <italic toggle="yes">in vitro</italic>, <italic toggle="yes">in vivo</italic> and <italic toggle="yes">in silico</italic> prediction.
The advantage of this is that (i) by achieving congruent measurements
between <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in silico</italic> systems
we enhance the accuracy of such methods, (ii) by achieving congruent
measurements between <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> systems we enable the use of <italic toggle="yes">in vitro</italic> systems to
study permeability dynamics without the use of animal models, and
(iii) by achieving congruent measurements between <italic toggle="yes">in silico</italic> and <italic toggle="yes">in vivo</italic> we demonstrate the translatability
of these measurements to predict drug permeability.</p><p>We now present
a community-led assessment of the best practices to follow for improving
permeability assay design:<list list-type="simple"><list-item><label>1.</label><p><italic toggle="yes">Work out the explicit assay
assumptions prior to performing a benchmark</italic>. During large
data set benchmarking between simulated permeabilities and experiments
(<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>), one should
be considerate of the specific details and opt for choices that <italic toggle="yes">improve</italic> the overlap of experimental conditions. These choices
include the cell line, the incorporation or inhibition of efflux effects
in the assay, and the type of solute being benchmarked. A justification
needs to be made in relation to their potential weaknesses. The choice
of the cell line can have order-of-magnitude differences on the experimental
permeability, while efflux effects are known to have significant impacts
on the permeability,<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> and this needs to
be carefully accounted for in assay design, such as opting away from
MDCK-MDR1 transfected cells, in which P-gp effects are captured, or
correcting for this in the transport coefficients.</p></list-item><list-item><label>2.</label><p><italic toggle="yes">Nature of permeant affects
outcome.</italic> As we discussed above, there is ample evidence that
solutes permeate complex membranes in group-type behavior.<sup><xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref202">202</xref></sup> Where atypical sized solutes are utilized, consider the challenges
of such a class of solute. Brocke et al. proposed five classes of
permeant behavior through complex membranes from simulations,<sup><xref ref-type="bibr" rid="ref202">202</xref></sup> while other groups narrowed this down to three
discrete classes of behavior.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Similarly,
peptide permeability requires specialized assays that differ from
those of small-molecule permeability, and do not generally follow
the Lipinski rule of 5.</p></list-item><list-item><label>3.</label><p><italic toggle="yes">Data utilization and data availability</italic>. To improve
the transparency of benchmarking, we recommend following
the FAIR (Findability, Accessibility, Interoperability, and Reusability)
data depositing guidelines recently proposed,<sup><xref ref-type="bibr" rid="ref203">203</xref>,<xref ref-type="bibr" rid="ref204">204</xref></sup> as this will improve the agreement to future simulation setups and
help new users in the community follow best practices. In practice,
this means depositing raw publishable data in a repository in such
a manner that the data arrangement obeys the FAIR guidelines. We do
not have a single repository in mind, as we appreciate the scientific
community is global and has unique challenges in different parts of
the world, but some popular ones include MDverse,<sup><xref ref-type="bibr" rid="ref205">205</xref></sup> MDDB (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://mddbr.eu/">https://mddbr.eu/</uri>) and BioExcel-CV19 (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://bioexcel-cv19.bsc.es/">https://bioexcel-cv19.bsc.es/</uri>). We recommend users follow the best practices for data sharing,
such as those laid out by JCIM.<sup><xref ref-type="bibr" rid="ref206">206</xref></sup> Similar
efforts for experimental data deposits have been proposed, e.g. NCBI
GEO databases to deposit gene expression and epigenomics data sets
generated by next-generation sequencing.<sup><xref ref-type="bibr" rid="ref207">207</xref></sup></p></list-item><list-item><label>4.</label><p><italic toggle="yes">Data checking.</italic> We
recommend that users carefully check the input data used for <italic toggle="yes">in silico</italic> prediction. This includes standard error checking
to ensure the best practices are followed. As an example, the ISD
framework requires inputs from both thermodynamics and diffusion estimation.
A breakdown of the error analysis and uncertainties for thermodynamics<sup><xref ref-type="bibr" rid="ref108">108</xref>,<xref ref-type="bibr" rid="ref208">208</xref></sup> and diffusion<sup><xref ref-type="bibr" rid="ref122">122</xref>,<xref ref-type="bibr" rid="ref123">123</xref>,<xref ref-type="bibr" rid="ref209">209</xref>,<xref ref-type="bibr" rid="ref210">210</xref></sup> have been reported elsewhere.
Following good practices<sup><xref ref-type="bibr" rid="ref208">208</xref></sup> for calculating
thermodynamics is of utmost importance to ensure reliable data. For
the TBC approach, the monitoring of the convergence and rigorous derivation
of the permeability expression has been discussed elsewhere.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> Similarly, the use of simulation force field for small-molecules,
e.g. GAFF<sup><xref ref-type="bibr" rid="ref211">211</xref></sup> or CGenFF,<sup><xref ref-type="bibr" rid="ref212">212</xref></sup> can vary widely in accuracy, and careful reoptimization
or inspection of the associated assigned penalties is very important.</p></list-item><list-item><label>5.</label><p><italic toggle="yes">Avoid pitfalls</italic>. For <italic toggle="yes">in vitro</italic> measurements, it is advised to confirm
integrity
of cellular monolayers prior to measurements to ensure that transport
is not dominated by the paracellular pathway. This can be done using
transendothelial electrical resistance (TEER) measurements and values
can be benchmarked to prior studies for consistency.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> Second, make sure to measure transport in the linear regime,
by conducting time course studies.<sup><xref ref-type="bibr" rid="ref88">88</xref></sup> Third,
make sure fluorescent intensity is linear with concentration, which
has been a standard practice for decades.<sup><xref ref-type="bibr" rid="ref144">144</xref></sup> Lastly, test the assumption validities in your experimental or simulation
setup. A number of resources for good experimental<sup><xref ref-type="bibr" rid="ref213">213</xref>&#8722;<xref ref-type="bibr" rid="ref216">216</xref></sup> and simulation<sup><xref ref-type="bibr" rid="ref204">204</xref>,<xref ref-type="bibr" rid="ref208">208</xref>,<xref ref-type="bibr" rid="ref217">217</xref></sup> setups (or &#8220;best practices&#8221;) exists, and the readers
are directed to those.</p></list-item><list-item><label>6.</label><p><italic toggle="yes">Data replication.</italic> Because
of the complications of attaining agreement between experimental and
simulated permeability, it is paramount that values be given with
statistical error bars, obtained from repeat experiments or simulations.
An excellent reference framework for this recommendation is the work
of Summerfield et al.<sup><xref ref-type="bibr" rid="ref66">66</xref></sup> in which permeabilities
from at least two methodologies are reproduced side-by-side descriptors
of mean and error.</p></list-item><list-item><label>7.</label><p><italic toggle="yes">Embrace multidisciplinary efforts.</italic> Use of multidisciplinary
efforts will be particularly powerful in
advancing studies of permeability. Given inherent assumptions and
limitations in individual approaches, collaborative efforts to benchmark
and compare across experiments and simulations will strengthen confidence
in findings and hint at mechanisms. For example, <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> work recently applied the bee venom
peptide melittin for transient opening of the BBB.<sup><xref ref-type="bibr" rid="ref218">218</xref></sup> Use of both an <italic toggle="yes">in vitro</italic> model using human
cells and rodent models, are complementary preclinical studies that
hint at dose discrepancies between <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> that require further study. While this work speculates
on mechanisms by live-cell imaging of 3D microvessels, recent <italic toggle="yes">in silico</italic> studies of melittin identify the membrane permeabilization
mechanism.<sup><xref ref-type="bibr" rid="ref219">219</xref></sup> This example highlights the
potential for <italic toggle="yes">in silico, in vitro</italic>, and <italic toggle="yes">in
vivo</italic> approaches to synergize toward improving drug delivery.</p></list-item></list></p></sec></sec><sec id="sec2"><title>Conclusion</title><p>In this community assessment,
we have laid
out the analytical framework
for multidisciplinary methodologies to calculate permeability: <italic toggle="yes">in silico</italic> assays using either transition-based counting
or the inhomogeneous-solubility diffusion approaches, <italic toggle="yes">in vitro</italic> permeability assays in 2D or 3D, and <italic toggle="yes">in vivo</italic> assays
utilizing <italic toggle="yes">in situ</italic> brain perfusion and the Patlak
method for clinical imaging. We have gone through the systematic derivation
of permeability expressions, and covered the underlying assumptions
made for each approach. We have performed a systematic benchmarking
of <italic toggle="yes">in silico</italic> to both <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic>, depicting the ways in which each benchmarking is
sensitive to the choices of assay design. Finally, we outlined recommendations
for best practices in permeability benchmarking and underscore the
significance of tailored permeability assays in driving advancements
in drug delivery research and development across diverse physiological
contexts. During benchmarking between simulated permeabilities and
experiments, the following should be taken into consideration: (1)
assay variability, including cell line and efflux effects; (2) the
class of solutes; (3) data utilization and data availability; (4)
input data checking for the <italic toggle="yes">in silico</italic> prediction;
(5) avoiding pitfalls; (6) data replication; and (7) embracing multidisciplinary
efforts.</p></sec></body><back><notes notes-type="data-availability" id="notes5"><title>Data Availability Statement</title><p>The data in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, as well as rudimentary
scripts to evaluate the transcellular molecular rate constant, are
to be found at the repository <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/chrisjorg/Permeability">https://github.com/chrisjorg/Permeability</uri>.</p></notes><notes notes-type="" id="notes1"><title>Author Contributions</title><p><sup>&#182;</sup> CJ and RML
are joint first authors. CJ and RML devised the perspective.
CJ wrote the original draft and devised the structure of the perspective.
IG contributed with the section on <italic toggle="yes">in vivo</italic> methods.
MV contributed with the section on diffusion estimation. RML contributed
with the section on <italic toggle="yes">in vitro</italic> methods. EL, CC and
EPT contributed to the literature review of the introduction section.
EPT, EL, FR, MBU, BS and CDL provided feedback on the manuscript.
BS was the MSCA Host supervisor for the project grant agreement No
101023783. All authors read and proofed the manuscript.</p></notes><notes notes-type="funding-statement" id="notes3"><p>CJ acknowledges
support from the European Union&#8217;s Horizon 2020 research and
innovation program under the Marie Sk&#322;odowska-Curie grant agreement
No 101023783. RML was supported by a postdoctoral fellowship from
NIH/NINDS (F32NS128067).</p></notes><notes notes-type="COI-statement" id="notes2"><p>The authors
declare the following competing financial interest(s): CJ and FR are
on the Early Career Board of JCIM. MBU is Chief Scientific Officer
at Eve Biotek. MV is a Senior Scientist at Schr&#246;dinger Inc.
FR is a Principal Scientist in Computational Chemistry at Kimia Therapeutics.</p></notes><ack><title>Acknowledgments</title><p>We wish to thank Peter C. Searson
for the mentorship.
We wish to thank Helen Fillmore for her feedback. CJ wishes to thank
Maria Clara Vazquez for her support.</p></ack><glossary id="dl1"><def-list><title>Abbreviations</title><def-item><term>CNS</term><def><p>central
nervous systems</p></def></def-item><def-item><term>BBB</term><def><p>blood&#8211;brain barrier</p></def></def-item><def-item><term>FDA</term><def><p>Food and Drug Administration</p></def></def-item><def-item><term>PBPK</term><def><p>physiologically based pharmacokinetic</p></def></def-item><def-item><term>ToF-SIMS</term><def><p>Time-of-Flight Secondary
Ion
Mass Spectrometry</p></def></def-item><def-item><term>MDCK</term><def><p>Madin-Darby canine kidney</p></def></def-item><def-item><term>Caco2</term><def><p>immortalized cell line of human
colorectal adenocarcinoma cells</p></def></def-item><def-item><term>hCMED/D3</term><def><p>Human Cerebral Microvascular
Endothelial Cell Line monoculture cells</p></def></def-item><def-item><term>MDCK-MDR1</term><def><p>Madin-Darby canine kidney
with Multidrug Resistance Protein 1 expressed</p></def></def-item><def-item><term>hBMEC</term><def><p>human brain microvascular endothelial
cell</p></def></def-item><def-item><term>iPSC</term><def><p>induced
pluripotent stem cell</p></def></def-item><def-item><term>ISD</term><def><p>inhomogeneous solubility-diffusion</p></def></def-item><def-item><term>ABF</term><def><p>adaptive biasing force</p></def></def-item><def-item><term>2D</term><def><p>two-dimensional</p></def></def-item><def-item><term>3D</term><def><p>three-dimensional</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name name-style="western"><surname>Rishton</surname><given-names>G. M.</given-names></name><article-title>Failure
and Success in Modern Drug Discovery: Guiding Principles in the Establishment
of High Probability of Success Drug Discovery Organizations</article-title>. <source>Med. Chem. (Los Angeles)</source><year>2005</year>, <volume>1</volume> (<issue>5</issue>), <fpage>519</fpage>&#8211;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.2174/1573406054864106</pub-id>.<pub-id pub-id-type="pmid">16787336</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name name-style="western"><surname>Wong</surname><given-names>C. H.</given-names></name>; <name name-style="western"><surname>Siah</surname><given-names>K. W.</given-names></name>; <name name-style="western"><surname>Lo</surname><given-names>A. W.</given-names></name><article-title>Estimation
of Clinical Trial Success
Rates and Related Parameters</article-title>. <source>Biostatistics</source><year>2019</year>, <volume>20</volume> (<issue>2</issue>), <fpage>273</fpage>&#8211;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1093/biostatistics/kxx069</pub-id>.<pub-id pub-id-type="pmid">29394327</pub-id><pub-id pub-id-type="pmcid">PMC6409418</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name><article-title>Predictions
from First-Principles of Membrane Permeability to Small Molecules:
How Useful Are They in Practice?</article-title>. <source>J. Chem. Inf
Model</source><year>2023</year>, <volume>63</volume> (<issue>15</issue>), <fpage>4533</fpage>&#8211;<lpage>4544</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.3c00686</pub-id>.<pub-id pub-id-type="pmid">37449868</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name name-style="western"><surname>Lipinski</surname><given-names>C. A.</given-names></name><article-title>Drug-like
Properties and the Causes of Poor Solubility and Poor Permeability</article-title>. <source>J. Pharmacol Toxicol Methods</source><year>2000</year>, <volume>44</volume> (<issue>1</issue>), <fpage>235</fpage>&#8211;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1016/S1056-8719(00)00107-6</pub-id>.<pub-id pub-id-type="pmid">11274893</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name name-style="western"><surname>Jorgensen</surname><given-names>W. L.</given-names></name>; <name name-style="western"><surname>Duffy</surname><given-names>E. M.</given-names></name><article-title>Prediction of Drug
Solubility from Structure</article-title>. <source>Adv. Drug Deliv Rev.</source><year>2002</year>, <volume>54</volume> (<issue>3</issue>), <fpage>355</fpage>&#8211;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/S0169-409X(02)00008-X</pub-id>.<pub-id pub-id-type="pmid">11922952</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name name-style="western"><surname>Vatansever</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Schlessinger</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Wacker</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Kaniskan</surname><given-names>H. &#220;.</given-names></name>; <name name-style="western"><surname>Jin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>B.</given-names></name><article-title>Artificial Intelligence and Machine
Learning-aided Drug Discovery in Central Nervous System Diseases:
State-of-the-arts and Future Directions</article-title>. <source>Med.
Res. Rev.</source><year>2021</year>, <volume>41</volume> (<issue>3</issue>), <fpage>1427</fpage>&#8211;<lpage>1473</lpage>. <pub-id pub-id-type="doi">10.1002/med.21764</pub-id>.<pub-id pub-id-type="pmid">33295676</pub-id><pub-id pub-id-type="pmcid">PMC8043990</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Gallagher</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Jorgensen</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Troendle</surname><given-names>E. P.</given-names></name>; <name name-style="western"><surname>Hu</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name><article-title>An Experimentally Validated Approach
to Calculate the Blood-Brain Barrier Permeability of Small Molecules</article-title>. <source>Sci. Rep.</source><year>2019</year>, <volume>9</volume> (<issue>1</issue>), <fpage>6117</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-42272-0</pub-id>.<pub-id pub-id-type="pmid">30992465</pub-id><pub-id pub-id-type="pmcid">PMC6467875</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name name-style="western"><surname>Jorgensen</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>Atomistic Model
of Solute Transport
across the Blood&#8211;Brain Barrier</article-title>. <source>ACS Omega</source><year>2022</year>, <volume>7</volume> (<issue>1</issue>), <fpage>1100</fpage>&#8211;<lpage>1112</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.1c05679</pub-id>.<pub-id pub-id-type="pmid">35036773</pub-id><pub-id pub-id-type="pmcid">PMC8757349</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name name-style="western"><surname>Kostewicz</surname><given-names>E. S.</given-names></name>; <name name-style="western"><surname>Aarons</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Bergstrand</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bolger</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Galetin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Hatley</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Jamei</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lloyd</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Pepin</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Rostami-Hodjegan</surname><given-names>A.</given-names></name>; et al. <article-title>PBPK Models for the Prediction of in Vivo
Performance of Oral Dosage Forms</article-title>. <source>Eur. J. Pharm.
Sci.</source><year>2014</year>, <volume>57</volume>, <fpage>300</fpage>&#8211;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2013.09.008</pub-id>.<pub-id pub-id-type="pmid">24060672</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name name-style="western"><surname>Bois</surname><given-names>F. Y.</given-names></name>; <name name-style="western"><surname>Jamei</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Clewell</surname><given-names>H. J.</given-names></name><article-title>PBPK Modelling of Inter-Individual
Variability in the Pharmacokinetics of Environmental Chemicals</article-title>. <source>Toxicology</source><year>2010</year>, <volume>278</volume> (<issue>3</issue>), <fpage>256</fpage>&#8211;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1016/j.tox.2010.06.007</pub-id>.<pub-id pub-id-type="pmid">20600548</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name name-style="western"><surname>Bouzom</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Ball</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Perdaems</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Walther</surname><given-names>B.</given-names></name><article-title>Physiologically
Based
Pharmacokinetic (PBPK) Modelling Tools: How to Fit with Our Needs?</article-title>. <source>Biopharm Drug Dispos</source><year>2012</year>, <volume>33</volume> (<issue>2</issue>), <fpage>55</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1002/bdd.1767</pub-id>.<pub-id pub-id-type="pmid">22228149</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name name-style="western"><surname>Jones</surname><given-names>H. M.</given-names></name>; <name name-style="western"><surname>Gardner</surname><given-names>I. B.</given-names></name>; <name name-style="western"><surname>Watson</surname><given-names>K. J.</given-names></name><article-title>Modelling
and PBPK Simulation in
Drug Discovery</article-title>. <source>AAPS J.</source><year>2009</year>, <volume>11</volume>, <fpage>155</fpage>&#8211;<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-009-9088-1</pub-id>.<pub-id pub-id-type="pmid">19280352</pub-id><pub-id pub-id-type="pmcid">PMC2664888</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="book" id="cit13"><person-group person-group-type="allauthors"><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Tsakalozou</surname><given-names>E.</given-names></name></person-group><article-title>The
Utility of
in Silico PBPK Absorption Modeling and Simulation as a Tool to Develop
Bio-Predictive Dissolution Methods</article-title>. <source>Dissolution
and translational modeling strategies enabling patient-centric product
development</source>, <year>2017</year>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name name-style="western"><surname>Troendle</surname><given-names>E. P.</given-names></name>; <name name-style="western"><surname>Khan</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name><article-title>Predicting
Drug Delivery Efficiency into Tumor Tissues through Molecular Simulation
of Transport in Complex Vascular Networks</article-title>. <source>Biophys.
J.</source><year>2018</year>, <volume>114</volume> (<issue>3</issue>), <fpage>679a</fpage><pub-id pub-id-type="doi">10.1016/j.bpj.2017.11.3664</pub-id>.<pub-id pub-id-type="pmcid">PMC10131895</pub-id><pub-id pub-id-type="pmid">30415016</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name name-style="western"><surname>Lloyd</surname><given-names>J. B.</given-names></name><article-title>Lysosome
Membrane Permeability: Implications for Drug Delivery</article-title>. <source>Adv. Drug Deliv Rev.</source><year>2000</year>, <volume>41</volume> (<issue>2</issue>), <fpage>189</fpage>&#8211;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/S0169-409X(99)00065-4</pub-id>.<pub-id pub-id-type="pmid">10699314</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name name-style="western"><surname>Azzi</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hebda</surname><given-names>J. K.</given-names></name>; <name name-style="western"><surname>Gavard</surname><given-names>J.</given-names></name><article-title>Vascular Permeability
and Drug Delivery
in Cancers</article-title>. <source>Front. Oncol.</source><year>2013</year>, <volume>3</volume>, <fpage>211</fpage><pub-id pub-id-type="doi">10.3389/fonc.2013.00211</pub-id>.<pub-id pub-id-type="pmid">23967403</pub-id><pub-id pub-id-type="pmcid">PMC3744053</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name name-style="western"><surname>Yee</surname><given-names>S.</given-names></name><article-title>In Vitro Permeability
across Caco-2 Cells (Colonic) Can Predict in Vivo (Small Intestinal)
Absorption in Man&#8212;Fact or Myth</article-title>. <source>Pharm.
Res.</source><year>1997</year>, <volume>14</volume>, <fpage>763</fpage>&#8211;<lpage>766</lpage>. <pub-id pub-id-type="doi">10.1023/A:1012102522787</pub-id>.<pub-id pub-id-type="pmid">9210194</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name name-style="western"><surname>Gaillard</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>de Boer</surname><given-names>A. G.</given-names></name><article-title>Relationship between Permeability Status of the Blood&#8211;Brain
Barrier and in Vitro Permeability Coefficient of a Drug</article-title>. <source>European journal of pharmaceutical sciences</source><year>2000</year>, <volume>12</volume> (<issue>2</issue>), <fpage>95</fpage>&#8211;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/S0928-0987(00)00152-4</pub-id>.<pub-id pub-id-type="pmid">11102736</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name name-style="western"><surname>Sarmento</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Andrade</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Silva</surname><given-names>S. B. da</given-names></name>; <name name-style="western"><surname>Rodrigues</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Das Neves</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Ferreira</surname><given-names>D.</given-names></name><article-title>Cell-Based in Vitro
Models for Predicting
Drug Permeability</article-title>. <source>Expert Opin Drug Metab Toxicol</source><year>2012</year>, <volume>8</volume> (<issue>5</issue>), <fpage>607</fpage>&#8211;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1517/17425255.2012.673586</pub-id>.<pub-id pub-id-type="pmid">22424145</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name name-style="western"><surname>Tse</surname><given-names>C. H.</given-names></name>; <name name-style="western"><surname>Comer</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name><article-title>Link between Membrane
Composition and Permeability to Drugs</article-title>. <source>J. Chem.
Theory Comput</source><year>2018</year>, <volume>14</volume> (<issue>6</issue>), <fpage>2895</fpage>&#8211;<lpage>2909</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.8b00272</pub-id>.<pub-id pub-id-type="pmid">29771515</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name name-style="western"><surname>Kansy</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Avdeef</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Fischer</surname><given-names>H.</given-names></name><article-title>Advances in Screening
for Membrane
Permeability: High-Resolution PAMPA for Medicinal Chemists</article-title>. <source>Drug Discov Today Technol.</source><year>2004</year>, <volume>1</volume> (<issue>4</issue>), <fpage>349</fpage>&#8211;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/j.ddtec.2004.11.013</pub-id>.<pub-id pub-id-type="pmid">24981614</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name name-style="western"><surname>Dezani</surname><given-names>A. B.</given-names></name>; <name name-style="western"><surname>Pereira</surname><given-names>T. M.</given-names></name>; <name name-style="western"><surname>Caffaro</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Reis</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>dos Reis
Serra</surname><given-names>C. H.</given-names></name><article-title>Determination of Lamivudine and Zidovudine Permeability
Using a Different Ex Vivo Method in Franz Cells</article-title>. <source>J. Pharmacol. Toxicol. Methods</source><year>2013</year>, <volume>67</volume> (<issue>3</issue>), <fpage>194</fpage>&#8211;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/j.vascn.2013.01.005</pub-id>.<pub-id pub-id-type="pmid">23337245</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name name-style="western"><surname>Bennion</surname><given-names>B. J.</given-names></name>; <name name-style="western"><surname>Be</surname><given-names>N. A.</given-names></name>; <name name-style="western"><surname>McNerney</surname><given-names>M. W.</given-names></name>; <name name-style="western"><surname>Lao</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Carlson</surname><given-names>E. M.</given-names></name>; <name name-style="western"><surname>Valdez</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Malfatti</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Enright</surname><given-names>H. A.</given-names></name>; <name name-style="western"><surname>Nguyen</surname><given-names>T. H.</given-names></name>; <name name-style="western"><surname>Lightstone</surname><given-names>F. C.</given-names></name>; et al. <article-title>Predicting a Drug&#8217;s
Membrane Permeability:
A Computational Model Validated with in Vitro Permeability Assay Data</article-title>. <source>J. Phys. Chem. B</source><year>2017</year>, <volume>121</volume> (<issue>20</issue>), <fpage>5228</fpage>&#8211;<lpage>5237</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jpcb.7b02914</pub-id>.<pub-id pub-id-type="pmid">28453293</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name name-style="western"><surname>Venable</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Kramer</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Pastor</surname><given-names>R. W.</given-names></name><article-title>Molecular
Dynamics Simulations of
Membrane Permeability</article-title>. <source>Chem. Rev.</source><year>2019</year>, <volume>119</volume> (<issue>9</issue>), <fpage>5954</fpage>&#8211;<lpage>5997</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00486</pub-id>.<pub-id pub-id-type="pmid">30747524</pub-id><pub-id pub-id-type="pmcid">PMC6506413</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name name-style="western"><surname>de
Souza Teixeira</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Vila Chagas</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Alonso</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Gonzalez-Alvarez</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Bermejo</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Polli</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Rezende</surname><given-names>K. R.</given-names></name><article-title>Biomimetic Artificial
Membrane Permeability Assay over Franz Cell Apparatus Using Bcs Model
Drugs</article-title>. <source>Pharmaceutics</source><year>2020</year>, <volume>12</volume> (<issue>10</issue>), <fpage>988</fpage><pub-id pub-id-type="doi">10.3390/pharmaceutics12100988</pub-id>.<pub-id pub-id-type="pmid">33086670</pub-id><pub-id pub-id-type="pmcid">PMC7589491</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name name-style="western"><surname>Khirevich</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Yutkin</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Patzek</surname><given-names>T. W.</given-names></name><article-title>Correct
Estimation of Permeability
Using Experiment and Simulation</article-title>. <source>Phys. Fluids</source><year>2022</year>, <pub-id pub-id-type="doi">10.1063/5.0123673</pub-id>.</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name name-style="western"><surname>Van
Meer</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Voelker</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Feigenson</surname><given-names>G. W.</given-names></name><article-title>Membrane Lipids: Where They Are and
How They Behave</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source><year>2008</year>, <volume>9</volume> (<issue>2</issue>), <fpage>112</fpage>&#8211;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2330</pub-id>.<pub-id pub-id-type="pmid">18216768</pub-id><pub-id pub-id-type="pmcid">PMC2642958</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name name-style="western"><surname>Sampaio</surname><given-names>J.
L.</given-names></name>; <name name-style="western"><surname>Gerl</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Klose</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ejsing</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Beug</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Simons</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Shevchenko</surname><given-names>A.</given-names></name><article-title>Membrane Lipidome of an Epithelial
Cell Line</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2011</year>, <volume>108</volume> (<issue>5</issue>), <fpage>1903</fpage>&#8211;<lpage>1907</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1019267108</pub-id>.<pub-id pub-id-type="pmid">21245337</pub-id><pub-id pub-id-type="pmcid">PMC3033259</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name name-style="western"><surname>Wong</surname><given-names>A. D.</given-names></name>; <name name-style="western"><surname>Ye</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Levy</surname><given-names>A. F.</given-names></name>; <name name-style="western"><surname>Rothstein</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Bergles</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>The Blood-Brain
Barrier: An Engineering Perspective</article-title>. <source>Front.
Neuroeng.</source><year>2013</year>, <volume>6</volume>, <fpage>7</fpage><pub-id pub-id-type="doi">10.3389/fneng.2013.00007</pub-id>.<pub-id pub-id-type="pmid">24009582</pub-id><pub-id pub-id-type="pmcid">PMC3757302</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name name-style="western"><surname>Abbott</surname><given-names>N. J.</given-names></name><article-title>Blood&#8211;Brain
Barrier Structure and Function and the Challenges for CNS Drug Delivery</article-title>. <source>J. Inherit Metab Dis</source><year>2013</year>, <volume>36</volume>, <fpage>437</fpage>&#8211;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1007/s10545-013-9608-0</pub-id>.<pub-id pub-id-type="pmid">23609350</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name name-style="western"><surname>Prausnitz</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Elias</surname><given-names>P. M.</given-names></name>; <name name-style="western"><surname>Franz</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Schmuth</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Tsai</surname><given-names>J.-C.</given-names></name>; <name name-style="western"><surname>Menon</surname><given-names>G. K.</given-names></name>; <name name-style="western"><surname>Holleran</surname><given-names>W. M.</given-names></name>; <name name-style="western"><surname>Feingold</surname><given-names>K. R.</given-names></name><article-title>Skin Barrier
and
Transdermal Drug Delivery</article-title>. <source>Dermatology</source><year>2012</year>, <volume>3</volume>, <fpage>2065</fpage>&#8211;<lpage>2073</lpage>.</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name name-style="western"><surname>Pardridge</surname><given-names>W. M.</given-names></name><article-title>The Blood-Brain
Barrier: Bottleneck in Brain Drug Development</article-title>. <source>NeuroRx</source><year>2005</year>, <volume>2</volume>, <fpage>3</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1602/neurorx.2.1.3</pub-id>.<pub-id pub-id-type="pmid">15717053</pub-id><pub-id pub-id-type="pmcid">PMC539316</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name name-style="western"><surname>Pardridge</surname><given-names>W. M.</given-names></name><article-title>Transport
of Small Molecules through the Blood-Brain Barrier: Biology and Methodology</article-title>. <source>Adv. Drug Deliv Rev.</source><year>1995</year>, <volume>15</volume> (<issue>1&#8211;3</issue>), <fpage>5</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/0169-409X(95)00003-P</pub-id>.<pub-id pub-id-type="pmid">35524389</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name name-style="western"><surname>Zlokovic</surname><given-names>B. V.</given-names></name><article-title>The Blood-Brain
Barrier in Health and Chronic Neurodegenerative Disorders</article-title>. <source>Neuron</source><year>2008</year>, <volume>57</volume> (<issue>2</issue>), <fpage>178</fpage>&#8211;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.01.003</pub-id>.<pub-id pub-id-type="pmid">18215617</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name name-style="western"><surname>Doniger</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Hofmann</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Yeh</surname><given-names>J.</given-names></name><article-title>Predicting CNS Permeability
of Drug
Molecules: Comparison of Neural Network and Support Vector Machine
Algorithms</article-title>. <source>Journal of computational biology</source><year>2002</year>, <volume>9</volume> (<issue>6</issue>), <fpage>849</fpage>&#8211;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1089/10665270260518317</pub-id>.<pub-id pub-id-type="pmid">12614551</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name name-style="western"><surname>Gao</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Cai</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name><article-title>Predict Drug Permeability
to Blood&#8211;Brain-Barrier from Clinical Phenotypes: Drug Side
Effects and Drug Indications</article-title>. <source>Bioinformatics</source><year>2017</year>, <volume>33</volume> (<issue>6</issue>), <fpage>901</fpage>&#8211;<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw713</pub-id>.<pub-id pub-id-type="pmid">27993785</pub-id><pub-id pub-id-type="pmcid">PMC5860495</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name name-style="western"><surname>Lipinski</surname><given-names>C. A.</given-names></name><article-title>Rule of
Five in 2015 and beyond: Target and Ligand Structural Limitations,
Ligand Chemistry Structure and Drug Discovery Project Decisions</article-title>. <source>Adv. Drug Deliv Rev.</source><year>2016</year>, <volume>101</volume>, <fpage>34</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2016.04.029</pub-id>.<pub-id pub-id-type="pmid">27154268</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name name-style="western"><surname>Boxer</surname><given-names>S. G.</given-names></name>; <name name-style="western"><surname>Kraft</surname><given-names>M. L.</given-names></name>; <name name-style="western"><surname>Weber</surname><given-names>P. K.</given-names></name><article-title>Advances in Imaging
Secondary Ion
Mass Spectrometry for Biological Samples</article-title>. <source>Annu.
Rev. Biophys</source><year>2009</year>, <volume>38</volume>, <fpage>53</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biophys.050708.133634</pub-id>.<pub-id pub-id-type="pmid">19086820</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name name-style="western"><surname>Buchoux</surname><given-names>S.</given-names></name><article-title>FATSLiM: A
Fast and Robust Software to Analyze MD Simulations of Membranes</article-title>. <source>Bioinformatics</source><year>2017</year>, <volume>33</volume> (<issue>1</issue>), <fpage>133</fpage>&#8211;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw563</pub-id>.<pub-id pub-id-type="pmid">27578804</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name name-style="western"><surname>Smith</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Lorenz</surname><given-names>C. D.</given-names></name><article-title>LiPyphilic: A Python
Toolkit for the Analysis of Lipid
Membrane Simulations</article-title>. <source>J. Chem. Theory Comput</source><year>2021</year>, <volume>17</volume> (<issue>9</issue>), <fpage>5907</fpage>&#8211;<lpage>5919</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.1c00447</pub-id>.<pub-id pub-id-type="pmid">34450002</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name name-style="western"><surname>Song</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Corey</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Ansell</surname><given-names>T. B.</given-names></name>; <name name-style="western"><surname>Cassidy</surname><given-names>C. K.</given-names></name>; <name name-style="western"><surname>Horrell</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Duncan</surname><given-names>A. L.</given-names></name>; <name name-style="western"><surname>Stansfeld</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Sansom</surname><given-names>M. S. P.</given-names></name><article-title>PyLipID: A Python
Package for Analysis of Protein&#8211;Lipid Interactions from Molecular
Dynamics Simulations</article-title>. <source>J. Chem. Theory Comput</source><year>2022</year>, <volume>18</volume> (<issue>2</issue>), <fpage>1188</fpage>&#8211;<lpage>1201</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.1c00708</pub-id>.<pub-id pub-id-type="pmid">35020380</pub-id><pub-id pub-id-type="pmcid">PMC8830038</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name name-style="western"><surname>McGibbon</surname><given-names>R. T.</given-names></name>; <name name-style="western"><surname>Beauchamp</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Harrigan</surname><given-names>M. P.</given-names></name>; <name name-style="western"><surname>Klein</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Swails</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Hern&#225;ndez</surname><given-names>C. X.</given-names></name>; <name name-style="western"><surname>Schwantes</surname><given-names>C. R.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>L.-P.</given-names></name>; <name name-style="western"><surname>Lane</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Pande</surname><given-names>V. S.</given-names></name><article-title>MDTraj: A Modern Open Library for the Analysis of Molecular
Dynamics Trajectories</article-title>. <source>Biophys. J.</source><year>2015</year>, <volume>109</volume> (<issue>8</issue>), <fpage>1528</fpage>&#8211;<lpage>1532</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2015.08.015</pub-id>.<pub-id pub-id-type="pmid">26488642</pub-id><pub-id pub-id-type="pmcid">PMC4623899</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name name-style="western"><surname>Michaud-Agrawal</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Denning</surname><given-names>E. J.</given-names></name>; <name name-style="western"><surname>Woolf</surname><given-names>T. B.</given-names></name>; <name name-style="western"><surname>Beckstein</surname><given-names>O.</given-names></name><article-title>MDAnalysis:
A Toolkit for the Analysis of Molecular Dynamics Simulations</article-title>. <source>J. Comput. Chem.</source><year>2011</year>, <volume>32</volume> (<issue>10</issue>), <fpage>2319</fpage>&#8211;<lpage>2327</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21787</pub-id>.<pub-id pub-id-type="pmid">21500218</pub-id><pub-id pub-id-type="pmcid">PMC3144279</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name name-style="western"><surname>Lorent</surname><given-names>J. H.</given-names></name>; <name name-style="western"><surname>Levental</surname><given-names>K. R.</given-names></name>; <name name-style="western"><surname>Ganesan</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Rivera-Longsworth</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Sezgin</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Doktorova</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lyman</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Levental</surname><given-names>I.</given-names></name><article-title>Plasma Membranes
Are Asymmetric in Lipid Unsaturation, Packing and Protein Shape</article-title>. <source>Nat. Chem. Biol.</source><year>2020</year>, <volume>16</volume> (<issue>6</issue>), <fpage>644</fpage>&#8211;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-020-0529-6</pub-id>.<pub-id pub-id-type="pmid">32367017</pub-id><pub-id pub-id-type="pmcid">PMC7246138</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name name-style="western"><surname>Hossein</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Deserno</surname><given-names>M.</given-names></name><article-title>Spontaneous Curvature,
Differential Stress, and Bending
Modulus of Asymmetric Lipid Membranes</article-title>. <source>Biophys.
J.</source><year>2020</year>, <volume>118</volume> (<issue>3</issue>), <fpage>624</fpage>&#8211;<lpage>642</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2019.11.3398</pub-id>.<pub-id pub-id-type="pmid">31954503</pub-id><pub-id pub-id-type="pmcid">PMC7002915</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name name-style="western"><surname>Lambden</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name><article-title>Novel Gramicidin-Derived &#946;-Helical
Antimicrobial
Peptides</article-title>. <source>bioRxiv</source><year>2024</year>, <fpage>2012</fpage>&#8211;<lpage>2023</lpage>.</mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name name-style="western"><surname>Smith</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Owen</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Lorenz</surname><given-names>C. D.</given-names></name>; <name name-style="western"><surname>Makarova</surname><given-names>M.</given-names></name><article-title>Asymmetric Glycerophospholipids
Impart Distinctive Biophysical Properties to Lipid Bilayers</article-title>. <source>Biophys. J.</source><year>2021</year>, <volume>120</volume> (<issue>9</issue>), <fpage>1746</fpage>&#8211;<lpage>1754</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2021.02.046</pub-id>.<pub-id pub-id-type="pmid">33705758</pub-id><pub-id pub-id-type="pmcid">PMC8204391</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name name-style="western"><surname>Hristova</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Selsted</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>White</surname><given-names>S. H.</given-names></name><article-title>Critical
Role of Lipid Composition
in Membrane Permeabilization by Rabbit Neutrophil Defensins</article-title>. <source>J. Biol. Chem.</source><year>1997</year>, <volume>272</volume> (<issue>39</issue>), <fpage>24224</fpage>&#8211;<lpage>24233</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.39.24224</pub-id>.<pub-id pub-id-type="pmid">9305875</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="book" id="cit49"><person-group person-group-type="allauthors"><name name-style="western"><surname>Rosenbaum</surname><given-names>S. E.</given-names></name></person-group><source>Basic Pharmacokinetics
and Pharmacodynamics: An Integrated Textbook and Computer Simulations</source>; <publisher-name>John Wiley &amp; Sons</publisher-name>, <year>2016</year>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="book" id="cit50"><person-group person-group-type="allauthors"><name name-style="western"><surname>Hedaya</surname><given-names>M. A.</given-names></name></person-group><source>Basic Pharmacokinetics</source>; <publisher-name>CRC Press</publisher-name>, <year>2012</year>.</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name name-style="western"><surname>Matsson</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Kihlberg</surname><given-names>J.</given-names></name><article-title>How Big Is Too Big
for Cell Permeability?</article-title>. <source>Journal of medicinal
chemistry</source><year>2017</year>, <volume>60</volume>, <fpage>1662</fpage>&#8211;<lpage>1664</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b00237</pub-id>.<pub-id pub-id-type="pmid">28234469</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name name-style="western"><surname>Fernandes</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Cardoso</surname><given-names>V. F.</given-names></name>; <name name-style="western"><surname>Lanceros-M&#233;ndez</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>L&#250;cio</surname><given-names>M.</given-names></name><article-title>Lipid Microfluidic
Biomimetic Models for Drug Screening: A Comprehensive Review</article-title>. <source>Adv. Funct Mater.</source><year>2024</year>, <volume>34</volume>, <elocation-id>2315166</elocation-id><pub-id pub-id-type="doi">10.1002/adfm.202315166</pub-id>.</mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name name-style="western"><surname>Guha</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Ghimire</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Wimley</surname><given-names>W. C.</given-names></name><article-title>Mechanistic Landscape
of Membrane-Permeabilizing Peptides</article-title>. <source>Chem. Rev.</source><year>2019</year>, <volume>119</volume> (<issue>9</issue>), <fpage>6040</fpage>&#8211;<lpage>6085</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00520</pub-id>.<pub-id pub-id-type="pmid">30624911</pub-id><pub-id pub-id-type="pmcid">PMC9235363</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name name-style="western"><surname>Ulmschneider</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name><article-title>Molecular Dynamics Simulations Are Redefining Our View
of Peptides Interacting with Biological Membranes</article-title>. <source>Acc. Chem. Res.</source><year>2018</year>, <volume>51</volume> (<issue>5</issue>), <fpage>1106</fpage>&#8211;<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1021/acs.accounts.7b00613</pub-id>.<pub-id pub-id-type="pmid">29667836</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name name-style="western"><surname>Komin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bogorad</surname><given-names>M. I.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Cui</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name>; <name name-style="western"><surname>Hristova</surname><given-names>K.</given-names></name><article-title>A Peptide for Transcellular Cargo
Delivery: Structure-Function
Relationship and Mechanism of Action</article-title>. <source>J. Controlled
Release</source><year>2020</year>, <volume>324</volume>, <fpage>633</fpage>&#8211;<lpage>643</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2020.05.030</pub-id>.<pub-id pub-id-type="pmcid">PMC7429318</pub-id><pub-id pub-id-type="pmid">32474121</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name name-style="western"><surname>Chen</surname><given-names>C. H.</given-names></name>; <name name-style="western"><surname>Starr</surname><given-names>C. G.</given-names></name>; <name name-style="western"><surname>Troendle</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Wiedman</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Wimley</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name><article-title>Simulation-Guided Rational de Novo
Design of a Small Pore-Forming Antimicrobial Peptide</article-title>. <source>J. Am. Chem. Soc.</source><year>2019</year>, <volume>141</volume> (<issue>12</issue>), <fpage>4839</fpage>&#8211;<lpage>4848</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.8b11939</pub-id>.<pub-id pub-id-type="pmid">30839209</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name name-style="western"><surname>Wiedman</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Fuselier</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name>; <name name-style="western"><surname>Hristova</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Wimley</surname><given-names>W. C.</given-names></name><article-title>Highly Efficient
Macromolecule-Sized Poration of Lipid
Bilayers by a Synthetically Evolved Peptide</article-title>. <source>J. Am. Chem. Soc.</source><year>2014</year>, <volume>136</volume> (<issue>12</issue>), <fpage>4724</fpage>&#8211;<lpage>4731</lpage>. <pub-id pub-id-type="doi">10.1021/ja500462s</pub-id>.<pub-id pub-id-type="pmid">24588399</pub-id><pub-id pub-id-type="pmcid">PMC3985440</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name name-style="western"><surname>Wiedman</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Herman</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Wimley</surname><given-names>W. C.</given-names></name>; <name name-style="western"><surname>Hristova</surname><given-names>K.</given-names></name><article-title>The Electrical
Response of Bilayers to the Bee Venom Toxin Melittin: Evidence for
Transient Bilayer Permeabilization</article-title>. <source>Biochimica
et Biophysica Acta (BBA)-Biomembranes</source><year>2013</year>, <volume>1828</volume> (<issue>5</issue>), <fpage>1357</fpage>&#8211;<lpage>1364</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2013.01.021</pub-id>.<pub-id pub-id-type="pmid">23384418</pub-id><pub-id pub-id-type="pmcid">PMC4020439</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name name-style="western"><surname>Safa</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Vaithiyanathan</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sombolestani</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Charles</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Melvin</surname><given-names>A. T.</given-names></name><article-title>Population-Based
Analysis of Cell-Penetrating Peptide Uptake Using a Microfluidic Droplet
Trapping Array</article-title>. <source>Anal Bioanal Chem.</source><year>2019</year>, <volume>411</volume>, <fpage>2729</fpage>&#8211;<lpage>2741</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-019-01713-5</pub-id>.<pub-id pub-id-type="pmid">30854596</pub-id><pub-id pub-id-type="pmcid">PMC6472966</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name name-style="western"><surname>Kasper</surname><given-names>S. H.</given-names></name>; <name name-style="western"><surname>Otten</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Squadroni</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Orr-Terry</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Kuang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Mussallem</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Ge</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Yan</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Kannan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Verma</surname><given-names>C. S.</given-names></name>; et al. <article-title>A High-throughput
Microfluidic
Mechanoporation Platform to Enable Intracellular Delivery of Cyclic
Peptides in Cell-based Assays</article-title>. <source>Bioeng. Transl.
Med.</source><year>2023</year>, <volume>8</volume> (<issue>5</issue>), <elocation-id>e10542</elocation-id><pub-id pub-id-type="doi">10.1002/btm2.10542</pub-id>.<pub-id pub-id-type="pmid">37693049</pub-id><pub-id pub-id-type="pmcid">PMC10487316</pub-id></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name name-style="western"><surname>Chung</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>H.-W.</given-names></name>; <name name-style="western"><surname>Nam</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Oh</surname><given-names>H. J.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>Y. H.</given-names></name>; <name name-style="western"><surname>Chung</surname><given-names>S.</given-names></name><article-title>Microfluidic in Vitro Brain Endothelial
Monolayer Model to Evaluate Cell-Penetrating Peptides</article-title>. <source>Micro Nano Syst. Lett.</source><year>2019</year>, <volume>7</volume>, <fpage>1</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1186/s40486-019-0092-7</pub-id>.</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name name-style="western"><surname>Brahm</surname><given-names>J.</given-names></name><article-title>Urea Permeability
of Human Red Cells</article-title>. <source>J. Gen Physiol</source><year>1983</year>, <volume>82</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.82.1.1</pub-id>.<pub-id pub-id-type="pmid">6411854</pub-id><pub-id pub-id-type="pmcid">PMC2228688</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal" id="cit63"><name name-style="western"><surname>Garberg</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Ball</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Borg</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Cecchelli</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Fenart</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Hurst</surname><given-names>R. D.</given-names></name>; <name name-style="western"><surname>Lindmark</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Mabondzo</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Nilsson</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Raub</surname><given-names>T. J.</given-names></name>; et al. <article-title>In
Vitro Models for
the Blood&#8211;Brain Barrier</article-title>. <source>Toxicol. In
Vitro</source><year>2005</year>, <volume>19</volume> (<issue>3</issue>), <fpage>299</fpage>&#8211;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2004.06.011</pub-id>.<pub-id pub-id-type="pmid">15713540</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal" id="cit64"><name name-style="western"><surname>Sun</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Lennernas</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Welage</surname><given-names>L. S.</given-names></name>; <name name-style="western"><surname>Barnett</surname><given-names>J. L.</given-names></name>; <name name-style="western"><surname>Landowski</surname><given-names>C. P.</given-names></name>; <name name-style="western"><surname>Foster</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Fleisher</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Lee</surname><given-names>K.-D.</given-names></name>; <name name-style="western"><surname>Amidon</surname><given-names>G. L.</given-names></name><article-title>Comparison
of Human Duodenum and Caco-2 Gene Expression Profiles for 12,000 Gene
Sequences Tags and Correlation with Permeability of 26 Drugs</article-title>. <source>Pharm. Res.</source><year>2002</year>, <volume>19</volume>, <fpage>1400</fpage>&#8211;<lpage>1416</lpage>. <pub-id pub-id-type="doi">10.1023/A:1020483911355</pub-id>.<pub-id pub-id-type="pmid">12425456</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal" id="cit65"><name name-style="western"><surname>Hellinger</surname><given-names>&#201;.</given-names></name>; <name name-style="western"><surname>Veszelka</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>T&#243;th</surname><given-names>A. E.</given-names></name>; <name name-style="western"><surname>Walter</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Kittel</surname><given-names>&#193;.</given-names></name>; <name name-style="western"><surname>Bakk</surname><given-names>M. L.</given-names></name>; <name name-style="western"><surname>Tihanyi</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>H&#225;da</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Nakagawa</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Duy</surname><given-names>T. D. H.</given-names></name>; et al. <article-title>Comparison of Brain
Capillary Endothelial Cell-Based and Epithelial (MDCK-MDR1, Caco-2,
and VB-Caco-2) Cell-Based Surrogate Blood&#8211;Brain Barrier Penetration
Models</article-title>. <source>Eur. J. Pharm. Biopharm.</source><year>2012</year>, <volume>82</volume> (<issue>2</issue>), <fpage>340</fpage>&#8211;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpb.2012.07.020</pub-id>.<pub-id pub-id-type="pmid">22906709</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal" id="cit66"><name name-style="western"><surname>Summerfield</surname><given-names>S. G.</given-names></name>; <name name-style="western"><surname>Read</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Begley</surname><given-names>D. J.</given-names></name>; <name name-style="western"><surname>Obradovic</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hidalgo</surname><given-names>I. J.</given-names></name>; <name name-style="western"><surname>Coggon</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Lewis</surname><given-names>A. V.</given-names></name>; <name name-style="western"><surname>Porter</surname><given-names>R. A.</given-names></name>; <name name-style="western"><surname>Jeffrey</surname><given-names>P.</given-names></name><article-title>Central Nervous System Drug Disposition:
The Relationship
between in Situ Brain Permeability and Brain Free Fraction</article-title>. <source>Journal of Pharmacology and Experimental Therapeutics</source><year>2007</year>, <volume>322</volume> (<issue>1</issue>), <fpage>205</fpage>&#8211;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.107.121525</pub-id>.<pub-id pub-id-type="pmid">17405866</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal" id="cit67"><name name-style="western"><surname>Pade</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Stavchansky</surname><given-names>S.</given-names></name><article-title>Link between Drug Absorption Solubility and Permeability
Measurements in Caco-2 Cells</article-title>. <source>J. Pharm. Sci.</source><year>1998</year>, <volume>87</volume> (<issue>12</issue>), <fpage>1604</fpage>&#8211;<lpage>1607</lpage>. <pub-id pub-id-type="doi">10.1021/js980111k</pub-id>.<pub-id pub-id-type="pmid">10189274</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal" id="cit68"><name name-style="western"><surname>Yang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Lin</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Mu</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Wu</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Zhi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>L.</given-names></name><article-title>Neurons Enhance
Blood-Brain Barrier
Function via Upregulating Claudin-5 and VE-Cadherin Expression Due
to GDNF Secretion</article-title>. <source>bioRxiv</source><year>2024</year>, <fpage>2022</fpage>&#8211;<lpage>2024</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.96161</pub-id><pub-id pub-id-type="pmcid">PMC11524583</pub-id><pub-id pub-id-type="pmid">39475379</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal" id="cit69"><name name-style="western"><surname>Boateng</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Nilson</surname><given-names>A. N.</given-names></name>; <name name-style="western"><surname>Placide</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Pham</surname><given-names>M. L.</given-names></name>; <name name-style="western"><surname>Jakobs</surname><given-names>F. M.</given-names></name>; <name name-style="western"><surname>Boldizsar</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>McIntosh</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Stallings</surname><given-names>L. S.</given-names></name>; <name name-style="western"><surname>Korankyi</surname><given-names>I. V.</given-names></name>; <name name-style="western"><surname>Kelshikar</surname><given-names>S.</given-names></name>; et al. <article-title>Pharmacology and Therapeutic
Potential of Benzothiazole Analogues for Cocaine Use Disorder</article-title>. <source>J. Med. Chem.</source><year>2023</year>, <volume>66</volume> (<issue>17</issue>), <fpage>12141</fpage>&#8211;<lpage>12162</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.3c00734</pub-id>.<pub-id pub-id-type="pmid">37646374</pub-id><pub-id pub-id-type="pmcid">PMC10510399</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal" id="cit70"><name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Duan</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Fisher</surname><given-names>J.</given-names></name><article-title>Application
of Physiologically Based
Absorption Modeling to Characterize the Pharmacokinetic Profiles of
Oral Extended Release Methylphenidate Products in Adults</article-title>. <source>PLoS One</source><year>2016</year>, <volume>11</volume> (<issue>10</issue>), <elocation-id>e0164641</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0164641</pub-id>.<pub-id pub-id-type="pmid">27723791</pub-id><pub-id pub-id-type="pmcid">PMC5056674</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal" id="cit71"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Oprea</surname><given-names>T. I.</given-names></name>; <name name-style="western"><surname>Golbraikh</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Tropsha</surname><given-names>A.</given-names></name><article-title>QSAR Modeling of the
Blood&#8211;Brain Barrier Permeability for Diverse Organic Compounds</article-title>. <source>Pharm. Res.</source><year>2008</year>, <volume>25</volume>, <fpage>1902</fpage>&#8211;<lpage>1914</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-008-9609-0</pub-id>.<pub-id pub-id-type="pmid">18553217</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal" id="cit72"><name name-style="western"><surname>Shah</surname><given-names>M. V.</given-names></name>; <name name-style="western"><surname>Audus</surname><given-names>K. L.</given-names></name>; <name name-style="western"><surname>Borchardt</surname><given-names>R. T.</given-names></name><article-title>The Application
of Bovine Brain Microvessel
Endothelial-Cell Monolayers Grown onto Polycarbonate Membranes in
Vitro to Estimate the Potential Permeability of Solutes through the
Blood&#8211;Brain Barrier</article-title>. <source>Pharm. Res.</source><year>1989</year>, <volume>6</volume>, <fpage>624</fpage>&#8211;<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1023/A:1015913817221</pub-id>.<pub-id pub-id-type="pmid">2798313</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="book" id="cit73"><person-group person-group-type="allauthors"><name name-style="western"><surname>Avdeef</surname><given-names>A.</given-names></name></person-group><source>Absorption and Drug Development:
Solubility, Permeability, and Charge State</source>; <publisher-name>John Wiley &amp; Sons</publisher-name>, <year>2012</year>.</mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal" id="cit74"><name name-style="western"><surname>Adson</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Burton</surname><given-names>P. S.</given-names></name>; <name name-style="western"><surname>Raub</surname><given-names>T. J.</given-names></name>; <name name-style="western"><surname>Barsuhn</surname><given-names>C. L.</given-names></name>; <name name-style="western"><surname>Audus</surname><given-names>K. L.</given-names></name>; <name name-style="western"><surname>Ho</surname><given-names>N. F. H.</given-names></name><article-title>Passive Diffusion of Weak Organic
Electrolytes across
Caco-2 Cell Monolayers: Uncoupling the Contributions of Hydrodynamic,
Transcellular, and Paracellular Barriers</article-title>. <source>J.
Pharm. Sci.</source><year>1995</year>, <volume>84</volume> (<issue>10</issue>), <fpage>1197</fpage>&#8211;<lpage>1204</lpage>. <pub-id pub-id-type="doi">10.1002/jps.2600841011</pub-id>.<pub-id pub-id-type="pmid">8801334</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal" id="cit75"><name name-style="western"><surname>Franke</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Galla</surname><given-names>H.-J.</given-names></name>; <name name-style="western"><surname>Beuckmann</surname><given-names>C. T.</given-names></name><article-title>An Improved Low-Permeability in Vitro-Model
of the Blood&#8211;Brain Barrier: Transport Studies on Retinoids,
Sucrose, Haloperidol Caffeine and Mannitol</article-title>. <source>Brain Res.</source><year>1999</year>, <volume>818</volume> (<issue>1</issue>), <fpage>65</fpage>&#8211;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(98)01282-7</pub-id>.<pub-id pub-id-type="pmid">9914438</pub-id></mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal" id="cit76"><name name-style="western"><surname>Yamashita</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Furubayashi</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Kataoka</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sakane</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Sezaki</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Tokuda</surname><given-names>H.</given-names></name><article-title>Optimized Conditions for Prediction
of Intestinal Drug
Permeability Using Caco-2 Cells</article-title>. <source>European journal
of pharmaceutical sciences</source><year>2000</year>, <volume>10</volume> (<issue>3</issue>), <fpage>195</fpage>&#8211;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/S0928-0987(00)00076-2</pub-id>.<pub-id pub-id-type="pmid">10767597</pub-id></mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal" id="cit77"><name name-style="western"><surname>Katt</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Mayo</surname><given-names>L. N.</given-names></name>; <name name-style="western"><surname>Ellis</surname><given-names>S. E.</given-names></name>; <name name-style="western"><surname>Mahairaki</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Rothstein</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Cheng</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>The Role
of Mutations
Associated with Familial Neurodegenerative Disorders on Blood&#8211;Brain
Barrier Function in an IPSC Model</article-title>. <source>Fluids Barriers
CNS</source><year>2019</year>, <volume>16</volume>, <fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1186/s12987-019-0139-4</pub-id>.<pub-id pub-id-type="pmid">31303172</pub-id><pub-id pub-id-type="pmcid">PMC6628493</pub-id></mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal" id="cit78"><name name-style="western"><surname>Friend</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Smedley</surname><given-names>S. I.</given-names></name><article-title>Solvent Drag in
Ethanol/Ethyl Acetate Enhanced Skin
Permeation of d-Norgestrel</article-title>. <source>Int. J. Pharm.</source><year>1993</year>, <volume>97</volume> (<issue>1&#8211;3</issue>), <fpage>39</fpage>&#8211;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/0378-5173(93)90124-X</pub-id>.</mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal" id="cit79"><name name-style="western"><surname>Whittembury</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Mart&#237;nez</surname><given-names>C. V.
De</given-names></name>; <name name-style="western"><surname>Linares</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Paz-Aliaga</surname><given-names>A.</given-names></name><article-title>Solvent Drag
of Large Solutes Indicates Paracellular Water Flow in Leaky Epithelia</article-title>. <source>Proc. R Soc. Lond B Biol. Sci.</source><year>1980</year>, <volume>211</volume> (<issue>1182</issue>), <fpage>63</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1098/rspb.1980.0158</pub-id>.<pub-id pub-id-type="pmid">6111075</pub-id></mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal" id="cit80"><name name-style="western"><surname>Mullen</surname><given-names>T. L.</given-names></name>; <name name-style="western"><surname>Muller</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Van Bruggen</surname><given-names>J. T.</given-names></name><article-title>Role of
Solute Drag in Intestinal
Transport</article-title>. <source>J. Gen Physiol</source><year>1985</year>, <volume>85</volume> (<issue>3</issue>), <fpage>347</fpage>&#8211;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.85.3.347</pub-id>.<pub-id pub-id-type="pmid">3989502</pub-id><pub-id pub-id-type="pmcid">PMC2215792</pub-id></mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal" id="cit81"><name name-style="western"><surname>Van
Bruggen</surname><given-names>J. T.</given-names></name>; <name name-style="western"><surname>Chalmers</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Muller</surname><given-names>M.</given-names></name><article-title>Effects of Solvent
and Solute Drag on Transmembrane Diffusion</article-title>. <source>J. Gen Physiol</source><year>1982</year>, <volume>79</volume> (<issue>3</issue>), <fpage>507</fpage>&#8211;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1085/jgp.79.3.507</pub-id>.<pub-id pub-id-type="pmid">6804595</pub-id><pub-id pub-id-type="pmcid">PMC2215754</pub-id></mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal" id="cit82"><name name-style="western"><surname>Hashimoto</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Greene</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Munnich</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Campbell</surname><given-names>M.</given-names></name><article-title>The CLDN5 Gene at the
Blood-Brain Barrier in Health and Disease</article-title>. <source>Fluids
Barriers CNS</source><year>2023</year>, <volume>20</volume> (<issue>1</issue>), <fpage>22</fpage><pub-id pub-id-type="doi">10.1186/s12987-023-00424-5</pub-id>.<pub-id pub-id-type="pmid">36978081</pub-id><pub-id pub-id-type="pmcid">PMC10044825</pub-id></mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="journal" id="cit83"><name name-style="western"><surname>Anderson</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Van Itallie</surname><given-names>C. M.</given-names></name><article-title>Tight Junctions and the Molecular Basis for Regulation
of Paracellular Permeability.</article-title>. <source>American Journal
of Physiology-Gastrointestinal and Liver Physiology</source><year>1995</year>, <volume>269</volume> (<issue>4</issue>), <fpage>G467</fpage>&#8211;<lpage>G475</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.1995.269.4.G467</pub-id>.<pub-id pub-id-type="pmid">7485497</pub-id></mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal" id="cit84"><name name-style="western"><surname>Konsoula</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Barile</surname><given-names>F. A.</given-names></name><article-title>Correlation of in Vitro Cytotoxicity with Paracellular
Permeability in Caco-2 Cells</article-title>. <source>Toxicology in
Vitro</source><year>2005</year>, <volume>19</volume> (<issue>5</issue>), <fpage>675</fpage>&#8211;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2005.03.006</pub-id>.<pub-id pub-id-type="pmid">15896555</pub-id></mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal" id="cit85"><name name-style="western"><surname>Ward</surname><given-names>P. D.</given-names></name>; <name name-style="western"><surname>Tippin</surname><given-names>T. K.</given-names></name>; <name name-style="western"><surname>Thakker</surname><given-names>D. R.</given-names></name><article-title>Enhancing Paracellular
Permeability
by Modulating Epithelial Tight Junctions</article-title>. <source>Pharm.
Sci. Technol. Today</source><year>2000</year>, <volume>3</volume> (<issue>10</issue>), <fpage>346</fpage>&#8211;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1016/S1461-5347(00)00302-3</pub-id>.<pub-id pub-id-type="pmid">11050459</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal" id="cit86"><name name-style="western"><surname>Hu</surname><given-names>Y.-J.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Y.-D.</given-names></name>; <name name-style="western"><surname>Tan</surname><given-names>F.-Q.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>W.-X.</given-names></name><article-title>Regulation of Paracellular
Permeability: Factors and Mechanisms</article-title>. <source>Mol. Biol.
Rep</source><year>2013</year>, <volume>40</volume>, <fpage>6123</fpage>&#8211;<lpage>6142</lpage>. <pub-id pub-id-type="doi">10.1007/s11033-013-2724-y</pub-id>.<pub-id pub-id-type="pmid">24062072</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="book" id="cit87"><person-group person-group-type="allauthors"><name name-style="western"><surname>V&#225;radi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Szak&#225;cs</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Bakos</surname><given-names>&#201;.</given-names></name>; <name name-style="western"><surname>Sarkadi</surname><given-names>B.</given-names></name></person-group><article-title>P Glycoprotein
and the Mechanism of Multidrug Resistance</article-title>. In <source>Mechanisms of Drug Resistance in Epilepsy: Novartis Foundation Symposium
243</source>; <publisher-name>Wiley Online Library</publisher-name>, <year>2002</year>; Vol. <volume>243</volume>, pp <fpage>54</fpage>&#8211;<lpage>68</lpage>.<pub-id pub-id-type="pmid">11990782</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal" id="cit88"><name name-style="western"><surname>Sharom</surname><given-names>F.
J.</given-names></name><article-title>The P-Glycoprotein
Multidrug Transporter</article-title>. <source>Essays Biochem</source><year>2011</year>, <volume>50</volume>, <fpage>161</fpage>&#8211;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1042/bse0500161</pub-id>.<pub-id pub-id-type="pmid">21967057</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal" id="cit89"><name name-style="western"><surname>Cordon-Cardo</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Obrien</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Boccia</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Casals</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Bertino</surname><given-names>J. R.</given-names></name>; <name name-style="western"><surname>Melamed</surname><given-names>M. R.</given-names></name><article-title>Expression of the
Multidrug Resistance Gene Product
(P-Glycoprotein) in Human Normal and Tumor Tissues</article-title>. <source>J. Histochem. Cytochem.</source><year>1990</year>, <volume>38</volume> (<issue>9</issue>), <fpage>1277</fpage>&#8211;<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1177/38.9.1974900</pub-id>.<pub-id pub-id-type="pmid">1974900</pub-id></mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal" id="cit90"><name name-style="western"><surname>Goda</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Bacs&#243;</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Szab&#243;</surname><given-names>G.</given-names></name><article-title>Multidrug Resistance through the
Spectacle of P-Glycoprotein</article-title>. <source>Curr. Cancer Drug
Targets</source><year>2009</year>, <volume>9</volume> (<issue>3</issue>), <fpage>281</fpage>&#8211;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.2174/156800909788166493</pub-id>.<pub-id pub-id-type="pmid">19442049</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal" id="cit91"><name name-style="western"><surname>Bradley</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Ling</surname><given-names>V.</given-names></name><article-title>P-Glycoprotein, Multidrug Resistance
and Tumor Progression</article-title>. <source>Cancer and Metastasis
Reviews</source><year>1994</year>, <volume>13</volume>, <fpage>223</fpage>&#8211;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1007/BF00689638</pub-id>.<pub-id pub-id-type="pmid">7923552</pub-id></mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal" id="cit92"><name name-style="western"><surname>Nielsen</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Skovsgaard</surname><given-names>T.</given-names></name><article-title>P-Glycoprotein
as Multidrug Transporter: A Critical
Review of Current Multidrug Resistant Cell Lines</article-title>. <source>Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease</source><year>1992</year>, <volume>1139</volume> (<issue>3</issue>), <fpage>169</fpage>&#8211;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/0925-4439(92)90131-6</pub-id>.<pub-id pub-id-type="pmid">1352705</pub-id></mixed-citation></ref><ref id="ref93"><mixed-citation publication-type="journal" id="cit93"><name name-style="western"><surname>Elfadadny</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>El-Husseiny</surname><given-names>H. M.</given-names></name>; <name name-style="western"><surname>Abugomaa</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Ragab</surname><given-names>R. F.</given-names></name>; <name name-style="western"><surname>Mady</surname><given-names>E. A.</given-names></name>; <name name-style="western"><surname>Aboubakr</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Samir</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Mandour</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>El-Mleeh</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>El-Far</surname><given-names>A. H.</given-names></name>; et al. <article-title>Role of Multidrug Resistance-Associated Proteins
in Cancer Therapeutics: Past, Present, and Future Perspectives</article-title>. <source>Environ. Sci. Pollut. Res.</source><year>2021</year>, <volume>28</volume>, <fpage>49447</fpage>&#8211;<lpage>49466</lpage>. <pub-id pub-id-type="doi">10.1007/s11356-021-15759-5</pub-id>.<pub-id pub-id-type="pmid">34355314</pub-id></mixed-citation></ref><ref id="ref94"><mixed-citation publication-type="journal" id="cit94"><name name-style="western"><surname>Catalano</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Iacopetta</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Ceramella</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Scumaci</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Giuzio</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Saturnino</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Aquaro</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Rosano</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sinicropi</surname><given-names>M. S.</given-names></name><article-title>Multidrug
Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies</article-title>. <source>Molecules</source><year>2022</year>, <volume>27</volume> (<issue>3</issue>), <fpage>616</fpage><pub-id pub-id-type="doi">10.3390/molecules27030616</pub-id>.<pub-id pub-id-type="pmid">35163878</pub-id><pub-id pub-id-type="pmcid">PMC8839222</pub-id></mixed-citation></ref><ref id="ref95"><mixed-citation publication-type="journal" id="cit95"><name name-style="western"><surname>Emran</surname><given-names>T. B.</given-names></name>; <name name-style="western"><surname>Shahriar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Mahmud</surname><given-names>A. R.</given-names></name>; <name name-style="western"><surname>Rahman</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Abir</surname><given-names>M. H.</given-names></name>; <name name-style="western"><surname>Siddiquee</surname><given-names>M. F.-R.</given-names></name>; <name name-style="western"><surname>Ahmed</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Rahman</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Nainu</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Wahyudin</surname><given-names>E.</given-names></name>; et al. <article-title>Multidrug Resistance
in Cancer: Understanding
Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.</article-title>. <source>Front. Oncol.</source><year>2022</year>, <volume>12</volume>, <elocation-id>891652</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2022.891652</pub-id>.<pub-id pub-id-type="pmid">35814435</pub-id><pub-id pub-id-type="pmcid">PMC9262248</pub-id></mixed-citation></ref><ref id="ref96"><mixed-citation publication-type="journal" id="cit96"><name name-style="western"><surname>Jedlicka</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Becker</surname><given-names>B. F.</given-names></name>; <name name-style="western"><surname>Chappell</surname><given-names>D.</given-names></name><article-title>Endothelial Glycocalyx</article-title>. <source>Crit Care Clin</source><year>2020</year>, <volume>36</volume> (<issue>2</issue>), <fpage>217</fpage>&#8211;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccc.2019.12.007</pub-id>.<pub-id pub-id-type="pmid">32172810</pub-id></mixed-citation></ref><ref id="ref97"><mixed-citation publication-type="journal" id="cit97"><name name-style="western"><surname>Kutuzov</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Flyvbjerg</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Lauritzen</surname><given-names>M.</given-names></name><article-title>Contributions of the Glycocalyx,
Endothelium, and Extravascular Compartment to the Blood&#8211;Brain
Barrier</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2018</year>, <volume>115</volume> (<issue>40</issue>), <fpage>E9429</fpage>&#8211;<lpage>E9438</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1802155115</pub-id>.<pub-id pub-id-type="pmid">30217895</pub-id><pub-id pub-id-type="pmcid">PMC6176561</pub-id></mixed-citation></ref><ref id="ref98"><mixed-citation publication-type="journal" id="cit98"><name name-style="western"><surname>Weinbaum</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Tarbell</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Damiano</surname><given-names>E. R.</given-names></name><article-title>The Structure and Function of the
Endothelial Glycocalyx Layer</article-title>. <source>Annu. Rev. Biomed.
Eng.</source><year>2007</year>, <volume>9</volume>, <fpage>121</fpage>&#8211;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.bioeng.9.060906.151959</pub-id>.<pub-id pub-id-type="pmid">17373886</pub-id></mixed-citation></ref><ref id="ref99"><mixed-citation publication-type="journal" id="cit99"><name name-style="western"><surname>McCammon</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Gelin</surname><given-names>B. R.</given-names></name>; <name name-style="western"><surname>Karplus</surname><given-names>M.</given-names></name><article-title>Dynamics of Folded Proteins</article-title>. <source>Nature</source><year>1977</year>, <volume>267</volume> (<issue>5612</issue>), <fpage>585</fpage>&#8211;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1038/267585a0</pub-id>.<pub-id pub-id-type="pmid">301613</pub-id></mixed-citation></ref><ref id="ref100"><mixed-citation publication-type="journal" id="cit100"><name name-style="western"><surname>Hollingsworth</surname><given-names>S. A.</given-names></name>; <name name-style="western"><surname>Dror</surname><given-names>R. O.</given-names></name><article-title>Molecular Dynamics
Simulation for
All</article-title>. <source>Neuron</source><year>2018</year>, <volume>99</volume> (<issue>6</issue>), <fpage>1129</fpage>&#8211;<lpage>1143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.011</pub-id>.<pub-id pub-id-type="pmid">30236283</pub-id><pub-id pub-id-type="pmcid">PMC6209097</pub-id></mixed-citation></ref><ref id="ref101"><mixed-citation publication-type="journal" id="cit101"><name name-style="western"><surname>Levitt</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Warshel</surname><given-names>A.</given-names></name><article-title>Computer Simulation
of Protein Folding</article-title>. <source>Nature</source><year>1975</year>, <volume>253</volume> (<issue>5494</issue>), <fpage>694</fpage>&#8211;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1038/253694a0</pub-id>.<pub-id pub-id-type="pmid">1167625</pub-id></mixed-citation></ref><ref id="ref102"><mixed-citation publication-type="journal" id="cit102"><name name-style="western"><surname>Rahman</surname><given-names>A.</given-names></name><article-title>Correlations in the Motion of Atoms
in Liquid Argon</article-title>. <source>Physical review</source><year>1964</year>, <volume>136</volume> (<issue>2A</issue>), <fpage>A405</fpage><pub-id pub-id-type="doi">10.1103/PhysRev.136.A405</pub-id>.</mixed-citation></ref><ref id="ref103"><mixed-citation publication-type="journal" id="cit103"><name name-style="western"><surname>Awoonor-Williams</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Rowley</surname><given-names>C. N.</given-names></name><article-title>Molecular Simulation
of Nonfacilitated
Membrane Permeation</article-title>. <source>Biochimica et Biophysica
Acta (BBA)-Biomembranes</source><year>2016</year>, <volume>1858</volume> (<issue>7</issue>), <fpage>1672</fpage>&#8211;<lpage>1687</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2015.12.014</pub-id>.<pub-id pub-id-type="pmid">26706099</pub-id></mixed-citation></ref><ref id="ref104"><mixed-citation publication-type="journal" id="cit104"><name name-style="western"><surname>Orsi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sanderson</surname><given-names>W. E.</given-names></name>; <name name-style="western"><surname>Essex</surname><given-names>J. W.</given-names></name><article-title>Permeability of
Small Molecules through a Lipid Bilayer: A Multiscale Simulation Study</article-title>. <source>J. Phys. Chem. B</source><year>2009</year>, <volume>113</volume> (<issue>35</issue>), <fpage>12019</fpage>&#8211;<lpage>12029</lpage>. <pub-id pub-id-type="doi">10.1021/jp903248s</pub-id>.<pub-id pub-id-type="pmid">19663489</pub-id></mixed-citation></ref><ref id="ref105"><mixed-citation publication-type="journal" id="cit105"><name name-style="western"><surname>Orsi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Essex</surname><given-names>J. W.</given-names></name><article-title>Permeability of
Drugs and Hormones
through a Lipid Bilayer: Insights from Dual-Resolution Molecular Dynamics</article-title>. <source>Soft Matter</source><year>2010</year>, <volume>6</volume> (<issue>16</issue>), <fpage>3797</fpage>&#8211;<lpage>3808</lpage>. <pub-id pub-id-type="doi">10.1039/c0sm00136h</pub-id>.</mixed-citation></ref><ref id="ref106"><mixed-citation publication-type="journal" id="cit106"><name name-style="western"><surname>Lee</surname><given-names>C. T.</given-names></name>; <name name-style="western"><surname>Comer</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Herndon</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Leung</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Pavlova</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Swift</surname><given-names>R. V.</given-names></name>; <name name-style="western"><surname>Tung</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Rowley</surname><given-names>C. N.</given-names></name>; <name name-style="western"><surname>Amaro</surname><given-names>R. E.</given-names></name>; <name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name>; et al. <article-title>Simulation-Based
Approaches
for Determining Membrane Permeability of Small Compounds</article-title>. <source>J. Chem. Inf. Model</source><year>2016</year>, <volume>56</volume> (<issue>4</issue>), <fpage>721</fpage>&#8211;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.6b00022</pub-id>.<pub-id pub-id-type="pmid">27043429</pub-id><pub-id pub-id-type="pmcid">PMC5280572</pub-id></mixed-citation></ref><ref id="ref107"><mixed-citation publication-type="journal" id="cit107"><name name-style="western"><surname>Menichetti</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Kanekal</surname><given-names>K. H.</given-names></name>; <name name-style="western"><surname>Kremer</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Bereau</surname><given-names>T.</given-names></name><article-title>Computational
High-Throughput Screening of Drug-Membrane Thermodynamics</article-title>. <source>APS March Meeting Abstracts</source><year>2018</year>, <volume>2018</volume>, <fpage>S20</fpage>&#8211;<lpage>006</lpage>.</mixed-citation></ref><ref id="ref108"><mixed-citation publication-type="book" id="cit108"><person-group person-group-type="allauthors"><name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Pohorille</surname><given-names>A.</given-names></name></person-group><source>Free Energy Calculations</source>; <publisher-name>Springer</publisher-name>, <year>2007</year>; Vol. <volume>86</volume>.</mixed-citation></ref><ref id="ref109"><mixed-citation publication-type="journal" id="cit109"><name name-style="western"><surname>Brown</surname><given-names>D. G.</given-names></name>; <name name-style="western"><surname>Wobst</surname><given-names>H. J.</given-names></name><article-title>A Decade of FDA-Approved
Drugs (2010&#8211;2019):
Trends and Future Directions</article-title>. <source>J. Med. Chem.</source><year>2021</year>, <volume>64</volume> (<issue>5</issue>), <fpage>2312</fpage>&#8211;<lpage>2338</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c01516</pub-id>.<pub-id pub-id-type="pmid">33617254</pub-id></mixed-citation></ref><ref id="ref110"><mixed-citation publication-type="journal" id="cit110"><name name-style="western"><surname>Torrie</surname><given-names>G. M.</given-names></name>; <name name-style="western"><surname>Valleau</surname><given-names>J. P.</given-names></name><article-title>Nonphysical Sampling Distributions
in Monte Carlo Free-Energy Estimation: Umbrella Sampling</article-title>. <source>J. Comput. Phys.</source><year>1977</year>, <volume>23</volume> (<issue>2</issue>), <fpage>187</fpage>&#8211;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9991(77)90121-8</pub-id>.</mixed-citation></ref><ref id="ref111"><mixed-citation publication-type="journal" id="cit111"><name name-style="western"><surname>Laio</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Parrinello</surname><given-names>M.</given-names></name><article-title>Escaping Free-Energy
Minima</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2002</year>, <volume>99</volume> (<issue>20</issue>), <fpage>12562</fpage>&#8211;<lpage>12566</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.202427399</pub-id>.<pub-id pub-id-type="pmid">12271136</pub-id><pub-id pub-id-type="pmcid">PMC130499</pub-id></mixed-citation></ref><ref id="ref112"><mixed-citation publication-type="journal" id="cit112"><name name-style="western"><surname>Darve</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Rodr&#237;guez-G&#243;mez</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Pohorille</surname><given-names>A.</given-names></name><article-title>Adaptive Biasing
Force Method for Scalar and Vector
Free Energy Calculations</article-title>. <source>J. Chem. Phys.</source><year>2008</year>, <pub-id pub-id-type="doi">10.1063/1.2829861</pub-id>.<pub-id pub-id-type="pmid">18412436</pub-id></mixed-citation></ref><ref id="ref113"><mixed-citation publication-type="journal" id="cit113"><name name-style="western"><surname>Park</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Schulten</surname><given-names>K.</given-names></name><article-title>Calculating Potentials
of Mean Force
from Steered Molecular Dynamics Simulations</article-title>. <source>J. Chem. Phys.</source><year>2004</year>, <volume>120</volume> (<issue>13</issue>), <fpage>5946</fpage>&#8211;<lpage>5961</lpage>. <pub-id pub-id-type="doi">10.1063/1.1651473</pub-id>.<pub-id pub-id-type="pmid">15267476</pub-id></mixed-citation></ref><ref id="ref114"><mixed-citation publication-type="journal" id="cit114"><name name-style="western"><surname>Tiwary</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>van de Walle</surname><given-names>A.</given-names></name><article-title>A Review of
Enhanced Sampling Approaches
for Accelerated Molecular Dynamics</article-title>. <source>Multiscale
materials modeling for nanomechanics</source><year>2016</year>, <volume>245</volume>, <fpage>195</fpage>&#8211;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-33480-6_6</pub-id>.</mixed-citation></ref><ref id="ref115"><mixed-citation publication-type="undeclared" id="cit115"><person-group person-group-type="allauthors"><name name-style="western"><surname>H&#233;nin</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Leli&#232;vre</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Shirts</surname><given-names>M. R.</given-names></name>; <name name-style="western"><surname>Valsson</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Delemotte</surname><given-names>L.</given-names></name></person-group><article-title>Enhanced
Sampling Methods for Molecular Dynamics Simulations</article-title>. <source>arXiv</source> preprint <elocation-id>arXiv:2202.04164</elocation-id>, <year>2022</year>.</mixed-citation></ref><ref id="ref116"><mixed-citation publication-type="journal" id="cit116"><name name-style="western"><surname>Ghaemi</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Alberga</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Carloni</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Laio</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lattanzi</surname><given-names>G.</given-names></name><article-title>Permeability Coefficients of Lipophilic
Compounds Estimated
by Computer Simulations</article-title>. <source>J. Chem. Theory Comput</source><year>2016</year>, <volume>12</volume> (<issue>8</issue>), <fpage>4093</fpage>&#8211;<lpage>4099</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.5b01126</pub-id>.<pub-id pub-id-type="pmid">27392273</pub-id></mixed-citation></ref><ref id="ref117"><mixed-citation publication-type="journal" id="cit117"><name name-style="western"><surname>Sun</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Dama</surname><given-names>J. F.</given-names></name>; <name name-style="western"><surname>Tan</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Rose</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Voth</surname><given-names>G. A.</given-names></name><article-title>Transition-Tempered
Metadynamics Is a Promising Tool for Studying the Permeation of Drug-like
Molecules through Membranes</article-title>. <source>J. Chem. Theory
Comput</source><year>2016</year>, <volume>12</volume> (<issue>10</issue>), <fpage>5157</fpage>&#8211;<lpage>5169</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.6b00206</pub-id>.<pub-id pub-id-type="pmid">27598403</pub-id></mixed-citation></ref><ref id="ref118"><mixed-citation publication-type="journal" id="cit118"><name name-style="western"><surname>Shaw</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Deneroff</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Dror</surname><given-names>R. O.</given-names></name>; <name name-style="western"><surname>Kuskin</surname><given-names>J. S.</given-names></name>; <name name-style="western"><surname>Larson</surname><given-names>R. H.</given-names></name>; <name name-style="western"><surname>Salmon</surname><given-names>J. K.</given-names></name>; <name name-style="western"><surname>Young</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Batson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bowers</surname><given-names>K. J.</given-names></name>; <name name-style="western"><surname>Chao</surname><given-names>J. C.</given-names></name>; et al. <article-title>Anton, a Special-Purpose
Machine for Molecular Dynamics Simulation</article-title>. <source>Commun.
ACM</source><year>2008</year>, <volume>51</volume> (<issue>7</issue>), <fpage>91</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1145/1364782.1364802</pub-id>.</mixed-citation></ref><ref id="ref119"><mixed-citation publication-type="book" id="cit119"><person-group person-group-type="allauthors"><name name-style="western"><surname>Shaw</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Grossman</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Bank</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Batson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Butts</surname><given-names>J.
A.</given-names></name>; <name name-style="western"><surname>Chao</surname><given-names>J.
C.</given-names></name>; <name name-style="western"><surname>Deneroff</surname><given-names>M. M.</given-names></name>; <name name-style="western"><surname>Dror</surname><given-names>R. O.</given-names></name>; <name name-style="western"><surname>Even</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Fenton</surname><given-names>C. H</given-names></name></person-group>. <article-title>Anton 2: Raising
the Bar for Performance and Programmability in a Special-Purpose Molecular
Dynamics Supercomputer</article-title>. In <source>SC&#8217;14: Proceedings
of the International Conference for High Performance Computing, Networking,
Storage and Analysis</source>; <publisher-name>IEEE</publisher-name>, <year>2014</year>; pp <fpage>41</fpage>&#8211;<lpage>53</lpage>.</mixed-citation></ref><ref id="ref120"><mixed-citation publication-type="conf-proc" id="cit120"><person-group person-group-type="allauthors"><name name-style="western"><surname>Shaw</surname><given-names>D. E.</given-names></name>; <name name-style="western"><surname>Adams</surname><given-names>P. J.</given-names></name>; <name name-style="western"><surname>Azaria</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bank</surname><given-names>J.
A.</given-names></name>; <name name-style="western"><surname>Batson</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Bell</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bergdorf</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bhatt</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Butts</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Correia</surname><given-names>T.</given-names></name></person-group><article-title>Anton 3: Twenty Microseconds of Molecular Dynamics
Simulation before Lunch</article-title>. In <source>Proceedings of
the International Conference for High Performance Computing, Networking,
Storage and Analysis</source>; <year>2021</year>; pp <fpage>1</fpage>&#8211;<lpage>11</lpage>.</mixed-citation></ref><ref id="ref121"><mixed-citation publication-type="journal" id="cit121"><name name-style="western"><surname>Parrinello</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Rahman</surname><given-names>A.</given-names></name><article-title>Polymorphic Transitions in Single
Crystals: A New Molecular Dynamics Method</article-title>. <source>J.
Appl. Phys.</source><year>1981</year>, <volume>52</volume> (<issue>12</issue>), <fpage>7182</fpage>&#8211;<lpage>7190</lpage>. <pub-id pub-id-type="doi">10.1063/1.328693</pub-id>.</mixed-citation></ref><ref id="ref122"><mixed-citation publication-type="journal" id="cit122"><name name-style="western"><surname>Hummer</surname><given-names>G.</given-names></name><article-title>Position-Dependent
Diffusion Coefficients and Free
Energies from Bayesian Analysis of Equilibrium and Replica Molecular
Dynamics Simulations</article-title>. <source>New J. Phys.</source><year>2005</year>, <volume>7</volume> (<issue>1</issue>), <fpage>34</fpage><pub-id pub-id-type="doi">10.1088/1367-2630/7/1/034</pub-id>.</mixed-citation></ref><ref id="ref123"><mixed-citation publication-type="journal" id="cit123"><name name-style="western"><surname>Ghysels</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Venable</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Pastor</surname><given-names>R. W.</given-names></name>; <name name-style="western"><surname>Hummer</surname><given-names>G.</given-names></name><article-title>Position-Dependent
Diffusion Tensors in Anisotropic Media from Simulation: Oxygen Transport
in and through Membranes</article-title>. <source>J. Chem. Theory Comput</source><year>2017</year>, <volume>13</volume> (<issue>6</issue>), <fpage>2962</fpage>&#8211;<lpage>2976</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.7b00039</pub-id>.<pub-id pub-id-type="pmid">28482659</pub-id><pub-id pub-id-type="pmcid">PMC6311093</pub-id></mixed-citation></ref><ref id="ref124"><mixed-citation publication-type="journal" id="cit124"><name name-style="western"><surname>Jorgensen</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Troendle</surname><given-names>E. P.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name><article-title>A Least-Squares-Fitting
Procedure
for an Efficient Preclinical Ranking of Passive Transport across the
Blood&#8211;Brain Barrier Endothelium</article-title>. <source>J. Comput.
Aided Mol. Des</source><year>2023</year>, <volume>37</volume> (<issue>11</issue>), <fpage>537</fpage>&#8211;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-023-00525-1</pub-id>.<pub-id pub-id-type="pmid">37573260</pub-id><pub-id pub-id-type="pmcid">PMC10505096</pub-id></mixed-citation></ref><ref id="ref125"><mixed-citation publication-type="journal" id="cit125"><name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Comer</surname><given-names>J.</given-names></name><article-title>Subdiffusion in Membrane
Permeation
of Small Molecules</article-title>. <source>Sci. Rep.</source><year>2016</year>, <volume>6</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/srep35913</pub-id>.<pub-id pub-id-type="pmid">27805049</pub-id><pub-id pub-id-type="pmcid">PMC5090971</pub-id></mixed-citation></ref><ref id="ref126"><mixed-citation publication-type="journal" id="cit126"><name name-style="western"><surname>Comer</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Gonz&#225;lez-Nilo</surname><given-names>F. D.</given-names></name><article-title>Calculating
Position-Dependent Diffusivity in Biased Molecular Dynamics Simulations</article-title>. <source>J. Chem. Theory Comput</source><year>2013</year>, <volume>9</volume> (<issue>2</issue>), <fpage>876</fpage>&#8211;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1021/ct300867e</pub-id>.<pub-id pub-id-type="pmid">26588731</pub-id></mixed-citation></ref><ref id="ref127"><mixed-citation publication-type="journal" id="cit127"><name name-style="western"><surname>Marrink</surname><given-names>S.-J.</given-names></name>; <name name-style="western"><surname>Berendsen</surname><given-names>H. J. C.</given-names></name><article-title>Simulation
of Water Transport through
a Lipid Membrane</article-title>. <source>J. Phys. Chem.</source><year>1994</year>, <volume>98</volume> (<issue>15</issue>), <fpage>4155</fpage>&#8211;<lpage>4168</lpage>. <pub-id pub-id-type="doi">10.1021/j100066a040</pub-id>.</mixed-citation></ref><ref id="ref128"><mixed-citation publication-type="journal" id="cit128"><name name-style="western"><surname>Lin</surname><given-names>Y.-C.</given-names></name>; <name name-style="western"><surname>Luo</surname><given-names>Y. L.</given-names></name><article-title>Unifying Single-Channel Permeability
From Rare-Event Sampling and Steady-State Flux</article-title>. <source>Front Mol. Biosci</source><year>2022</year>, <volume>9</volume>, <elocation-id>860933</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2022.860933</pub-id>.<pub-id pub-id-type="pmid">35495625</pub-id><pub-id pub-id-type="pmcid">PMC9043130</pub-id></mixed-citation></ref><ref id="ref129"><mixed-citation publication-type="journal" id="cit129"><name name-style="western"><surname>Harris</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Roux</surname><given-names>B.</given-names></name><article-title>Statistical Mechanical
Theories of Membrane Permeability</article-title>. <source>J. Phys.
Chem. B</source><year>2024</year>, <volume>128</volume>, <fpage>9183</fpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.4c05020</pub-id>.<pub-id pub-id-type="pmid">39283709</pub-id><pub-id pub-id-type="pmcid">PMC11701864</pub-id></mixed-citation></ref><ref id="ref130"><mixed-citation publication-type="journal" id="cit130"><name name-style="western"><surname>T&#252;rkcan</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Alexandrou</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Masson</surname><given-names>J.-B.</given-names></name><article-title>A Bayesian Inference
Scheme to Extract Diffusivity and Potential Fields from Confined Single-Molecule
Trajectories</article-title>. <source>Biophys. J.</source><year>2012</year>, <volume>102</volume> (<issue>10</issue>), <fpage>2288</fpage>&#8211;<lpage>2298</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2012.01.063</pub-id>.<pub-id pub-id-type="pmid">22677382</pub-id><pub-id pub-id-type="pmcid">PMC3353014</pub-id></mixed-citation></ref><ref id="ref131"><mixed-citation publication-type="journal" id="cit131"><name name-style="western"><surname>Ray</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Parrinello</surname><given-names>M.</given-names></name><article-title>Kinetics from
Metadynamics: Principles, Applications,
and Outlook</article-title>. <source>J. Chem. Theory Comput</source><year>2023</year>, <volume>19</volume> (<issue>17</issue>), <fpage>5649</fpage>&#8211;<lpage>5670</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jctc.3c00660</pub-id>.<pub-id pub-id-type="pmid">37585703</pub-id></mixed-citation></ref><ref id="ref132"><mixed-citation publication-type="journal" id="cit132"><name name-style="western"><surname>Laio</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Rodriguez-Fortea</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Gervasio</surname><given-names>F. L.</given-names></name>; <name name-style="western"><surname>Ceccarelli</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Parrinello</surname><given-names>M.</given-names></name><article-title>Assessing the Accuracy of Metadynamics</article-title>. <source>J. Phys. Chem. B</source><year>2005</year>, <volume>109</volume> (<issue>14</issue>), <fpage>6714</fpage>&#8211;<lpage>6721</lpage>. <pub-id pub-id-type="doi">10.1021/jp045424k</pub-id>.<pub-id pub-id-type="pmid">16851755</pub-id></mixed-citation></ref><ref id="ref133"><mixed-citation publication-type="journal" id="cit133"><name name-style="western"><surname>Mamonov</surname><given-names>A. B.</given-names></name>; <name name-style="western"><surname>Kurnikova</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Coalson</surname><given-names>R. D.</given-names></name><article-title>Diffusion Constant
of K+ inside Gramicidin A: A Comparative Study of Four Computational
Methods</article-title>. <source>Biophys Chem.</source><year>2006</year>, <volume>124</volume> (<issue>3</issue>), <fpage>268</fpage>&#8211;<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpc.2006.03.019</pub-id>.<pub-id pub-id-type="pmid">16797116</pub-id><pub-id pub-id-type="pmcid">PMC2266632</pub-id></mixed-citation></ref><ref id="ref134"><mixed-citation publication-type="journal" id="cit134"><name name-style="western"><surname>Marrink</surname><given-names>S. J.</given-names></name>; <name name-style="western"><surname>Berendsen</surname><given-names>H. J. C.</given-names></name><article-title>Permeation
Process of Small Molecules
across Lipid Membranes Studied by Molecular Dynamics Simulations</article-title>. <source>J. Phys. Chem.</source><year>1996</year>, <volume>100</volume> (<issue>41</issue>), <fpage>16729</fpage>&#8211;<lpage>16738</lpage>. <pub-id pub-id-type="doi">10.1021/jp952956f</pub-id>.</mixed-citation></ref><ref id="ref135"><mixed-citation publication-type="journal" id="cit135"><name name-style="western"><surname>Pardridge</surname><given-names>W. M.</given-names></name>; <name name-style="western"><surname>Triguero</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Cancilla</surname><given-names>P. A.</given-names></name><article-title>Comparison
of in Vitro and in Vivo Models of Drug Transcytosis through the Blood-Brain
Barrier</article-title>. <source>J. Pharmacol. Exp. Ther.</source><year>1990</year>, <volume>253</volume> (<issue>2</issue>), <fpage>884</fpage>&#8211;<lpage>891</lpage>.<pub-id pub-id-type="pmid">2338660</pub-id></mixed-citation></ref><ref id="ref136"><mixed-citation publication-type="journal" id="cit136"><name name-style="western"><surname>Bednarek</surname><given-names>R.</given-names></name><article-title>In Vitro Methods for
Measuring the Permeability of
Cell Monolayers</article-title>. <source>Methods Protoc</source><year>2022</year>, <volume>5</volume> (<issue>1</issue>), <fpage>17</fpage><pub-id pub-id-type="doi">10.3390/mps5010017</pub-id>.<pub-id pub-id-type="pmid">35200533</pub-id><pub-id pub-id-type="pmcid">PMC8874757</pub-id></mixed-citation></ref><ref id="ref137"><mixed-citation publication-type="journal" id="cit137"><name name-style="western"><surname>Linville</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>DeStefano</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Sklar</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Farrell</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Bogorad</surname><given-names>M. I.</given-names></name>; <name name-style="western"><surname>Chu</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Walczak</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Cheng</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Mahairaki</surname><given-names>V.</given-names></name>; et al. <article-title>Human IPSC-Derived Blood-Brain
Barrier Microvessels: Validation of Barrier Function and Endothelial
Cell Behavior</article-title>. <source>Biomaterials</source><year>2019</year>, <volume>190</volume>, <fpage>24</fpage>&#8211;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.10.023</pub-id>.<pub-id pub-id-type="pmid">30391800</pub-id><pub-id pub-id-type="pmcid">PMC6289621</pub-id></mixed-citation></ref><ref id="ref138"><mixed-citation publication-type="journal" id="cit138"><name name-style="western"><surname>Shamul</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Gong</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Ou</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>White</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Moniz-Garcia</surname><given-names>D. P.</given-names></name>; <name name-style="western"><surname>Gu</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Clyne</surname><given-names>A. M.</given-names></name>; <name name-style="western"><surname>Qui&#241;ones-Hinojosa</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>He</surname><given-names>X.</given-names></name><article-title>Meta-Analysis of the
Make-up and Properties of in Vitro Models of the Healthy and Diseased
Blood&#8211;Brain Barrier</article-title>. <source>Nat. Biomed Eng.</source><year>2024</year>, <fpage>1</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1038/s41551-024-01250-2</pub-id>.<pub-id pub-id-type="pmid">39304761</pub-id><pub-id pub-id-type="pmcid">PMC11922799</pub-id></mixed-citation></ref><ref id="ref139"><mixed-citation publication-type="journal" id="cit139"><name name-style="western"><surname>Artursson</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Palm</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Luthman</surname><given-names>K.</given-names></name><article-title>Caco-2 Monolayers
in
Experimental and Theoretical Predictions of Drug Transport</article-title>. <source>Adv. Drug Deliv Rev.</source><year>2012</year>, <volume>64</volume>, <fpage>280</fpage>&#8211;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2012.09.005</pub-id>.<pub-id pub-id-type="pmid">11259831</pub-id></mixed-citation></ref><ref id="ref140"><mixed-citation publication-type="journal" id="cit140"><name name-style="western"><surname>Van Breemen</surname><given-names>R. B.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><article-title>Caco-2 Cell Permeability
Assays to
Measure Drug Absorption</article-title>. <source>Expert Opin Drug Metab
Toxicol</source><year>2005</year>, <volume>1</volume> (<issue>2</issue>), <fpage>175</fpage>&#8211;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1517/17425255.1.2.175</pub-id>.<pub-id pub-id-type="pmid">16922635</pub-id></mixed-citation></ref><ref id="ref141"><mixed-citation publication-type="journal" id="cit141"><name name-style="western"><surname>Lippmann</surname><given-names>E. S.</given-names></name>; <name name-style="western"><surname>Azarin</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Palecek</surname><given-names>S. P.</given-names></name>; <name name-style="western"><surname>Shusta</surname><given-names>E. V.</given-names></name><article-title>Commentary
on Human Pluripotent Stem Cell-Based Blood&#8211;Brain Barrier Models</article-title>. <source>Fluids Barriers CNS</source><year>2020</year>, <volume>17</volume>, <fpage>1</fpage>&#8211;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1186/s12987-020-00222-3</pub-id>.<pub-id pub-id-type="pmid">33076946</pub-id><pub-id pub-id-type="pmcid">PMC7574179</pub-id></mixed-citation></ref><ref id="ref142"><mixed-citation publication-type="journal" id="cit142"><name name-style="western"><surname>Linville</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>Next-Generation in Vitro Blood&#8211;Brain
Barrier Models: Benchmarking and Improving Model Accuracy</article-title>. <source>Fluids Barriers CNS</source><year>2021</year>, <volume>18</volume>, <fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1186/s12987-021-00291-y</pub-id>.<pub-id pub-id-type="pmid">34876171</pub-id><pub-id pub-id-type="pmcid">PMC8650371</pub-id></mixed-citation></ref><ref id="ref143"><mixed-citation publication-type="journal" id="cit143"><name name-style="western"><surname>DeStefano</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Jamieson</surname><given-names>J. J.</given-names></name>; <name name-style="western"><surname>Linville</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>Benchmarking
in Vitro Tissue-Engineered Blood&#8211;Brain Barrier Models</article-title>. <source>Fluids Barriers CNS</source><year>2018</year>, <volume>15</volume>, <fpage>1</fpage>&#8211;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1186/s12987-018-0117-2</pub-id>.<pub-id pub-id-type="pmid">30514389</pub-id><pub-id pub-id-type="pmcid">PMC6280508</pub-id></mixed-citation></ref><ref id="ref144"><mixed-citation publication-type="journal" id="cit144"><name name-style="western"><surname>Huxley</surname><given-names>V. H.</given-names></name>; <name name-style="western"><surname>Curry</surname><given-names>F. E.</given-names></name>; <name name-style="western"><surname>Adamson</surname><given-names>R. H.</given-names></name><article-title>Quantitative Fluorescence
Microscopy on Single Capillaries: Alpha-Lactalbumin Transport</article-title>. <source>American Journal of Physiology-Heart and Circulatory Physiology</source><year>1987</year>, <volume>252</volume> (<issue>1</issue>), <fpage>H188</fpage>&#8211;<lpage>H197</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1987.252.1.H188</pub-id>.<pub-id pub-id-type="pmid">3492924</pub-id></mixed-citation></ref><ref id="ref145"><mixed-citation publication-type="journal" id="cit145"><name name-style="western"><surname>Chrobak</surname><given-names>K. M.</given-names></name>; <name name-style="western"><surname>Potter</surname><given-names>D. R.</given-names></name>; <name name-style="western"><surname>Tien</surname><given-names>J.</given-names></name><article-title>Formation of Perfused,
Functional Microvascular Tubes in Vitro</article-title>. <source>Microvasc
Res.</source><year>2006</year>, <volume>71</volume> (<issue>3</issue>), <fpage>185</fpage>&#8211;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/j.mvr.2006.02.005</pub-id>.<pub-id pub-id-type="pmid">16600313</pub-id></mixed-citation></ref><ref id="ref146"><mixed-citation publication-type="journal" id="cit146"><name name-style="western"><surname>Campisi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Shin</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Osaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hajal</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chiono</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Kamm</surname><given-names>R. D.</given-names></name><article-title>3D Self-Organized Microvascular Model
of the Human Blood-Brain Barrier with Endothelial Cells Pericytes
and Astrocytes</article-title>. <source>Biomaterials</source><year>2018</year>, <volume>180</volume>, <fpage>117</fpage>&#8211;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.07.014</pub-id>.<pub-id pub-id-type="pmid">30032046</pub-id><pub-id pub-id-type="pmcid">PMC6201194</pub-id></mixed-citation></ref><ref id="ref147"><mixed-citation publication-type="journal" id="cit147"><name name-style="western"><surname>Menaceur</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Gosselet</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Fenart</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Saint-Pol</surname><given-names>J.</given-names></name><article-title>The Blood&#8211;Brain
Barrier, an Evolving Concept Based on Technological Advances and Cell&#8211;Cell
Communications</article-title>. <source>Cells</source><year>2022</year>, <volume>11</volume> (<issue>1</issue>), <fpage>133</fpage><pub-id pub-id-type="doi">10.3390/cells11010133</pub-id>.<pub-id pub-id-type="pmcid">PMC8750298</pub-id><pub-id pub-id-type="pmid">35011695</pub-id></mixed-citation></ref><ref id="ref148"><mixed-citation publication-type="journal" id="cit148"><name name-style="western"><surname>Balimane</surname><given-names>P. V.</given-names></name>; <name name-style="western"><surname>Chong</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Morrison</surname><given-names>R. A.</given-names></name><article-title>Current
Methodologies
Used for Evaluation of Intestinal Permeability and Absorption</article-title>. <source>J. Pharmacol Toxicol Methods</source><year>2000</year>, <volume>44</volume> (<issue>1</issue>), <fpage>301</fpage>&#8211;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1016/S1056-8719(00)00113-1</pub-id>.<pub-id pub-id-type="pmid">11274897</pub-id></mixed-citation></ref><ref id="ref149"><mixed-citation publication-type="journal" id="cit149"><name name-style="western"><surname>Fernandez-Carrera</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Vigo</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Regueiro-Rodr&#237;guez</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Gonz&#225;lez-Fern&#225;ndez</surname><given-names>&#193;.</given-names></name>; <name name-style="western"><surname>Olivieri</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Aroeira</surname><given-names>L. S.</given-names></name><article-title>Sensitive
and Non-Invasive Method for the in Vivo Analysis of Membrane Permeability
in Small Animals</article-title>. <source>Laboratory Investigation</source><year>2017</year>, <volume>97</volume> (<issue>9</issue>), <fpage>1114</fpage>&#8211;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2017.66</pub-id>.<pub-id pub-id-type="pmid">28737767</pub-id></mixed-citation></ref><ref id="ref150"><mixed-citation publication-type="journal" id="cit150"><name name-style="western"><surname>Radu</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Chernoff</surname><given-names>J.</given-names></name><article-title>An in Vivo Assay to Test Blood Vessel
Permeability</article-title>. <source>J. Vis. Exp.</source><year>2013</year>, <pub-id pub-id-type="doi">10.3791/50062-v</pub-id>.<pub-id pub-id-type="pmcid">PMC3639515</pub-id><pub-id pub-id-type="pmid">23524912</pub-id></mixed-citation></ref><ref id="ref151"><mixed-citation publication-type="journal" id="cit151"><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Fu</surname><given-names>B. M.</given-names></name><article-title>Quantification of
Blood-Brain Barrier Solute Permeability and Brain Transport by Multiphoton
Microscopy</article-title>. <source>J. Biomech Eng.</source><year>2014</year>, <volume>136</volume> (<issue>3</issue>), <elocation-id>031005</elocation-id><pub-id pub-id-type="doi">10.1115/1.4025892</pub-id>.<pub-id pub-id-type="pmid">24193698</pub-id></mixed-citation></ref><ref id="ref152"><mixed-citation publication-type="journal" id="cit152"><name name-style="western"><surname>Renkin</surname><given-names>E. M.</given-names></name><article-title>Transport of Potassium-42 from Blood
to Tissue in Isolated
Mammalian Skeletal Muscles</article-title>. <source>American Journal
of Physiology-Legacy Content</source><year>1959</year>, <volume>197</volume> (<issue>6</issue>), <fpage>1205</fpage>&#8211;<lpage>1210</lpage>. <pub-id pub-id-type="doi">10.1152/ajplegacy.1959.197.6.1205</pub-id>.<pub-id pub-id-type="pmid">14437359</pub-id></mixed-citation></ref><ref id="ref153"><mixed-citation publication-type="journal" id="cit153"><name name-style="western"><surname>Crone</surname><given-names>C.</given-names></name><article-title>The Permeability of Capillaries in
Various Organs as Determined by
Use of the &#8216;Indicator Diffusion&#8217;Method</article-title>. <source>Acta Physiol Scand</source><year>1963</year>, <volume>58</volume> (<issue>4</issue>), <fpage>292</fpage>&#8211;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1111/j.1748-1716.1963.tb02652.x</pub-id>.<pub-id pub-id-type="pmid">14078649</pub-id></mixed-citation></ref><ref id="ref154"><mixed-citation publication-type="journal" id="cit154"><name name-style="western"><surname>Fenstermacher</surname><given-names>J. D.</given-names></name>; <name name-style="western"><surname>Blasberg</surname><given-names>R. G.</given-names></name>; <name name-style="western"><surname>Patlak</surname><given-names>C. S.</given-names></name><article-title>Methods
for Quantifying
the Transport of Drugs across Brain Barrier Systems</article-title>. <source>Pharmacol Ther</source><year>1981</year>, <volume>14</volume> (<issue>2</issue>), <fpage>217</fpage>&#8211;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/0163-7258(81)90062-0</pub-id>.<pub-id pub-id-type="pmid">7031708</pub-id></mixed-citation></ref><ref id="ref155"><mixed-citation publication-type="journal" id="cit155"><name name-style="western"><surname>Patlak</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Blasberg</surname><given-names>R. G.</given-names></name>; <name name-style="western"><surname>Fenstermacher</surname><given-names>J. D.</given-names></name><article-title>Graphical
Evaluation of Blood-to-Brain Transfer Constants from Multiple Time
Uptake Data</article-title>. <source>J. Cereb Blood Flow Metabol</source><year>1983</year>, <volume>3</volume>, <fpage>1</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1983.1</pub-id>.<pub-id pub-id-type="pmid">6822610</pub-id></mixed-citation></ref><ref id="ref156"><mixed-citation publication-type="journal" id="cit156"><name name-style="western"><surname>Hom</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Dankbaar</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Soares</surname><given-names>B. P.</given-names></name>; <name name-style="western"><surname>Schneider</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Cheng</surname><given-names>S.-C.</given-names></name>; <name name-style="western"><surname>Bredno</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Lau</surname><given-names>B. C.</given-names></name>; <name name-style="western"><surname>Smith</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Dillon</surname><given-names>W. P.</given-names></name>; <name name-style="western"><surname>Wintermark</surname><given-names>M.</given-names></name><article-title>Blood-Brain
Barrier Permeability
Assessed by Perfusion CT Predicts Symptomatic Hemorrhagic Transformation
and Malignant Edema in Acute Ischemic Stroke</article-title>. <source>American journal of neuroradiology</source><year>2011</year>, <volume>32</volume> (<issue>1</issue>), <fpage>41</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.3174/ajnr.A2244</pub-id>.<pub-id pub-id-type="pmid">20947643</pub-id><pub-id pub-id-type="pmcid">PMC7964964</pub-id></mixed-citation></ref><ref id="ref157"><mixed-citation publication-type="journal" id="cit157"><name name-style="western"><surname>Tien</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>Linville</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Feldman</surname><given-names>E. J.</given-names></name><article-title>Comparison
of Blind Deconvolution-and Patlak Analysis-Based Methods for Determining
Vascular Permeability</article-title>. <source>Microvasc Res.</source><year>2021</year>, <volume>133</volume>, <elocation-id>104102</elocation-id><pub-id pub-id-type="doi">10.1016/j.mvr.2020.104102</pub-id>.<pub-id pub-id-type="pmid">33166578</pub-id></mixed-citation></ref><ref id="ref158"><mixed-citation publication-type="journal" id="cit158"><name name-style="western"><surname>Karakatsanis</surname><given-names>N. A.</given-names></name>; <name name-style="western"><surname>Lodge</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Tahari</surname><given-names>A. K.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Wahl</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Rahmim</surname><given-names>A.</given-names></name><article-title>Dynamic Whole-Body
PET Parametric
Imaging: I. Concept, Acquisition Protocol Optimization and Clinical
Application</article-title>. <source>Phys. Med. Biol.</source><year>2013</year>, <volume>58</volume> (<issue>20</issue>), <fpage>7391</fpage><pub-id pub-id-type="doi">10.1088/0031-9155/58/20/7391</pub-id>.<pub-id pub-id-type="pmid">24080962</pub-id><pub-id pub-id-type="pmcid">PMC3941007</pub-id></mixed-citation></ref><ref id="ref159"><mixed-citation publication-type="journal" id="cit159"><name name-style="western"><surname>Varatharaj</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Liljeroth</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Darekar</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Larsson</surname><given-names>H. B. W.</given-names></name>; <name name-style="western"><surname>Galea</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Cramer</surname><given-names>S. P.</given-names></name><article-title>Blood&#8211;Brain
Barrier Permeability
Measured Using Dynamic Contrast-enhanced Magnetic Resonance Imaging:
A Validation Study</article-title>. <source>J. Physiol</source><year>2019</year>, <volume>597</volume> (<issue>3</issue>), <fpage>699</fpage>&#8211;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1113/JP276887</pub-id>.<pub-id pub-id-type="pmid">30417928</pub-id><pub-id pub-id-type="pmcid">PMC6355631</pub-id></mixed-citation></ref><ref id="ref160"><mixed-citation publication-type="journal" id="cit160"><name name-style="western"><surname>Fluckiger</surname><given-names>J. U.</given-names></name>; <name name-style="western"><surname>Schabel</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>DiBella</surname><given-names>E. V. R.</given-names></name><article-title>The Effect of
Temporal Sampling on Quantitative Pharmacokinetic and Three-Time-Point
Analysis of Breast DCE-MRI</article-title>. <source>Magn Reson Imaging</source><year>2012</year>, <volume>30</volume> (<issue>7</issue>), <fpage>934</fpage>&#8211;<lpage>943</lpage>. <pub-id pub-id-type="doi">10.1016/j.mri.2012.02.011</pub-id>.<pub-id pub-id-type="pmid">22513074</pub-id></mixed-citation></ref><ref id="ref161"><mixed-citation publication-type="journal" id="cit161"><name name-style="western"><surname>Schabel</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>Morrell</surname><given-names>G. R.</given-names></name>; <name name-style="western"><surname>Oh</surname><given-names>K. Y.</given-names></name>; <name name-style="western"><surname>Walczak</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Barlow</surname><given-names>R. B.</given-names></name>; <name name-style="western"><surname>Neumayer</surname><given-names>L. A.</given-names></name><article-title>Pharmacokinetic Mapping for Lesion
Classification in Dynamic Breast MRI</article-title>. <source>Journal
of Magnetic Resonance Imaging</source><year>2010</year>, <volume>31</volume> (<issue>6</issue>), <fpage>1371</fpage>&#8211;<lpage>1378</lpage>. <pub-id pub-id-type="doi">10.1002/jmri.22179</pub-id>.<pub-id pub-id-type="pmid">20512889</pub-id><pub-id pub-id-type="pmcid">PMC4657573</pub-id></mixed-citation></ref><ref id="ref162"><mixed-citation publication-type="journal" id="cit162"><name name-style="western"><surname>Truslow</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Tien</surname><given-names>J.</given-names></name><article-title>Determination of Vascular
Permeability
Coefficients under Slow Luminal Filling</article-title>. <source>Microvasc
Res.</source><year>2013</year>, <volume>90</volume>, <fpage>117</fpage>&#8211;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1016/j.mvr.2013.07.003</pub-id>.<pub-id pub-id-type="pmid">23891569</pub-id><pub-id pub-id-type="pmcid">PMC3849343</pub-id></mixed-citation></ref><ref id="ref163"><mixed-citation publication-type="journal" id="cit163"><name name-style="western"><surname>Fluckiger</surname><given-names>J. U.</given-names></name>; <name name-style="western"><surname>Schabel</surname><given-names>M. C.</given-names></name>; <name name-style="western"><surname>DiBella</surname><given-names>E. V. R.</given-names></name><article-title>Model-based Blind
Estimation of Kinetic Parameters in Dynamic Contrast Enhanced (DCE)-MRI</article-title>. <source>Magnetic Resonance in Medicine: An Official Journal of the
International Society for Magnetic Resonance in Medicine</source><year>2009</year>, <volume>62</volume> (<issue>6</issue>), <fpage>1477</fpage>&#8211;<lpage>1486</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.22101</pub-id>.<pub-id pub-id-type="pmcid">PMC2884174</pub-id><pub-id pub-id-type="pmid">19859949</pub-id></mixed-citation></ref><ref id="ref164"><mixed-citation publication-type="journal" id="cit164"><name name-style="western"><surname>Riabkov</surname><given-names>D.
Y.</given-names></name>; <name name-style="western"><surname>Di Bella</surname><given-names>E. V. R.</given-names></name><article-title>Estimation
of Kinetic Parameters
without Input Functions: Analysis of Three Methods for Multichannel
Blind Identification</article-title>. <source>IEEE Trans Biomed Eng.</source><year>2002</year>, <volume>49</volume> (<issue>11</issue>), <fpage>1318</fpage>&#8211;<lpage>1327</lpage>. <pub-id pub-id-type="doi">10.1109/TBME.2002.804588</pub-id>.<pub-id pub-id-type="pmid">12450362</pub-id></mixed-citation></ref><ref id="ref165"><mixed-citation publication-type="journal" id="cit165"><name name-style="western"><surname>Gr&#252;ner</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Taxt</surname><given-names>T.</given-names></name><article-title>Iterative Blind Deconvolution in
Magnetic Resonance Brain Perfusion Imaging</article-title>. <source>Magnetic Resonance in Medicine: An Official Journal of the International
Society for Magnetic Resonance in Medicine</source><year>2006</year>, <volume>55</volume> (<issue>4</issue>), <fpage>805</fpage>&#8211;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.20850</pub-id>.<pub-id pub-id-type="pmid">16526016</pub-id></mixed-citation></ref><ref id="ref166"><mixed-citation publication-type="journal" id="cit166"><name name-style="western"><surname>Karakatsanis</surname><given-names>N. A.</given-names></name>; <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Lodge</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Casey</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Wahl</surname><given-names>R. L.</given-names></name>; <name name-style="western"><surname>Zaidi</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Rahmim</surname><given-names>A.</given-names></name><article-title>Generalized
Whole-Body
Patlak Parametric Imaging for Enhanced Quantification in Clinical
PET</article-title>. <source>Phys. Med. Biol.</source><year>2015</year>, <volume>60</volume> (<issue>22</issue>), <fpage>8643</fpage><pub-id pub-id-type="doi">10.1088/0031-9155/60/22/8643</pub-id>.<pub-id pub-id-type="pmid">26509251</pub-id><pub-id pub-id-type="pmcid">PMC4710061</pub-id></mixed-citation></ref><ref id="ref167"><mixed-citation publication-type="journal" id="cit167"><name name-style="western"><surname>Patlak</surname><given-names>C. S.</given-names></name>; <name name-style="western"><surname>Blasberg</surname><given-names>R. G.</given-names></name><article-title>Graphical Evaluation
of Blood-to-Brain
Transfer Constants from Multiple-Time Uptake Data Generalizations</article-title>. <source>Journal of Cerebral Blood Flow &amp; Metabolism</source><year>1985</year>, <volume>5</volume> (<issue>4</issue>), <fpage>584</fpage>&#8211;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.1985.87</pub-id>.<pub-id pub-id-type="pmid">4055928</pub-id></mixed-citation></ref><ref id="ref168"><mixed-citation publication-type="journal" id="cit168"><name name-style="western"><surname>Sjogren</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Dahlgren</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Roos</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Lennernas</surname><given-names>H.</given-names></name><article-title>Human in Vivo
Regional Intestinal Permeability: Quantitation Using Site-Specific
Drug Absorption Data</article-title>. <source>Mol. Pharmaceutics</source><year>2015</year>, <volume>12</volume> (<issue>6</issue>), <fpage>2026</fpage>&#8211;<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.1021/mp500834v</pub-id>.<pub-id pub-id-type="pmid">25919764</pub-id></mixed-citation></ref><ref id="ref169"><mixed-citation publication-type="journal" id="cit169"><name name-style="western"><surname>Kang</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Shoji</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Sun</surname><given-names>R.</given-names></name><article-title>Impact of
the Unstirred Water Layer on the Permeation of Small-Molecule Drugs</article-title>. <source>J. Chem. Inf Model</source><year>2024</year>, <volume>64</volume> (<issue>3</issue>), <fpage>933</fpage>&#8211;<lpage>943</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.3c01629</pub-id>.<pub-id pub-id-type="pmid">38206804</pub-id></mixed-citation></ref><ref id="ref170"><mixed-citation publication-type="journal" id="cit170"><name name-style="western"><surname>Dejana</surname><given-names>E.</given-names></name><article-title>Endothelial Adherens Junctions: Implications
in the
Control of Vascular Permeability and Angiogenesis</article-title>. <source>J. Clin Invest</source><year>1996</year>, <volume>98</volume> (<issue>9</issue>), <fpage>1949</fpage>&#8211;<lpage>1953</lpage>. <pub-id pub-id-type="doi">10.1172/JCI118997</pub-id>.<pub-id pub-id-type="pmid">8903311</pub-id><pub-id pub-id-type="pmcid">PMC507636</pub-id></mixed-citation></ref><ref id="ref171"><mixed-citation publication-type="journal" id="cit171"><name name-style="western"><surname>Schneeberger</surname><given-names>E. E.</given-names></name>; <name name-style="western"><surname>Lynch</surname><given-names>R. D.</given-names></name><article-title>Tight Junctions.
Their Structure,
Composition, and Function</article-title>. <source>Circ. Res.</source><year>1984</year>, <volume>55</volume> (<issue>6</issue>), <fpage>723</fpage>&#8211;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.55.6.723</pub-id>.<pub-id pub-id-type="pmid">6388896</pub-id></mixed-citation></ref><ref id="ref172"><mixed-citation publication-type="journal" id="cit172"><name name-style="western"><surname>Matter</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Balda</surname><given-names>M. S.</given-names></name><article-title>Functional Analysis of Tight Junctions</article-title>. <source>Methods</source><year>2003</year>, <volume>30</volume> (<issue>3</issue>), <fpage>228</fpage>&#8211;<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1016/S1046-2023(03)00029-X</pub-id>.<pub-id pub-id-type="pmid">12798137</pub-id></mixed-citation></ref><ref id="ref173"><mixed-citation publication-type="journal" id="cit173"><name name-style="western"><surname>Yilmaz</surname><given-names>O.</given-names></name>; <name name-style="western"><surname>Afsar</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Ortiz</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Kanbay</surname><given-names>M.</given-names></name><article-title>The Role of
Endothelial Glycocalyx in Health and Disease</article-title>. <source>Clin Kidney J.</source><year>2019</year>, <volume>12</volume> (<issue>5</issue>), <fpage>611</fpage>&#8211;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1093/ckj/sfz042</pub-id>.<pub-id pub-id-type="pmid">31583086</pub-id><pub-id pub-id-type="pmcid">PMC6768294</pub-id></mixed-citation></ref><ref id="ref174"><mixed-citation publication-type="journal" id="cit174"><name name-style="western"><surname>Kim</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name><article-title>Molecular Structure of Human P-Glycoprotein in the
ATP-Bound, Outward-Facing Conformation</article-title>. <source>Science
(1979)</source><year>2018</year>, <volume>359</volume> (<issue>6378</issue>), <fpage>915</fpage>&#8211;<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1126/science.aar7389</pub-id>.<pub-id pub-id-type="pmid">29371429</pub-id></mixed-citation></ref><ref id="ref175"><mixed-citation publication-type="journal" id="cit175"><name name-style="western"><surname>Kikuchi</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>de Morais</surname><given-names>S. M.</given-names></name>; <name name-style="western"><surname>Kalvass</surname><given-names>J. C.</given-names></name><article-title>In Vitro P-Glycoprotein
Efflux Ratio Can Predict the in Vivo Brain Penetration Regardless
of Biopharmaceutics Drug Disposition Classification System Class</article-title>. <source>Drug Metab. Dispos.</source><year>2013</year>, <volume>41</volume> (<issue>12</issue>), <fpage>2012</fpage>&#8211;<lpage>2017</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.113.053868</pub-id>.<pub-id pub-id-type="pmid">24009309</pub-id></mixed-citation></ref><ref id="ref176"><mixed-citation publication-type="journal" id="cit176"><name name-style="western"><surname>Dolghih</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Jacobson</surname><given-names>M. P.</given-names></name><article-title>Predicting Efflux
Ratios and Blood-Brain
Barrier Penetration from Chemical Structure: Combining Passive Permeability
with Active Efflux by P-Glycoprotein</article-title>. <source>ACS Chem.
Neurosci.</source><year>2013</year>, <volume>4</volume> (<issue>2</issue>), <fpage>361</fpage>&#8211;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1021/cn3001922</pub-id>.<pub-id pub-id-type="pmid">23421687</pub-id><pub-id pub-id-type="pmcid">PMC3582291</pub-id></mixed-citation></ref><ref id="ref177"><mixed-citation publication-type="journal" id="cit177"><name name-style="western"><surname>Jorgensen</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>Modeling Substrate
Entry into the P-Glycoprotein Efflux Pump at the Blood&#8211;Brain
Barrier</article-title>. <source>J. Med. Chem.</source><year>2023</year>, <volume>66</volume> (<issue>24</issue>), <fpage>16615</fpage>&#8211;<lpage>16627</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.3c01069</pub-id>.<pub-id pub-id-type="pmid">38097510</pub-id><pub-id pub-id-type="pmcid">PMC12036829</pub-id></mixed-citation></ref><ref id="ref178"><mixed-citation publication-type="journal" id="cit178"><name name-style="western"><surname>Meng</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Ellens</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Bentz</surname><given-names>J.</given-names></name><article-title>Extrapolation
of Elementary
Rate Constants of P-Glycoprotein&#8211;Mediated Transport from MDCKII-HMDR1-NKI
to Caco-2 Cells</article-title>. <source>Drug Metab. Dispos.</source><year>2017</year>, <volume>45</volume> (<issue>2</issue>), <fpage>190</fpage>&#8211;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.116.072140</pub-id>.<pub-id pub-id-type="pmid">27856526</pub-id></mixed-citation></ref><ref id="ref179"><mixed-citation publication-type="journal" id="cit179"><name name-style="western"><surname>Andreone</surname><given-names>B. J.</given-names></name>; <name name-style="western"><surname>Chow</surname><given-names>B. W.</given-names></name>; <name name-style="western"><surname>Tata</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lacoste</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Ben-Zvi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bullock</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Deik</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Ginty</surname><given-names>D. D.</given-names></name>; <name name-style="western"><surname>Clish</surname><given-names>C. B.</given-names></name>; <name name-style="western"><surname>Gu</surname><given-names>C.</given-names></name><article-title>Blood-Brain Barrier Permeability
Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated
Transcytosis</article-title>. <source>Neuron</source><year>2017</year>, <volume>94</volume> (<issue>3</issue>), <fpage>581</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.043</pub-id>.<pub-id pub-id-type="pmid">28416077</pub-id><pub-id pub-id-type="pmcid">PMC5474951</pub-id></mixed-citation></ref><ref id="ref180"><mixed-citation publication-type="journal" id="cit180"><name name-style="western"><surname>Andreone</surname><given-names>B. J.</given-names></name>; <name name-style="western"><surname>Chow</surname><given-names>B. W.</given-names></name>; <name name-style="western"><surname>Tata</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lacoste</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Ben-Zvi</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Bullock</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Deik</surname><given-names>A. A.</given-names></name>; <name name-style="western"><surname>Ginty</surname><given-names>D. D.</given-names></name>; <name name-style="western"><surname>Clish</surname><given-names>C. B.</given-names></name>; <name name-style="western"><surname>Gu</surname><given-names>C.</given-names></name><article-title>Blood-Brain Barrier
Permeability
Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated
Transcytosis</article-title>. <source>Neuron</source><year>2017</year>, <volume>94</volume> (<issue>3</issue>), <fpage>581</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.043</pub-id>.<pub-id pub-id-type="pmid">28416077</pub-id><pub-id pub-id-type="pmcid">PMC5474951</pub-id></mixed-citation></ref><ref id="ref181"><mixed-citation publication-type="journal" id="cit181"><name name-style="western"><surname>Stevens</surname><given-names>J. A.</given-names></name>; <name name-style="western"><surname>Gr&#252;newald</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>van Tilburg</surname><given-names>P. A. M.</given-names></name>; <name name-style="western"><surname>K&#246;nig</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Gilbert</surname><given-names>B. R.</given-names></name>; <name name-style="western"><surname>Brier</surname><given-names>T. A.</given-names></name>; <name name-style="western"><surname>Thornburg</surname><given-names>Z. R.</given-names></name>; <name name-style="western"><surname>Luthey-Schulten</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Marrink</surname><given-names>S. J.</given-names></name><article-title>Molecular Dynamics
Simulation of
an Entire Cell</article-title>. <source>Front. Chem.</source><year>2023</year>, <volume>11</volume>, <fpage>1106495</fpage><pub-id pub-id-type="doi">10.3389/fchem.2023.1106495</pub-id>.<pub-id pub-id-type="pmid">36742032</pub-id><pub-id pub-id-type="pmcid">PMC9889929</pub-id></mixed-citation></ref><ref id="ref182"><mixed-citation publication-type="journal" id="cit182"><name name-style="western"><surname>Rapoport</surname><given-names>S. I.</given-names></name>; <name name-style="western"><surname>Ohno</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Pettigrew</surname><given-names>K. D.</given-names></name><article-title>Drug Entry
into the Brain</article-title>. <source>Brain Res.</source><year>1979</year>, <volume>172</volume> (<issue>2</issue>), <fpage>354</fpage>&#8211;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(79)90546-8</pub-id>.<pub-id pub-id-type="pmid">466480</pub-id></mixed-citation></ref><ref id="ref183"><mixed-citation publication-type="journal" id="cit183"><name name-style="western"><surname>Collins</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Dedrick</surname><given-names>R. L.</given-names></name><article-title>Distributed Model
for Drug Delivery
to CSF and Brain Tissue</article-title>. <source>American Journal of
Physiology-Regulatory, Integrative and Comparative Physiology</source><year>1983</year>, <volume>245</volume> (<issue>3</issue>), <fpage>R303</fpage>&#8211;<lpage>R310</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.1983.245.3.R303</pub-id>.<pub-id pub-id-type="pmid">6614201</pub-id></mixed-citation></ref><ref id="ref184"><mixed-citation publication-type="journal" id="cit184"><name name-style="western"><surname>Kielbasa</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Kalvass</surname><given-names>J. C.</given-names></name>; <name name-style="western"><surname>Stratford</surname><given-names>R.</given-names></name><article-title>Microdialysis
Evaluation of Atomoxetine Brain Penetration and Central Nervous System
Pharmacokinetics in Rats</article-title>. <source>Drug metabolism and
disposition</source><year>2009</year>, <volume>37</volume> (<issue>1</issue>), <fpage>137</fpage>&#8211;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.108.023119</pub-id>.<pub-id pub-id-type="pmid">18936112</pub-id></mixed-citation></ref><ref id="ref185"><mixed-citation publication-type="journal" id="cit185"><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Welty</surname><given-names>D. R.</given-names></name><article-title>The Simultaneous Estimation of the
Influx and Efflux Blood-Brain Barrier Permeabilities of Gabapentin
Using a Microdialysis-Pharmacokinetic Approach</article-title>. <source>Pharm. Res.</source><year>1996</year>, <volume>13</volume>, <fpage>398</fpage>&#8211;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1023/A:1016092525901</pub-id>.<pub-id pub-id-type="pmid">8692732</pub-id></mixed-citation></ref><ref id="ref186"><mixed-citation publication-type="journal" id="cit186"><name name-style="western"><surname>Dufek</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Knight</surname><given-names>B. M.</given-names></name>; <name name-style="western"><surname>Bridges</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Thakker</surname><given-names>D. R.</given-names></name><article-title>P-Glycoprotein
Increases Portal Bioavailability of Loperamide in Mouse by Reducing
First-Pass Intestinal Metabolism</article-title>. <source>Drug Metab.
Dispos.</source><year>2013</year>, <volume>41</volume> (<issue>3</issue>), <fpage>642</fpage>&#8211;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.112.049965</pub-id>.<pub-id pub-id-type="pmid">23288866</pub-id></mixed-citation></ref><ref id="ref187"><mixed-citation publication-type="journal" id="cit187"><name name-style="western"><surname>Wandel</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Wood</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Wood</surname><given-names>A.</given-names></name><article-title>Interaction
of Morphine, Fentanyl, Sufentanil, Alfentanil, and Loperamide with
the Efflux Drug Transporter P-Glycoprotein</article-title>. <source>Journal of the American Society of Anesthesiologists</source><year>2002</year>, <volume>96</volume> (<issue>4</issue>), <fpage>913</fpage>&#8211;<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1097/00000542-200204000-00019</pub-id>.<pub-id pub-id-type="pmid">11964599</pub-id></mixed-citation></ref><ref id="ref188"><mixed-citation publication-type="journal" id="cit188"><name name-style="western"><surname>Seleman</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Chapy</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Cisternino</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Courtin</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Smirnova</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Schlatter</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Chiadmi</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Scherrmann</surname><given-names>J.-M.</given-names></name>; <name name-style="western"><surname>Noble</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Marie-Claire</surname><given-names>C.</given-names></name><article-title>Impact of
P-Glycoprotein at the Blood-Brain Barrier on the Uptake of Heroin
and Its Main Metabolites: Behavioral Effects and Consequences on the
Transcriptional Responses and Reinforcing Properties</article-title>. <source>Psychopharmacology (Berl)</source><year>2014</year>, <volume>231</volume>, <fpage>3139</fpage>&#8211;<lpage>3149</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-014-3490-9</pub-id>.<pub-id pub-id-type="pmid">24705903</pub-id></mixed-citation></ref><ref id="ref189"><mixed-citation publication-type="journal" id="cit189"><name name-style="western"><surname>Yousif</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Saubam&#233;a</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Cisternino</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Marie-Claire</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Dauchy</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Scherrmann</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Decl&#232;ves</surname><given-names>X.</given-names></name><article-title>Effect of Chronic Exposure to Morphine on the Rat Blood&#8211;Brain
Barrier: Focus on the P-glycoprotein</article-title>. <source>J. Neurochem</source><year>2008</year>, <volume>107</volume> (<issue>3</issue>), <fpage>647</fpage>&#8211;<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05647.x</pub-id>.<pub-id pub-id-type="pmid">18761714</pub-id></mixed-citation></ref><ref id="ref190"><mixed-citation publication-type="journal" id="cit190"><name name-style="western"><surname>Bien-Ly</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>Yu</surname><given-names>Y. J.</given-names></name>; <name name-style="western"><surname>Bumbaca</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Elstrott</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Boswell</surname><given-names>C. A.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Luk</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Lu</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Dennis</surname><given-names>M. S.</given-names></name>; <name name-style="western"><surname>Weimer</surname><given-names>R. M.</given-names></name>; et al. <article-title>Transferrin Receptor
(TfR) Trafficking Determines Brain Uptake of TfR Antibody Affinity
Variants</article-title>. <source>J. Exp. Med.</source><year>2014</year>, <volume>211</volume> (<issue>2</issue>), <fpage>233</fpage><pub-id pub-id-type="doi">10.1084/jem.20131660</pub-id>.<pub-id pub-id-type="pmid">24470444</pub-id><pub-id pub-id-type="pmcid">PMC3920563</pub-id></mixed-citation></ref><ref id="ref191"><mixed-citation publication-type="journal" id="cit191"><name name-style="western"><surname>Zhao</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Zhang</surname><given-names>N.</given-names></name>; <name name-style="western"><surname>An</surname><given-names>Z.</given-names></name><article-title>Engineering
Antibody
and Protein Therapeutics to Cross the Blood&#8211;Brain Barrier</article-title>. <source>Antib Ther</source><year>2022</year>, <volume>5</volume> (<issue>4</issue>), <fpage>311</fpage>&#8211;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1093/abt/tbac028</pub-id>.<pub-id pub-id-type="pmid">36540309</pub-id><pub-id pub-id-type="pmcid">PMC9759110</pub-id></mixed-citation></ref><ref id="ref192"><mixed-citation publication-type="journal" id="cit192"><name name-style="western"><surname>Edavettal</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Cejudo-Martin</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Dasgupta</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Yang</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Buschman</surname><given-names>M. D.</given-names></name>; <name name-style="western"><surname>Domingo</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Van Kolen</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Jaiprasat</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Gordon</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Schutsky</surname><given-names>K.</given-names></name>; et al. <article-title>Enhanced
Delivery of Antibodies across the Blood-Brain Barrier via TEMs with
Inherent Receptor-Mediated Phagocytosis</article-title>. <source>Med</source><year>2022</year>, <volume>3</volume> (<issue>12</issue>), <fpage>860</fpage>&#8211;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1016/j.medj.2022.09.007</pub-id>.<pub-id pub-id-type="pmid">36257298</pub-id></mixed-citation></ref><ref id="ref193"><mixed-citation publication-type="journal" id="cit193"><name name-style="western"><surname>Ebert</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Dahley</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Goss</surname><given-names>K.-U.</given-names></name><article-title>Pitfalls in Evaluating
Permeability Experiments with Caco-2/MDCK Cell Monolayers</article-title>. <source>European Journal of Pharmaceutical Sciences</source><year>2024</year>, <volume>194</volume>, <elocation-id>106699</elocation-id><pub-id pub-id-type="doi">10.1016/j.ejps.2024.106699</pub-id>.<pub-id pub-id-type="pmid">38232636</pub-id></mixed-citation></ref><ref id="ref194"><mixed-citation publication-type="journal" id="cit194"><name name-style="western"><surname>Bittermann</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Goss</surname><given-names>K.-U.</given-names></name><article-title>Predicting Apparent
Passive Permeability
of Caco-2 and MDCK Cell-Monolayers: A Mechanistic Model</article-title>. <source>PLoS One</source><year>2017</year>, <volume>12</volume> (<issue>12</issue>), <elocation-id>e0190319</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0190319</pub-id>.<pub-id pub-id-type="pmid">29281711</pub-id><pub-id pub-id-type="pmcid">PMC5744993</pub-id></mixed-citation></ref><ref id="ref195"><mixed-citation publication-type="journal" id="cit195"><name name-style="western"><surname>Volpe</surname><given-names>D. A.</given-names></name><article-title>Variability in Caco-2 and MDCK Cell-Based
Intestinal
Permeability Assays</article-title>. <source>J. Pharm. Sci.</source><year>2008</year>, <volume>97</volume> (<issue>2</issue>), <fpage>712</fpage>&#8211;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1002/jps.21010</pub-id>.<pub-id pub-id-type="pmid">17542022</pub-id></mixed-citation></ref><ref id="ref196"><mixed-citation publication-type="journal" id="cit196"><name name-style="western"><surname>Easton</surname><given-names>A. S.</given-names></name>; <name name-style="western"><surname>Sarker</surname><given-names>M. H.</given-names></name>; <name name-style="western"><surname>Fraser</surname><given-names>P. A.</given-names></name><article-title>Two Components
of
Blood-brain Barrier Disruption in the Rat</article-title>. <source>J.
Physiol</source><year>1997</year>, <volume>503</volume> (<issue>3</issue>), <fpage>613</fpage>&#8211;<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1997.613bg.x</pub-id>.<pub-id pub-id-type="pmid">9379415</pub-id><pub-id pub-id-type="pmcid">PMC1159845</pub-id></mixed-citation></ref><ref id="ref197"><mixed-citation publication-type="journal" id="cit197"><name name-style="western"><surname>Yuan</surname><given-names>W.</given-names></name>; <name name-style="western"><surname>Lv</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Zeng</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Fu</surname><given-names>B. M.</given-names></name><article-title>Non-Invasive
Measurement of Solute Permeability in Cerebral Microvessels of the
Rat</article-title>. <source>Microvasc Res.</source><year>2009</year>, <volume>77</volume> (<issue>2</issue>), <fpage>166</fpage>&#8211;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.mvr.2008.08.004</pub-id>.<pub-id pub-id-type="pmid">18838082</pub-id></mixed-citation></ref><ref id="ref198"><mixed-citation publication-type="journal" id="cit198"><name name-style="western"><surname>Campisi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Shin</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Osaki</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Hajal</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chiono</surname><given-names>V.</given-names></name>; <name name-style="western"><surname>Kamm</surname><given-names>R. D.</given-names></name><article-title>3D Self-Organized
Microvascular Model
of the Human Blood-Brain Barrier with Endothelial Cells Pericytes
and Astrocytes</article-title>. <source>Biomaterials</source><year>2018</year>, <volume>180</volume>, <fpage>117</fpage>&#8211;<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.07.014</pub-id>.<pub-id pub-id-type="pmid">30032046</pub-id><pub-id pub-id-type="pmcid">PMC6201194</pub-id></mixed-citation></ref><ref id="ref199"><mixed-citation publication-type="journal" id="cit199"><name name-style="western"><surname>Dong</surname><given-names>X.</given-names></name><article-title>Current Strategies for Brain Drug
Delivery</article-title>. <source>Theranostics</source><year>2018</year>, <volume>8</volume> (<issue>6</issue>), <fpage>1481</fpage><pub-id pub-id-type="doi">10.7150/thno.21254</pub-id>.<pub-id pub-id-type="pmid">29556336</pub-id><pub-id pub-id-type="pmcid">PMC5858162</pub-id></mixed-citation></ref><ref id="ref200"><mixed-citation publication-type="journal" id="cit200"><name name-style="western"><surname>Gonz&#225;lez-Mariscal</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Posadas</surname><given-names>Y.</given-names></name>; <name name-style="western"><surname>Miranda</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Uc</surname><given-names>P. Y.</given-names></name>; <name name-style="western"><surname>Ortega-Olvera</surname><given-names>J. M.</given-names></name>; <name name-style="western"><surname>Hern&#225;ndez</surname><given-names>S.</given-names></name><article-title>Strategies
That Target Tight Junctions for Enhanced Drug Delivery</article-title>. <source>Curr. Pharm. Des</source><year>2016</year>, <volume>22</volume> (<issue>35</issue>), <fpage>5313</fpage>&#8211;<lpage>5346</lpage>. <pub-id pub-id-type="doi">10.2174/1381612822666160720163656</pub-id>.<pub-id pub-id-type="pmid">27510485</pub-id></mixed-citation></ref><ref id="ref201"><mixed-citation publication-type="journal" id="cit201"><name name-style="western"><surname>Linville</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>DeStefano</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Sklar</surname><given-names>M. B.</given-names></name>; <name name-style="western"><surname>Chu</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Walczak</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>Modeling
Hyperosmotic Blood&#8211;Brain
Barrier Opening within Human Tissue-Engineered in Vitro Brain Microvessels</article-title>. <source>Journal of Cerebral Blood Flow &amp; Metabolism</source><year>2020</year>, <volume>40</volume> (<issue>7</issue>), <fpage>1517</fpage>&#8211;<lpage>1532</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X19867980</pub-id>.<pub-id pub-id-type="pmid">31394959</pub-id><pub-id pub-id-type="pmcid">PMC7308510</pub-id></mixed-citation></ref><ref id="ref202"><mixed-citation publication-type="journal" id="cit202"><name name-style="western"><surname>Brocke</surname><given-names>S. A.</given-names></name>; <name name-style="western"><surname>Degen</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>MacKerell</surname><given-names>A. D.</given-names><suffix>Jr</suffix></name>; <name name-style="western"><surname>Dutagaci</surname><given-names>B.</given-names></name>; <name name-style="western"><surname>Feig</surname><given-names>M.</given-names></name><article-title>Prediction of Membrane
Permeation of Drug Molecules by Combining an Implicit Membrane Model
with Machine Learning</article-title>. <source>J. Chem. Inf Model</source><year>2019</year>, <volume>59</volume> (<issue>3</issue>), <fpage>1147</fpage>&#8211;<lpage>1162</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00648</pub-id>.<pub-id pub-id-type="pmid">30540459</pub-id><pub-id pub-id-type="pmcid">PMC6433486</pub-id></mixed-citation></ref><ref id="ref203"><mixed-citation publication-type="journal" id="cit203"><name name-style="western"><surname>Abraham</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Apostolov</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Barnoud</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bauer</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Blau</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Bonvin</surname><given-names>A. M. J. J.</given-names></name>; <name name-style="western"><surname>Chavent</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Chodera</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>&#268;ondi&#263;-Jurki&#263;</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Delemotte</surname><given-names>L.</given-names></name><article-title>Sharing Data
from Molecular Simulations</article-title>. <source>J. Chem. Inf. Model</source><year>2019</year>, <volume>59</volume> (<issue>10</issue>), <fpage>4093</fpage>&#8211;<lpage>4099</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00665</pub-id>.<pub-id pub-id-type="pmid">31525920</pub-id></mixed-citation></ref><ref id="ref204"><mixed-citation publication-type="undeclared" id="cit204"><person-group person-group-type="allauthors"><name name-style="western"><surname>Amaro</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>&#197;qvist</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Bahar</surname><given-names>I.</given-names></name>; <name name-style="western"><surname>Battistini</surname><given-names>F.</given-names></name>; <name name-style="western"><surname>Bellaiche</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Beltran</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Biggin</surname><given-names>P. C.</given-names></name>; <name name-style="western"><surname>Bonomi</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bowman</surname><given-names>G. R.</given-names></name>; <name name-style="western"><surname>Bryce</surname><given-names>R.</given-names></name></person-group><article-title>The Need to Implement FAIR Principles
in Biomolecular Simulations</article-title>. <source>arXiv</source> preprint <elocation-id>arXiv:2407.16584</elocation-id>, <year>2024</year>.</mixed-citation></ref><ref id="ref205"><mixed-citation publication-type="journal" id="cit205"><name name-style="western"><surname>Tiemann</surname><given-names>J. K. S.</given-names></name>; <name name-style="western"><surname>Szczuka</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Bouarroudj</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Oussaren</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Garcia</surname><given-names>S.</given-names></name>; <name name-style="western"><surname>Howard</surname><given-names>R. J.</given-names></name>; <name name-style="western"><surname>Delemotte</surname><given-names>L.</given-names></name>; <name name-style="western"><surname>Lindahl</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Baaden</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Lindorff-Larsen</surname><given-names>K.</given-names></name>; et al. <article-title>MDverse, Shedding Light on the Dark Matter of Molecular Dynamics
Simulations</article-title>. <source>Elife</source><year>2024</year>, <volume>12</volume>, <elocation-id>RP90061</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.90061</pub-id>.<pub-id pub-id-type="pmid">39212001</pub-id><pub-id pub-id-type="pmcid">PMC11364437</pub-id></mixed-citation></ref><ref id="ref206"><mixed-citation publication-type="journal" id="cit206"><name name-style="western"><surname>Soares</surname><given-names>T. A.</given-names></name>; <name name-style="western"><surname>Cournia</surname><given-names>Z.</given-names></name>; <name name-style="western"><surname>Naidoo</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Amaro</surname><given-names>R.</given-names></name>; <name name-style="western"><surname>Wahab</surname><given-names>H.</given-names></name>; <name name-style="western"><surname>Merz</surname><given-names>K. M.</given-names><suffix>Jr</suffix></name><article-title>Guidelines for
Reporting Molecular Dynamics Simulations in JCIM Publications</article-title>. <source>J. Chem. Inf. Model.</source><year>2023</year>, <volume>63</volume>, <fpage>3227</fpage>&#8211;<lpage>3229</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.3c00599</pub-id>.<pub-id pub-id-type="pmid">37191169</pub-id></mixed-citation></ref><ref id="ref207"><mixed-citation publication-type="journal" id="cit207"><name name-style="western"><surname>Clough</surname><given-names>E.</given-names></name>; <name name-style="western"><surname>Barrett</surname><given-names>T.</given-names></name>; <name name-style="western"><surname>Wilhite</surname><given-names>S. E.</given-names></name>; <name name-style="western"><surname>Ledoux</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Evangelista</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Kim</surname><given-names>I. F.</given-names></name>; <name name-style="western"><surname>Tomashevsky</surname><given-names>M.</given-names></name>; <name name-style="western"><surname>Marshall</surname><given-names>K. A.</given-names></name>; <name name-style="western"><surname>Phillippy</surname><given-names>K. H.</given-names></name>; <name name-style="western"><surname>Sherman</surname><given-names>P. M.</given-names></name>; et al. <article-title>NCBI
GEO: Archive for Gene Expression and Epigenomics Data Sets: 23-Year
Update</article-title>. <source>Nucleic Acids Res.</source><year>2024</year>, <volume>52</volume> (<issue>D1</issue>), <fpage>D138</fpage>&#8211;<lpage>D144</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkad965</pub-id>.<pub-id pub-id-type="pmid">37933855</pub-id><pub-id pub-id-type="pmcid">PMC10767856</pub-id></mixed-citation></ref><ref id="ref208"><mixed-citation publication-type="journal" id="cit208"><name name-style="western"><surname>Pohorille</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Jarzynski</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Chipot</surname><given-names>C.</given-names></name><article-title>Good Practices in Free-Energy
Calculations</article-title>. <source>J. Phys. Chem. B</source><year>2010</year>, <volume>114</volume> (<issue>32</issue>), <fpage>10235</fpage>&#8211;<lpage>10253</lpage>. <pub-id pub-id-type="doi">10.1021/jp102971x</pub-id>.<pub-id pub-id-type="pmid">20701361</pub-id></mixed-citation></ref><ref id="ref209"><mixed-citation publication-type="journal" id="cit209"><name name-style="western"><surname>Fitzgerald</surname><given-names>J. E.</given-names></name>; <name name-style="western"><surname>Venable</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Pastor</surname><given-names>R. W.</given-names></name>; <name name-style="western"><surname>Lyman</surname><given-names>E. R.</given-names></name><article-title>Surface
Viscosities of Lipid Bilayers Determined from Equilibrium Molecular
Dynamics Simulations</article-title>. <source>Biophys. J.</source><year>2023</year>, <volume>122</volume> (<issue>6</issue>), <fpage>1094</fpage>&#8211;<lpage>1104</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2023.01.038</pub-id>.<pub-id pub-id-type="pmid">36739477</pub-id><pub-id pub-id-type="pmcid">PMC10111272</pub-id></mixed-citation></ref><ref id="ref210"><mixed-citation publication-type="journal" id="cit210"><name name-style="western"><surname>Camley</surname><given-names>B. A.</given-names></name>; <name name-style="western"><surname>Lerner</surname><given-names>M. G.</given-names></name>; <name name-style="western"><surname>Pastor</surname><given-names>R. W.</given-names></name>; <name name-style="western"><surname>Brown</surname><given-names>F. L. H.</given-names></name><article-title>Strong
Influence of Periodic Boundary Conditions on Lateral Diffusion in
Lipid Bilayer Membranes</article-title>. <source>J. Chem. Phys.</source><year>2015</year>, <pub-id pub-id-type="doi">10.1063/1.4932980</pub-id>.<pub-id pub-id-type="pmcid">PMC4608966</pub-id><pub-id pub-id-type="pmid">26723598</pub-id></mixed-citation></ref><ref id="ref211"><mixed-citation publication-type="journal" id="cit211"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Wolf</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Caldwell</surname><given-names>J. W.</given-names></name>; <name name-style="western"><surname>Kollman</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Case</surname><given-names>D. A.</given-names></name><article-title>Development and Testing of a General
Amber Force Field</article-title>. <source>J. Comput. Chem.</source><year>2004</year>, <volume>25</volume> (<issue>9</issue>), <fpage>1157</fpage>&#8211;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20035</pub-id>.<pub-id pub-id-type="pmid">15116359</pub-id></mixed-citation></ref><ref id="ref212"><mixed-citation publication-type="journal" id="cit212"><name name-style="western"><surname>Vanommeslaeghe</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>MacKerell</surname><given-names>A. D.</given-names><suffix>Jr</suffix></name><article-title>Automation of
the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom
Typing</article-title>. <source>J. Chem. Inf Model</source><year>2012</year>, <volume>52</volume> (<issue>12</issue>), <fpage>3144</fpage>&#8211;<lpage>3154</lpage>. <pub-id pub-id-type="doi">10.1021/ci300363c</pub-id>.<pub-id pub-id-type="pmid">23146088</pub-id><pub-id pub-id-type="pmcid">PMC3528824</pub-id></mixed-citation></ref><ref id="ref213"><mixed-citation publication-type="journal" id="cit213"><name name-style="western"><surname>Valcourt</surname><given-names>D. M.</given-names></name>; <name name-style="western"><surname>Kapadia</surname><given-names>C. H.</given-names></name>; <name name-style="western"><surname>Scully</surname><given-names>M. A.</given-names></name>; <name name-style="western"><surname>Dang</surname><given-names>M. N.</given-names></name>; <name name-style="western"><surname>Day</surname><given-names>E. S.</given-names></name><article-title>Best Practices for Preclinical in
Vivo Testing of Cancer
Nanomedicines</article-title>. <source>Adv. Healthc. Mater.</source><year>2020</year>, <volume>9</volume> (<issue>12</issue>), <elocation-id>2000110</elocation-id><pub-id pub-id-type="doi">10.1002/adhm.202000110</pub-id>.<pub-id pub-id-type="pmcid">PMC7473451</pub-id><pub-id pub-id-type="pmid">32367687</pub-id></mixed-citation></ref><ref id="ref214"><mixed-citation publication-type="journal" id="cit214"><name name-style="western"><surname>Saunders</surname><given-names>N. R.</given-names></name>; <name name-style="western"><surname>Dreifuss</surname><given-names>J.-J.</given-names></name>; <name name-style="western"><surname>Dziegielewska</surname><given-names>K. M.</given-names></name>; <name name-style="western"><surname>Johansson</surname><given-names>P. A.</given-names></name>; <name name-style="western"><surname>Habgood</surname><given-names>M. D.</given-names></name>; <name name-style="western"><surname>Mo&#823;llg&#229;rd</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Bauer</surname><given-names>H.-C.</given-names></name><article-title>The Rights and Wrongs of Blood-Brain Barrier Permeability
Studies: A Walk through 100 Years of History</article-title>. <source>Front. Neurosci.</source><year>2014</year>, <volume>8</volume>, <fpage>404</fpage><pub-id pub-id-type="doi">10.3389/fnins.2014.00404</pub-id>.<pub-id pub-id-type="pmid">25565938</pub-id><pub-id pub-id-type="pmcid">PMC4267212</pub-id></mixed-citation></ref><ref id="ref215"><mixed-citation publication-type="journal" id="cit215"><name name-style="western"><surname>Bernas</surname><given-names>M. J.</given-names></name>; <name name-style="western"><surname>Cardoso</surname><given-names>F. L.</given-names></name>; <name name-style="western"><surname>Daley</surname><given-names>S. K.</given-names></name>; <name name-style="western"><surname>Weinand</surname><given-names>M. E.</given-names></name>; <name name-style="western"><surname>Campos</surname><given-names>A. R.</given-names></name>; <name name-style="western"><surname>Ferreira</surname><given-names>A. J. G.</given-names></name>; <name name-style="western"><surname>Hoying</surname><given-names>J. B.</given-names></name>; <name name-style="western"><surname>Witte</surname><given-names>M. H.</given-names></name>; <name name-style="western"><surname>Brites</surname><given-names>D.</given-names></name>; <name name-style="western"><surname>Persidsky</surname><given-names>Y.</given-names></name>; et al. <article-title>Establishment of Primary
Cultures of Human Brain Microvascular Endothelial Cells to Provide
an in Vitro Cellular Model of the Blood-Brain Barrier</article-title>. <source>Nat. Protoc.</source><year>2010</year>, <volume>5</volume> (<issue>7</issue>), <fpage>1265</fpage>&#8211;<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2010.76</pub-id>.<pub-id pub-id-type="pmid">20595955</pub-id><pub-id pub-id-type="pmcid">PMC3109429</pub-id></mixed-citation></ref><ref id="ref216"><mixed-citation publication-type="journal" id="cit216"><name name-style="western"><surname>Mensch</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Oyarzabal</surname><given-names>J.</given-names></name>; <name name-style="western"><surname>Mackie</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Augustijns</surname><given-names>P.</given-names></name><article-title>In Vivo, in
Vitro and in Silico Methods for Small Molecule Transfer across the
BBB</article-title>. <source>J. Pharm. Sci.</source><year>2009</year>, <volume>98</volume> (<issue>12</issue>), <fpage>4429</fpage>&#8211;<lpage>4468</lpage>. <pub-id pub-id-type="doi">10.1002/jps.21745</pub-id>.<pub-id pub-id-type="pmid">19408294</pub-id></mixed-citation></ref><ref id="ref217"><mixed-citation publication-type="journal" id="cit217"><name name-style="western"><surname>Hummer</surname><given-names>G.</given-names></name><article-title>Position-Dependent Diffusion Coefficients
and Free
Energies from Bayesian Analysis of Equilibrium and Replica Molecular
Dynamics Simulations</article-title>. <source>New J. Phys.</source><year>2005</year>, <volume>7</volume> (<issue>1</issue>), <fpage>34</fpage><pub-id pub-id-type="doi">10.1088/1367-2630/7/1/034</pub-id>.</mixed-citation></ref><ref id="ref218"><mixed-citation publication-type="journal" id="cit218"><name name-style="western"><surname>Linville</surname><given-names>R. M.</given-names></name>; <name name-style="western"><surname>Komin</surname><given-names>A.</given-names></name>; <name name-style="western"><surname>Lan</surname><given-names>X.</given-names></name>; <name name-style="western"><surname>DeStefano</surname><given-names>J. G.</given-names></name>; <name name-style="western"><surname>Chu</surname><given-names>C.</given-names></name>; <name name-style="western"><surname>Liu</surname><given-names>G.</given-names></name>; <name name-style="western"><surname>Walczak</surname><given-names>P.</given-names></name>; <name name-style="western"><surname>Hristova</surname><given-names>K.</given-names></name>; <name name-style="western"><surname>Searson</surname><given-names>P. C.</given-names></name><article-title>Reversible
Blood-Brain Barrier Opening Utilizing the Membrane Active Peptide
Melittin in Vitro and in Vivo</article-title>. <source>Biomaterials</source><year>2021</year>, <volume>275</volume>, <elocation-id>120942</elocation-id><pub-id pub-id-type="doi">10.1016/j.biomaterials.2021.120942</pub-id>.<pub-id pub-id-type="pmid">34147718</pub-id><pub-id pub-id-type="pmcid">PMC8330225</pub-id></mixed-citation></ref><ref id="ref219"><mixed-citation publication-type="journal" id="cit219"><name name-style="western"><surname>Ulmschneider</surname><given-names>J. P.</given-names></name>; <name name-style="western"><surname>Ulmschneider</surname><given-names>M. B.</given-names></name><article-title>Melittin
Can Permeabilize Membranes
via Large Transient Pores</article-title>. <source>Nat. Commun.</source><year>2024</year>, <volume>15</volume> (<issue>1</issue>), <fpage>7281</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-51691-1</pub-id>.<pub-id pub-id-type="pmid">39179607</pub-id><pub-id pub-id-type="pmcid">PMC11343860</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>